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ABSTRACT 
 
 
Genetic diversity generates variation at multiple phenotypic levels, ranging from 
the most basic molecular to higher-order cognitive and behavioral traits. The far-reaching 
impact that genes have on higher traits is apparent in several neuropsychiatric conditions 
such as stress and anxiety disorders. Like most, if not all, neural phenotypes, stress, 
anxiety, and other emotion-related traits are extremely complex and are defined by the 
interplay of multiple genetic, environmental, experiential, and epigenetic factors.  
 
The work presented in this dissertation is a multi-scalar, integrative analysis of the 
molecular and neuroanatomic substrates that underlie emotion-related behavior. The 
amygdala is a principle component of the limbic system that controls emotionality. Using 
BXD recombinant inbred (RI) mice as model organisms, the anatomy and cellular 
architecture of the amygdala—specifically, the basolateral amygdala (BLA)—was 
examined to assess the level of structural variation in this brain region. Quantitative trait 
locus (QTL) analysis was done to identify genetic loci that modulate the neuroanatomical 
traits of the BLA. The BXD RI mice were also tested using a variety of behavioral 
assays, and this showed a significant association between the BLA size and emotion-
related behavior. The effect of chronic stress on subsequent behavior and endocrine-
response was also examined in several genetically diverse inbred mice.  
 
Finally, to explore the molecular mediators of stress and anxiety, microarrays 
were used to assay gene expression in three key corticolimbic brain regions—the 
prefrontal cortex, amygdala, and hippocampus. Several large transcriptome data sets were 
also analyzed. These expression data sets brought focus on an interval on mouse distal 
chromosome 1 that modulates diverse neural and behavioral traits, and also controls the 
expression of a plethora of genes. This QTL rich region on mouse distal chromosome 1 
(Qrr1) provides insights into how the information in the DNA sequence is conveyed by 
networks of co-regulated genes that may in turn modulate networks of inter-related 
phenotypes. 
 v 
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CHAPTER 1. INTRODUCTION 
 
 
1.1 Complex Traits 
 
A major goal of genetics is to understand how variation in DNA sequence gives 
rise to the myriad of individual characteristics that influence traits such as vulnerability to 
diseases, physiological makeup, susceptibility to substance abuse and addiction, and even 
personality and behavior. There are few cases in which the link between genotype and 
phenotype is simple enough that a trait can be traced to a single causal mutation. For 
example, sickle cell anemia, the first disease identified to have a genetic basis, is caused 
by a single point mutation in the !-globin gene (Pauling et al., 1949; Ingram, 1958). 
However, unlike such a monogenic trait, most traits and diseases are complex and result 
from the interplay of multiple genetic, epigenetic, and environmental factors. Complex 
diseases with polygenics origins include metabolic disorders like hypercholesterolemia 
and diabetes, and neuropsychiatric disorders like schizophrenia, bipolar disorder, and 
stress and anxiety disorders (Riley & Kendler, 2006; Hovatta & Barlow, 2007; Sklar et 
al., 2008). 
 
Even in cases in which a single gene is strongly associated with a particular trait, 
the consequence on the phenotype may vary depending on the type of allelic variation. 
For example, a rare functionally deleterious knockout mutation in monoamine oxidase A 
(MAOA), a gene involved in neurotransmitter degradation, has been shown to cause 
violent aggressive behavior in males (Brunner et al., 1993). While this starkly 
demonstrates the profound influence genetic variation can have on human behavior, a 
more subtle effect of MAOA is seen when the DNA sequence variation is in the promoter 
region and effects variation in transcription efficiency rather than protein function (Caspi 
et al., 2002). This results in either high or low mRNA levels in individuals carrying the 
different alleles. The low expressing variant is associated with violent behavior but this 
behavioral trait develops only in males who experienced childhood mistreatment (Caspi 
et al., 2002). This underscores the fact that the path from the DNA to phenotype is rarely 
straight forward, and the penetrance of a phenotype often depends on environmental 
conditions. 
 
 
1.2 Genetics of Neural and Behavioral Phenotypes 
 
The brain is arguably the most complex organ in the human body. A large fraction 
of the mammalian genome, possibly over 75% of all genes, is recruited in the 
development and maintenance of the brain (Sutcliffe et al., 1988; Peirce & Williams, 
2006). Buttressed by this complex genetics, the brain has an intricate cytoarchitectur, 
composed of multiple morphologically discreet regions. It is the neurophysiology within 
each brain region and the circuitries between them that ultimately mediate the manifold 
functions of the brain and give rise to complex psychological traits and behavior. 
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A fundamental question is—how do structural and physiological differences in 
the neural structures affect function and behavior? And what are the genetic factors that 
contribute to these variations? Psychological traits such as emotional temperament and 
behavioral phenotypes show significant inter-individual variations. In addition to 
environmental factors and life experiences, multiple genetic factors play important roles 
in defining the emotionality and behavior of an individual (Gershenfeld & Paul, 1998). 
The heritability of personality traits has been estimated to be as high as 30–60% 
(Bouchard, 1994; Gershenfeld & Paul, 1998). It is the genetic differences that make one 
individual more vulnerable than another to stressful experiences, and confer risk factors 
for different neuropsychiatric conditions such as depression, anxiety disorders, and 
addiction (Charney & Manji, 2004; Goldman et al., 2005; Hariri & Holmes, 2006; 
Leygraf et al., 2006). 
 
The mouse has been extensively used as a model organism to study the genetics 
of behavior (Gershenfeld & Paul, 1998; Willis-Owen & Flint, 2006). Studying behavior 
in mice affords several advantages that are lacking in human studies. These include the 
ability to strictly control the environment of the animal, to carry out directed mating, and 
the availability of several inbred strains with diverse phenotypic profiles. Different 
behavioral measures have been used as indicators of cognition and emotionality in 
rodents, e.g. open field activity, elevated plus maze, light/dark environment preference, 
fear conditioning, forced swim test etc. These studies have uncovered complex genetics 
underlying behavior with multiple loci modulating stress responsiveness, fear, and 
anxiety levels in mice (Willis-Owen & Flint, 2006). Significant concordance between 
human and mouse traits also exists, e.g., the gene Rgs2 was shown to modulate anxiety in 
mice, and was subsequently found to be associated with anxiety in human (Yalcin et al., 
2004; Smoller et al., 2008). 
 
 
1.3 Neuroanatomy of Stress and Emotion-Related Behavior 
 
The amygdala is a neural structure central to the experience of emotions and 
expression of emotional behavior. Sensory inputs with emotional components are 
transmitted to the amygdala where they are processed and further relayed to other regions 
to modulate autonomic and behavioral responses, and to form emotional memories 
(LeDoux, 2000; Rosen, 2004). As a neural substrate of emotionality, many 
neuropsychiatric disorders have been associated with structural changes in the amygdala. 
Individuals with genetically predisposed susceptibility to anxiety and depression have 
been shown to have higher amygdala reactivity and smaller amygdala volumes (Pezawas 
et al., 2005). Structural changes in the amygdala have also been associated with traumatic 
stress disorder, bipolar disorder, and aggressive behavior (Hayek et al., 2005; Pezawas et 
al., 2005; Meyer-Lindenberg et al., 2006). In addition to the amygdala, abnormalities in 
structures such as the prefrontal cortex, hippocampus and other components of the limbic 
system have also been associated with several neuropsychiatric disorders (Drevets, 2000; 
Hajek et al., 2005; Vermetten et al., 2006).  
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Such associations between neuroanatomy and disease state however do not clarify 
whether the structural abnormalities are the cause or effect of neuropathological 
conditions. Some studies are beginning to indicate that the neuroanatomical traits may 
indeed be predisposing factors for certain disorders. For example, twin studies show that 
smaller hippocampal volume, rather than being a consequence of stress, may be a 
genetically determined phenotype that predisposes an individual to a higher risk for 
developing stress-related disorders (Gilbertson et al., 2002). Structural abnormalities in 
the amygdala and prefrontal cortex may also be preexisting risk factors for bipolar 
disorder (Hajek et al., 2005). These observations imply that some genetic factors may 
have pleiotropic influence on both neuroanatomy and behavior. The genetic analysis of 
relevant neural structures may therefore be invaluable in identifying the genes that 
modulate behavior. 
 
Studies in mice also show that neuroanatomical phenotypes such as the volume 
and cellular composition of the amygdala are highly variable traits with complex 
underlying genetics (Mozhui et al., 2007). And such natural variations in the anatomical 
phenotypes of the amygdala serve as significant predictors of stress-reactivity and fear-
related behaviors (Yang et al., 2008). These studies highlight the inextricable link 
between genetic factors and phenotypes at the structural, physiological, and behavioral 
levels, and calls for an integrative approach to analyze complex traits. 
 
 
1.4 Mapping Loci that Modulate Complex Traits 
 
 
1.4.1 Basics of QTL Analysis 
 
The large majority of biological traits are polygenic and show quantitative (or 
continuous), rather than qualitative (or discreet) variations. For example, body weight, 
brain size, levels of anxiety etc., are traits that show quantitative differences among 
individuals. The genetic regions that harbor the gene variants that contribute to such 
quantitative variations are referred to as quantitative trait loci or QTLs (Lynch & Walsh, 
1998). Both QTLs and Mendelian mutations are, simply put, genetic polymorphisms that 
lead to phenotypic variations; the main distinction between the two types of loci lies in 
the effect size, i.e. the amount of phenotypic variance generated by each locus. In contrast 
to Mendelian phenotypes, complex traits are shaped by the action of multiple QTLs, each 
QTL contributing to only a portion of the variance. In case of behavioral traits, a single 
QTL is estimated to usually contribute to less than 10% of behavioral variance (Flint, 
2003). 
 
Identifying the genetic loci that modulate a trait based on correlation between 
variation in phenotype and variation in genotype is the essence of genetic mapping. This 
first involves systematically genotyping a genetically diverse population using 
microsatellite or SNP markers. The phenotype of interest is then measured and its 
variability in the population assessed. A statistical test is then carried out to identify 
chromosomal regions that segregate with the trait and show linkage with the trait, i.e., 
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identify genetic regions that have the same genotype among individuals with similar trait 
values but differ between individuals with dissimilar trait values. The statistical 
significant of linkage of a QTL with the trait is expressed as the logarithm of odds ratio 
(LOD) or likelihood ratio statistic (LRS) scores with associate p-value. 
 
 
1.4.2 Inbred and Recombinant Inbred Mice 
 
An invaluable resource in the genetic dissection of complex traits is the 
availability of inbred strains of mice that can be used to generate experimental 
populations. At the initial step, two inbred strains with divergent phenotypes are selected 
as parental strains. To illustrate, C57BL/6J (B6) is a relatively seizure resistant strain 
while DBA/2J (D2) is seizure susceptible (Seyfried et al., 1980). Both B6 and D2 have 
been densely genotyped. In order to carry out a complex trait analysis of seizure 
susceptibility, the two strains can be used as parental strains to derive populations in with 
the phenotype and causal gene variants segregate. Firstly, B6 and D2 are crossed to 
generate heterozygous F1 hybrids. These hybrids are generally expected to show traits 
intermediate between the two parents. A population of F2 intercrosses can then be 
derived from the F1s (Figure 1-1). The F2s represent a genetically segregating 
population and will show varying levels of seizure susceptibility depending on the 
combination of alleles inherited from each parent. QTL analysis can be carried out using 
such a collection of F2. 
 
By inbreeding the F2 mice for over 20 generation, inbred mice that are 
recombinants of the parental genotype can be generated (Figure 1-1). An extensively 
used set of recombinant inbred (RI) strains is the BXD RI mice that were derived by 
inbreeding F2 progenies of B6 and D2 parents (Taylor, 1989; Taylor et al., 1999; 
Williams et al., 2001b). About a 100 different BXD RI strains, including advanced RI 
strains (inbred strains derived from progenitor BXD strains) have now been created for 
this mapping panel (Peirce et al., 2004). Such RI mice provide several advantages. Unlike 
F2 intercrosses, which are unique and studies with them irreproducible, RI strains are 
immortal colonies. The first obvious advantage is that multiple cases of the same RI 
strain can be phenotyped and the values averaged to control for environmental noise and 
technical error. Studies using RI strains can also be carried out many times under 
different environmental conditions or using different experimental protocols. Several 
different phenotypes have been measured from the BXDs over the years 
(http://www.genenetwork.org) and this allows comparison and correlation across data 
sets. For example, amygdala volume data that was collected in 2006 can be correlated 
with behavioral data collected in the 1990s to show significant association between the 
size of the amygdala and open field behavior (Jones et al., 1999; Mozhui et al., 2008). 
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Figure 1-1 Genetic segregation in F2 intercrosses and RI strains 
All pairs of autosomal chromosomes (chromosomes 1 to 19) in inbred mice are 
homozygous and carry identical maternal and paternal alleles. This figure illustrates one 
such pair of autosomal chromosome. F1 hybrid crosses are made by mating two parental 
inbred strains, in this case C57BL/6J (B6) and DBA/2J (D2). All mice in the F1 
generation are isogenic and inherit one allele from B6 and the other from D2. Because of 
reciprocal crossover events, the F1 gametes contain chromosomes that are recombinants 
of the two parental chromosomes and mating the F1 mice generates a genetically 
segregating F2 generation. The F2 mice can then be inbred to homozygosity over several 
generations to form strains of inbred mice that are recombinants of the parental 
chromosomes, and hence termed recombinant inbred (RI) strains. 
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1.5 Systems Genetics Approach to Complex Traits 
 
 
1.5.1 Gene Expression as an Intermediate Phenotype 
 
Genetic variation can cause marked differences in gene expression among 
individuals. By setting the rate of transcription and mRNA degradation, and coding for 
allelic variants and alternative splicing, the DNA sequence essentially directs the amount 
and type of RNA and protein produced by each gene. The quantitative and qualitative 
differences in mRNAs and proteins can be considered as phenotypes that are at the most 
basic molecular level (Damerval et al., 1994; de Vienne et al., 1994). Since it is from this 
milieu of molecules that all higher phenotypes emerge, understanding how genetic 
variation modulates gene expression is fundamental to understanding the molecular 
origins of complex traits.  
 
Microarray technology has been a boon in the study of gene expression. This 
technology has made it possible to efficiently profile the expression level of numerous 
genes in genetically diverse populations of organisms, including human and mice. Such 
transcriptomic data have been generate for a wide variety of cell types and tissues, 
including several different neural tissues from experimental mouse populations 
(Hitzemann et al., 2004; Chesler et al., 2005; Peirce et al., 2006; Yang et al., 2006). The 
expression level of an mRNA species can be highly variable and heritable in nature 
(Brem et al., 2002; Schadt et al., 2003; Chesler et al., 2005). Similar to organism-level 
phenotypes (now termed as ‘classical phenotypes’ to distinguish them from molecular 
phenotypes), expression traits can exhibit Mendelian or multigenic inheritance patterns 
and are therefore amenable to QTL analysis. 
 
One aspect of expression traits that differs from classical phenotypes is that each 
mRNA and protein species has a corresponding genetic locus that harbors the parent 
gene. Because of this, a QTL that modulates gene expression can either be located close 
to the parent gene or at a distance from the parent gene. A QTL that maps close to the 
parent gene indicates cis-acting regulatory mechanisms (cis-QTL), and implicates 
sequence variations within or close to the gene (e.g. in regulatory elements such as 
transcription factor binding sites) as being responsible for the variation in transcript level. 
A QTL that maps at a distance from the parent gene indicates trans-acting regulatory 
mechanisms controlling the expression of the gene (trans-QTLs).  
 
 
1.5.2 Systems Genetics 
 
The information in the DNA sequence is transmitted via networks of genes and 
molecular pathways and can have influence at multiple phenotypic levels. With the 
generation of transcriptome data sets, it is now possible to analyze gene expression on a 
global scale and identify gene networks that may be the molecular correlates of organism 
level phenotypes (Bystrykh et al., 2005; Chesler et al., 2005; Schadt et al., 2005). This 
has led to the conception of systems genetics, an integrative analytical approach that 
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attempts to develop a more comprehensive view of an organism by collectively studying 
many phenotypes and multiple genetic and environmental factors (Williams, 2006). 
Systems genetics has been defined as “the integrative study of a multitude of gene 
variants and a rich admixture of phenotypes.” Each phenotype is considered within the 
backdrop of many other interrelated phenotypes, and associated gene networks.  
 
Such an integrative approach to complex traits has become feasible only with the 
production of large genomics resources such as dense genotype and SNP sequences, and 
transcriptome and proteome data sets. Another area that has been vital to systems 
genetics has been the development of bioinformatics resources that curate large data sets, 
and provide sophisticated computational tools and analytical systems (e.g. the genome 
browser at http://genome.ucsc.edu, Mouse Phenome at http://www.phenome.jax.org, 
GeneNetwork at http://www.genenetwork.org).  
 
 
1.6 Organization of the Dissertation 
 
The work presented in this dissertation is a systems genetics approach to study 
neuroanatomical traits in relation to emotion-related behavior. The main focus is on the 
basolateral amygdala (BLA), but several other brain regions, including the prefrontal 
cortex, hippocampus, and striatum, have also been considered.  
 
To begin with, Chapter 2 examines the morphology and cytoarchitecture of the 
BLA in a panel of 35 BXD RI and parental strains, and F1 hybrids (Mozhui et al., 2006). 
This analysis revealed significant variation in structural traits of the BLA, and identified a 
significant QTL on chromosome associated with the volume of the BLA. In addition to 
the QTL on chromosome 8, few other suggestive QTLs were also detected.  
 
In Chapter 3, the natural variations in the BLA volume are associated with stress 
reactivity and fear learning behavior (Yang et al., 2008). This study showed that mice 
with smaller BLA exhibited more pronounced fear learning and released more 
corticosterone in response to stress. This demonstrates that structural trait of a brain 
region can have a significant influence on behavior. 
 
Chapter 4 examines the effect of chronic stress on subsequent behavior and 
endocrine response. To introduce more genetic diversity, seven inbred strains, including 
B6 and D2, were tested using behavioral assays of anxiety- and depression-related 
behavior. Gene expression in the BLA, PFC, and hippocampus of B6 and D2 mice was 
also evaluated. The expression study detected different sets of stress-sensitive genes in 
B6 and D2. This study especially highlighted several genes involved in controlling the 
circadian rhythm (e.g. Per1, Per2, Per3). Many of the stress sensitive genes are also 
known to be associated with neurological disorders in human. 
 
In Chapter 5, the focus is shifted to a genetic region that harbors many QTLs. 
This chapter examines the QTL rich on mouse distal chromosome 1 or Qrr1 (Mozhui et 
al., 2008). This QTL region appears to harbor multiple loci that control both gene 
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expression and several neural traits, including the volume of the hippocampus, and 
several emotion-related behavioral traits. Many genes detected to be differentially 
expressed between B6 and D2 are also located in this region. By apply high-resolution 
mapping and by examining multiple crosses, Qrr1 was subdivided into two broad QTL 
regions. Formin 2 (Fmn2) was identified as a high priority candidate gene that may be the 
chief modulator of expression traits that map to Qrr1. 
 
Finally, Chapter 6 summarises the results and gives a concluding discussion of 
the work reported in this dissertation. 
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CHAPTER 2. GENETIC AND STRUCTURAL ANALYSIS OF THE 
BASOLATERAL AMYGDALA COMPLEX IN BXD RECOMBINANT INBRED 
MICE
*
 
 
 
2.1 Synopsis 
 
The amygdala integrates and coordinates emotional and autonomic responses. The 
genetics that underlie variation in amygdala structure may be coupled to variation in 
levels of aggression, fear, anxiety, and affiliated behaviors. We systematically quantified 
the volume and cell populations of the basolateral amygdala complex (BLA) across 35 
BXD recombinant inbred (RI) lines, the parental strains—C57BL/6J (B6) and DBA/2J 
(D2)—and F1 hybrids (n cases = 199, bilateral analysis). Neuron number and volume 
vary 1.7- to 2-fold among strains (e.g., neuron number ranged from 88,000 to170,000). 
Glial and endothelial populations ranged more widely (5- to 8-fold), in part because of 
higher technical error. A quantitative trait locus (QTL) for the BLA size is located on 
chromosome (Chr) 8 near the Large gene. This locus may also influence volume of other 
regions including hippocampus and cerebellum. Cell populations in the BLA appear to be 
modulated more weakly by loci on Chrs 11 and 13. Candidate genes were selected on the 
basis of correlation with BLA traits, chromosomal location, SNP density, and expression 
patterns in the Allen Brain Atlas. Neurod2, a gene shown to be significant for the 
formation of the BLA by knockout studies, is among the candidate genes. Other 
candidates include Large, Neurocan, and Thra. Responses to drugs of abuse and 
locomotor activity were the most notable behavioral correlates of the BLA traits. 
 
 
2.2 Introduction 
 
The amygdala is a composite of functionally distinct nuclear groups in the 
forebrain. It is neuroanatomically intricate and comprised of as many as 13 different 
nuclei connected by complex intrinsic, and afferent and efferent connections (Pitkänen et 
al., 1997). It is a major constituent of the limbic system and is regarded as a crucial neural 
component underlying the experience of emotions and emotion-related cognitive 
functions (McIntyre et al., 2003; McGaugh, 2004). Evidence supports its role in the 
mediation of aversive and rewarding emotions (Rogan & LeDoux, 1996; LeDoux, 2000; 
Calder et al., 2001; Baxter & Murray, 2002; Lee et al., 2004), and the extensive 
connections it shares with the dopaminergic reward systems (Friedman et al., 2002) 
indicates an amygdalar contribution in the neurophysiology of reward, anxiety, 
motivation, and addiction (Phillips et al., 2003; Ciano & Everitt, 2004).  
 
A number of human psychopathological disorders are accompanied by alterations 
in the size and cytoarchitecture of the amygdala. Examples include abnormal reductions 
                                                
*
 Adapted with permission from Springer. Mozhui K, Hamre KM, Holmes A, Lu L, 
Williams RW (2007). Genetic and structural analysis of the basolateral amygdala 
complex in BXD recombinant inbred mice. Behav Genet 37:223–243. 
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in volume among patients with schizophrenia (Niu et al., 2004), bipolar disorder 
(Blumberg et al., 2003), depression (Rosso et al., 2005), and Williams Syndrome (Reiss 
et al., 2004); and abnormal increases in volume and cell density among autistic patients 
(Abell et al., 1999). Interestingly, recent studies suggest that functional abnormalities in 
the amygdala of certain patient groups may be partly of genetic origin. For example, 
polymorphic variants in the human serotonin transporter and monoamine oxidase A 
genes are associated with trait differences in amygdala volume and/or functional 
responses to aversive stimuli (Hariri & Holmes, 2006; Meyer-Lindenberg et al., 2006). 
Thus genetic analysis of the structural variations of the amygdala may provide insights 
into the functional and behavioral significance of such variances. 
 
Genetic heterogeneity generates significant variations in phenotypes ranging from 
expression levels of mRNAs and proteins, the size and shape of neurons and neural 
structures, through to innate and learned behaviors. We are just beginning to understand 
relations among sequence differences, environmental factors, and diverse multiscale 
phenotypes. Mice provide an excellent population model to study such genetic and 
phenotypic variability. The environment of diverse sets of strains (a test population) can 
be fixed or systematically varied. In particular, the set of BXD strains (Peirce et al., 2004) 
has proved to be an extremely valuable reference population to study networks of 
phenotypes and their modulation by gene variants (Chesler et al., 2003; Chesler et al., 
2005). The parental strains, B6 and D2, have been sequenced, and approximately 2 
million single nucleotide polymorphisms (SNPs) between them have been identified.  
 
Complex trait studies with the BXDs are also bolstered by the availability of a 
broad web-based data compilation of these strains’ genotypes, numerous behavioral and 
physiological phenotypes, and microarray expression profiles, and integrated analytical 
tools maintained in GeneNetwork (GN, http://www.genenetwork.org). Previous studies 
have used the BXD RI panel to analyze the genetic determinants of differences in size 
and cell number of brain structures including the cerebellum, hippocampus, neocortex, 
striatum, and olfactory bulb (Neumann et al., 1993; Rosen & Williams, 2001; Airey et al., 
2002; Seecharan et al., 2003; Airey et al., 2005; Li et al., 2005). In the present study, we 
have undertaken a complex trait analysis of the BLA. Its volume and densities of three 
cell types—neurons, glia, and endothelial cells—were measured from 35 BXD strains 
and their parental strains and F1 hybrids. In addition to identifying QTLs that may be 
significant for the development and structure of the BLA, we performed correlative 
analysis with mRNA expression levels in the brain, and with behavioral phenotypes 
catalogued in GN. Such an integrated study can potentially determine modulatory roles of 
multiple genetic factors in establishing brain morphology, and their influence on 
neurophysiology, function, and behavior (Chesler et al., 2003). 
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2.3 Materials and Methods 
 
 
2.3.1 Subjects 
 
Measurements were taken from brain sections of a set of 35 BXD RI strains, the 
parental B6 and D2 strains, and F1 hybrids. The serial sections used in this study are all 
part of the Mouse Brain Library (MBL) collection of physical sections. Images of these 
sections can also be downloaded from http://www.mbl.org (Lu et al., 2001; Rosen et al., 
2003; Seecharan et al., 2003). The BXD strains are completely inbred and have been 
generated by the repeated mating between siblings starting from the F2 stage (Taylor, 
1989; Taylor et al., 1999). The animals were purchased from the Jackson Laboratory (Bar 
Harbor, ME) and housed in a pathogen free colony at the University of Tennessee Health 
Science Center. Animals were acclimatized for at least two weeks in the University of 
Tennessee animal facility before use. Number of animals housed in a single cage did not 
exceed 5 and the average cage density was 3 per cage. They were maintained on a 14/10h 
light-dark cycle at 20-24˚ C and fed 5% fat Agway Prolab 3000 rat and mouse chow. The 
average age of mice from which data were collected was 96 days (ranging from 30 to 500 
days), and a total of 96 females and 103 males were used. All procedures followed the 
guidelines of institutional animal care and use committee. 
 
 
2.3.2 Fixation and Sectioning 
 
As described previously (Airey et al., 2001; Lu et al., 2001; Seecharan et al., 
2003), mice were deeply anaesthetized with Avertin, and perfused through the heart with 
0.1M phosphate buffered saline. This was followed by solutions of: 1.25% 
glutaraldehyde and 1.0% paraformaldehyde in phosphate buffer (0.1 M); and 2.5% 
glutaraldehyde and 2.0% paraformaldehyde in phosphate buffer. Brains were dissected 
out and weighed. Brain tissues were subsequently embedded in celloidin and sectioned 
along the coronal or horizontal planes at 30 !m thickness with a sliding microtome, and 
stained with cresyl violet. Every tenth section was mounted on a slide and coverslipped. 
An interval thickness of 300 !m separates adjacent sections on each slide (Rosen & 
Williams, 2001). In the MBL, the majority of the cases have two sets of serial section 
slides per brain (slide A and slide B).   
 
 
2.3.3 Volumetric Measurement 
 
Volumetric measurements were taken from a total of 199 brains. An average of 5 
subjects was used per strain, and with the exception of BXD37, all other strains’ means 
are representatives of at least four subjects. For BXD37, measurements were taken from 
only 2 individuals due to limited availability. We decided to include the BXD37 data 
because its inclusion or exclusion did not have a major affect on the subsequent linkage 
analysis. Of the 199 cases, 175 were coronal sections and 24 were horizontal sections. 
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The limited use of horizontal sections is because the outline of the BLA is more clearly 
definable in the coronal sections.  
 
The amygdala is a complex neural structure and has been divided into distinct 
nuclear complexes, and further sub-divided into nuclei and sub-nuclei regions (Pitkänen, 
2000). For this study, we took measurements from the portion of the BLA complex that is 
bordered laterally by the amygdalar capsule (amc) (Swanson & Petrovich, 1998), and 
medially by the external capsule (ec). These clear demarcations and definability would 
ensure consistent morphometric measurements. This portion of the BLA complex 
includes the lateral nucleus, which is further subdivided into the dorsolateral (LaDL), 
ventrolateral (LaVL) and ventromedial (LaVM) sub-nuclei, and the basolateral nucleus, 
which is further subdivided into the anterior magnocellular (BLA) and posterior 
parvicellular (BLP) sub-nuclei (Figure 2-1A). These divisions have been made according 
to a standard atlas of the brain of B6 (Franklin & Paxinos, 2001). The basomedial nucleus 
is also a part of the BLA complex but it was not included in our measurements because 
its border is less clearly definable and may have added to data inaccuracy. 
 
NIH Image (version 1.63) was used for volumetric analysis. Images from serial 
sections were captured from a Zeiss light microscope to a computer. After calibrating the 
instrument to a standard length of 1 mm, the border of the amygdala delineating the BLA 
was manually traced and area determined. Such manual measurements were taken along 
the entire rostrocaudal thickness of the BLA (approximately 6–9 sections for each brain) 
at an interval thickness of 300 !m. Measurements were taken bilaterally and the final 
values represent the left-right average. Because the majority of the cases have two sets of 
serial sections, the average BLA complex volume for most individual cases was  
 
 
 
 
Figure 2-1 Neuroanatomy of the basolateral amygdala 
(A) Nissl stained coronal section from MBL (bregma: –1.8). Outlined is the portion of the 
BLA complex that included the lateral nucleus (LaDL, LaVL) and the basolateral nucleus 
(BLA); amc: amygdalar capsule; ec: external capsule. (B) Expression of the Large gene 
in the BLA complex (in situ taken from Allen Brain Atlas; Large_277_030609127-2, 
positon: 6925). 
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calculated from a total of four sets of measurements, i.e. bilateral measurement from 
slides A and B. 
 
To correct for the volumetric shrinkage caused by histological processing, the 
measured values were divided by the total brain volume and multiplied by the brain 
volume expected for that brain weight. The brain density of the MBL tissues is taken to 
be 1.05 mg per mm3 of fixed tissue. The post-processing total brain volume was 
determined by point counting and the method is described in Williams (2000). After each 
individual volume measurement was corrected for shrinkage, the strain averages were 
determined. 
 
 
2.3.4 Stereological Methods 
 
We applied the three-dimensional direct cell counting technique that was 
developed by Williams and Rakic (1988) to estimate cell density and total number. We 
used the whole-section method as it gives a relatively unbiased estimate of cell number 
from a tissue section and avoids the error caused by differential shrinkage along the z-
axis (von Bartheld, 2001). A count box of 32 x 33 x 30 !m was superimposed over the 
live image of the section, and we followed the standard counting rules defined by 
Gundersen (1977), and Williams and Rakic (1988). The same counting protocol was used 
as described previously by Seecharan et al. (2003). Distinction between cell populations 
was based on established criteria (Ling et al., 1973; Satorre et al., 1986) and as used by 
Seecharan et al. (2003). Cells were classified into three groups: neurons, glial cells, and 
endothelial/other cells. No distinction was made between projection neurons and 
interneuron. Cells whose identity could not be discerned with certainty were included in 
the endothelial/other group. 
 
Stereological measurements were limited only to coronal sections from which the 
volumetric measurements were taken and the horizontal sections were excluded. From 
each serial section slide, the section that had the most complete representation of the 
BLA complex was chosen for cell counting. A total of 10 sites were sampled from each 
side of the BLA complex (2 sites for each sub-nuclei) by focusing the x100 oil objective 
(NA 1.25) over each sub-nuclei (LaDL, LaVL, LaVM, BLP, BLA). Counts were taken 
bilaterally and for each case, the final cell number represents the left and right average. 
The number of subjects used for each strain is lower for the stereological data at an 
average of 4 subjects per strain. The data for BXD37 and BXD11 represent the average 
of only two individuals.  
 
To assess the validity of stereological method we compared counts obtained from 
right and left sides. While there will be some genuine left-right asymmetry, most 
variation is likely to be due to sampling and technical errors (Williams et al., 1996). 
Paired t-test showed no significant difference between the cell counts taken from the left 
and right BLA (t165 = 1.72, p = 0.08 for glia; t165 = 1.15, p = 0.25 for endothelial cells;  
t166 = 1.54, p = 0.13 for neurons). However, BLA volume—which we consider to be the 
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most reliable data with a low coefficient of error—has a modest but statistically 
significant left-right asymmetry (t195 = 2.5, p = 0.01). 
 
 
2.3.5 Statistics 
 
Data were organized using a spreadsheet program (Excel) and most exploratory 
analysis and statistical tests were performed using Data Desk (http://www.datadesk.com). 
To examine effects of cofactors such as brain weight, body weight, age, and sex on the 
BLA, we applied multiple linear regression. In the case of the volume data, the plane of 
section was also included as a factor. In addition, the effect of each variable as a single 
factor was also examined by simple regression analysis, and the percentage of variance 
explained by a covariate was computed from the adjusted correlation coefficient. 
Individual trait values rather than strain means were used for regression analysis. 
Residual values were calculated only for those factors that were significant predictors. 
The corrected data, adjusted for these effects (residual + mean), provide a more accurate 
estimate of variability specific to the BLA. The adjusted data were also used for linkage 
analysis.  
 
Effect of strain on trait variance was used as an estimate of trait heritability. The 
intra-class correlation coefficient was computed by performing an analysis of variance 
(ANOVA) with strain as a single factor and this provides an estimate of strain effect on 
trait variance. 
 
 
2.3.6 Genotyping and QTL Mapping 
 
The B6 and D2 strains differ significantly in sequence and approximately 2 
million informative SNPs have been defined across the genome (see 
http://www.genenetwork.org/beta/snpBrowser.py). A subset of approximately 14,000 of 
these sequence variants (SNPs and microsatellites) have been used to genotype the BXD 
strains (Williams et al., 2001b; Peirce et al., 2004; Shifman et al., 2006; 
http://www.well.ox.ac.uk/mouse/INBREDS/). The BLA trait data were entered into GN 
and QTL mapping was performed using the WebQTL mapping module. 
 
For linkage analysis, WebQTL performs intervals mapping using 3,795 SNP and 
microsatellites as markers. The non-parametric p-value (alpha of 0.05) of the linkage 
ratio statistic (LRS) is computed by performing 1000 or more permutations. This 
threshold is denoted by the upper horizontal line in linkage maps. A suggestive LRS 
threshold is set at a genome-wide alpha of 0.63 and is denoted by the lower horizontal 
line in the linkage map. Two-thousand or more bootstraps are also performed by GN to 
estimate the confidence limit of the location of the QTL peak interval, and the results are 
represented as a “frequency of peak LRS value” histogram. Another parameter computed 
by WebQTL is the additive effect, which is an estimate of the quantitative effect of an 
allele on the measured phenotype. In the case of the BXDs, a locus can have a B6 allele 
(B) or a D2 allele (D) and the additive effect is half of the difference between the means 
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of homozygous cases and is calculated as: (mean of BB cases)–(mean of DD cases)/2. 
The red plot in the linkage graphs denotes a positive effect by the B allele and for 
computational purpose, GN gives it a nominal negative value; a positive effect by D 
allele is denoted by the green plot and is assigned a positive value. These values are in the 
same units as the data, in this case mm
3
 for volume, and number/mm
3
 for cell density. 
Using the additive effect value, the effect size of a QTL and the percentage of variance 
attributed to a QTL are approximated. 
 
Correlative analysis with behavioral phenotypes and gene transcript expression 
The GN analytical tools are integrated with data sets of numerous BXD behavioral and 
physiological phenotypes, and microarray data of gene expression in the brain (Chesler et 
al., 2003; Chesler et al., 2005), and this facilitates correlative analyses across a wide 
range of data sets. Transcript expression levels were treated as complex traits and their 
covariance with the BLA neuroanatomical traits analyzed. Both Pearson’s product-
moment and Spearman’s rank correlation can be computed. For this study, we calculated 
the Pearson’s product-moment correlation between the BLA traits and the mRNA 
expression level data “INIA Brain mRNA M430 (Jan06)”. We also referred to the in situ 
gene expression data provided by Allen Brain Atlas (ABA) (http://www.brain-map.org) 
to check for the expression levels of the candidate genes within the BLA. Correlation 
analysis was also done with BXD neuroanatomical and behavioral traits. 
 
 
2.4 Results 
 
 
2.4.1 Volume of the BLA Complex 
 
The BXD strains exhibit a wide range of variation in the volume of the BLA. 
BXD19 has the largest mean volume at 1.8 ± 0.08 mm
3
 and BXD29 has the smallest at 
1.07 ± 0.03 mm
3
 (Table 2-1). This amounts to a 1.7-fold difference in size. However, 
there is no significant difference between the parental strains (B6 at 1.628 ± 0.1 mm
3
, D2 
at 1.55 ± 0.06 mm
3
). Relatively small phenotypic difference between parental strains 
while the progeny RI strains display a wider range of variation is attributed to random 
assortment of multiple alleles at different loci (Neumann et al., 1993). Depending on the 
combination of alleles at multiple loci inherited from the parents, a phenotype may be 
either enhanced or diminished in the offspring. Approximately 35% of the variance in 
BLA volume is due to strain genotype (F (37, 198) = 2.16, p = 0.0005). 
 
F1 hybrids have the largest BLA and this is consistent with the F1s possessing 
larger traits for the lateral geniculate nucleus (LGN) (Seecharan et al., 2003), olfactory 
bulb (Williams et al., 2001a), body weight, and brain weight. More robust traits in the 
F1s can be explained by positive heterosis and hybrid-vigor (Falconer & Mackay, 1996). 
 
While the size of the BLA may be modulated by specific genetic factors, the BLA 
may also be under the influence of genes that have more widespread effects. It is possible 
that variation in its size could partially be accounted for by variations in the overall brain  
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Table 2-1 Basolateral amygdala volume and cell number 
 
Group N V
A
 
(mm
3
) 
V
B
 
(mm
3
) 
V
C
 
(mm
3
) 
N
D
 Neur 
(!1K) 
Gli 
(!1K) 
Endl
 
(!1K) 
         
C57BL/6J 6 1.63 1.49 1.61 5 119 17 19 
DBA/2J 6 1.55 1.63 1.56 5 116 14 14 
BXD1 6 1.57 1.46 1.58 5 146 25 23 
BXD2 5 1.43 1.4 1.39 5 131 16 14 
BXD5 6 1.60 1.36 1.6 4 129 16 18 
BXD6 5 1.22 1.32 1.26 4 88 7 15 
BXD8 5 1.51 1.51 1.5 5 134 10 11 
BXD9 5 1.51 1.5 1.52 3 145 7 15 
BXD11 5 1.48 1.47 1.5 2 158 26 7 
BXD12 6 1.47 1.44 1.45 5 169 19 15 
BXD13 6 1.39 1.41 1.38 6 145 20 9 
BXD14 5 1.49 1.44 1.44 5 134 17 14 
BXD15 5 1.42 1.35 1.35 3 152 4 13 
BXD16 6 1.55 1.48 1.54 5 130 14 11 
BXD18 6 1.48 1.5 1.48 5 135 9 13 
BXD19 6 1.80 1.82 1.81 5 151 14 15 
BXD20 4 1.52 1.59 1.53 4 141 9 19 
BXD21 4 1.45 1.45 1.45 5 128 11 15 
BXD22 8 1.57 1.5 1.55 5 126 15 17 
BXD23 5 1.48 1.44 1.45 5 102 15 13 
BXD24 5 1.52 1.55 1.49 4 140 9 13 
BXD25 5 1.40 1.48 1.47 5 111 11 21 
BXD27 5 1.43 1.6 1.43 4 127 11 25 
BXD28 4 1.37 1.45 1.39 3 117 17 24 
BXD29 5 1.07 1.19 1.09 4 115 7 25 
BXD30 5 1.14 1.34 1.19 4 121 9 16 
BXD31 5 1.52 1.56 1.49 3 169 14 24 
BXD32 6 1.61 1.56 1.61 6 132 16 22 
BXD33 5 1.32 1.34 1.35 5 140 15 23 
BXD34 6 1.54 1.56 1.53 6 148 17 22 
BXD35 5 1.47 1.47 1.48 5 113 16 24 
BXD36 6 1.44 1.49 1.48 4 150 17 11 
BXD37 2 1.40 1.42 1.34 2 117 25 5 
BXD38 5 1.43 1.47 1.44 3 111 9 15 
BXD39 5 1.34 1.4 1.38 5 97 12 18 
BXD40 6 1.50 1.5 1.54 5 117 19 22 
BXD42 5 1.44 1.37 1.45 4 106 8 23 
N: number of cases per strain for volumetric data; V
A
: raw BLA volume; V
B
: corrected 
volume after adjusting for brain weight; V
C
: corrected volume after adjusting for body 
weight; N
D
: number of cases per strain for stereology; Neur: number of neurons; Gli: 
number of glial cells; Endl: number of endothelial/other cells. 
 17 
weight, body weight, age, or sex. The degree of covariance of the BLA volume with 
these biological factors was evaluated by regression analyses. Multiple linear regression 
showed brain weight to be a significant predictor of the BLA volume (t195 = 4.96, p " 
0.0001). In contrast, body weight, age, and sex of an animal, and the plane of section, are 
not significant factors for the BLA volume. However, body weight, when used as a single 
regression factor, correlates significantly with the BLA volume (t195 = 3.1, p = 0.002) but 
is estimated to account for only ~5% of the variance. As a single factor, brain weight 
accounts for ~17% of the variance (t197 = 6.27, p " 0.0001). Sex, age, and plane of section 
continue to be insignificant predictors when used as single regression factors. After 
adjusting the data for the effects of brain weight, and body weight, the corrected data 
were used for linkage analyses (Table 2-1). 
 
 
2.4.2 BLA Cell Counts 
 
Neurons account for 80% of the cell population in the BLA. There is about a      
2-fold difference in both the number and density of neurons among the BXD strains. 
BXD12 has the highest population at 169,200 ± 14,300; BXD6 has the lowest at 88,100 ± 
8000 (Table 2-1). As was true for volume, parental strains do not differ significantly 
(118,800 ± 7,500 in B6 versus 115,600 ± 6,200 in D2). The number and density of non-
neuronal cells vary greatly among BXDs with as much as an 8-fold range in the 
population of glial cells (lowest for BXD15 at 3,700 ± 1,300 and highest for BXD11 at 
26,400 ± 6,500) and a 5-fold range in the population of endothelial cells (lowest for 
BXD37 at 5200 ± 3500 and highest for BXD27 at 25,200 ± 6400). We suspect that some 
of this variation must be technical, but there is no reciprocal relation between glial cell 
and endothelial cell counts expecting if cell identification were a major problem. As 
expected given its large volume, F1 hybrids possess the highest group means for both 
glial and endothelial cells (Table 2-1). However, the neuron population does not appear 
to follow this trend and F1s possess average number of neurons and somewhat lower 
neuron density. The effect of strain on variability in neuron number is over 40% (F (37,166) 
= 2.88, p < 0.0001). Strain also accounts for 30–40% of the variance in glial cell number 
(F (37,166) = 1.87, p = 0.005). 
 
For the neuron population, multiple linear regression with brain weight, body 
weight, age, and sex showed none of these factors to be significant predictors. However, 
regression analysis with body weight as a single factor revealed it to be a statistically 
significant predictor of the neuron number (t158 = 2.34, p = 0.02). Used as single 
regression factors, brain weight, age, and sex do not show significant covariance with 
neuron number. 
 
From the regression analyses, we note a great deal of similarity between the BLA 
volume and glial cell traits. As in the case of the volume, when multiple linear regression 
is done using brain weight, body weight, age, and sex as co-factors, only the brain weight 
serves as a significant predictor of the glial cell number, but body weight becomes a 
significant predictor of glial cell number when it is used as a single regression factor (t158 
= 3.28, p = 0.0013) and is estimated to account for 6% of the variance. The brain weight 
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is estimated to account for 7% of variance (t164 = 3.52, p = 0.0006). Age and sex are 
insignificant predictors of the glial cell population. The endothelial cell population 
appears to be unaffected by variations in brain weight, body weight, age and sex.  
We note a rather large coefficient of error (CE = standard error/group mean) in the case 
of the glial cells (average CE of 0.3) and endothelial cells (average CE of 0.2). This high 
CE is suggestive of high error rate in data collection, though there is also the possibility 
that there may be higher within-strain variation for the glial and endothelial cell 
populations than for neurons. The CE for both the BLA volume and neuronal population 
averages at only 0.06. 
 
 
2.4.3 QTL Analysis for BLA Volume 
 
The genome-wide linkage map for the raw BLA volume revealed a significant 
linkage interval on mid-Chr 8 (Figure 2-2A). This linkage interval is located between 65 
and 75 Mb, and has a peak LRS of 14, just above the significant threshold. At this locus, 
the D allele has the positive additive effect and is estimated to increase the volume by 
~10%. Two suggestive linkages are also detected on proximal Chr 1 (between 50 and 60 
Mb; LRS 9.0) and mid-proximal Chr 19 (between 22 and 28 Mb; LRS 9.2). At each of 
these suggestive linkage intervals, the B allele increases volume by ~10%. 
 
To assess global effects of brain weight and body weight on the linkage map, the 
BLA volume was regressed against these two factors and the adjusted data were used for 
interval mapping. Differences in QTLs between the adjusted and raw data would indicate 
the level of specificity of a particular QTL for the BLA. Adjusting for brain weight 
eliminates the suggestive linkages on Chr 1 and Chr 19 (Figure 2-2B). The linkage to 
Chr 8, though weakened, persists at a suggestive LRS of 10.7. The location of the linkage 
interval is unchanged (between 65–75 Mb) and the D allele continues to have the positive 
additive effect. Regression against body weight also decreases the linkages to Chr 1 and 
19, but augments the linkage to mid-Chr 8 to an LRS of 15 (Figure 2-2C). Thus the 
linkage to mid-Chr 8 is consistently detected on all the linkage maps for the BLA 
volume, and the significant strength of association (genome-wide p " 0.05) qualifies it as 
a QTL for the BLA volume. We will refer to this QTL as Vol8a. However, the reduction 
in its strength upon adjusting the data for the effect of brain weight indicates a pleiotropic 
interaction of Vol8a with the size of the BLA and the overall brain weight. Vol8a lies 
only ~10 Mb proximal to the Cerebellar size 8a (Cbs8a at 45 cM) QTL (Airey et al., 
2001). 
 
Simple interval mapping with the stereological data yielded only suggestive QTLs 
for the neuron (Figure 2-3A) and glial cell populations (Figure 2-3B). No linkage 
interval was uncovered for the endothelial cells. Both the neuron and glial cell densities 
share suggestive linkages to mid-proximal Chr 13. Though the overlap in not precise, the 
linkage intervals for both the neuron and glial traits reside at close proximity, the 
suggestive LRS peaking at 11.4 for the neuron density and at 10.2 for the glial density. It 
is noted that this linkage interval is also close to the hippocampal volume QTL, HipV13a 
(Peirce et al., 2003). At this locus, it is the D allele with the positive additive effect for 
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Figure 2-2 QTL analysis of BLA volume 
(A) BLA volume has a significant QTL on Chr 8 (LRS 14) and suggestive peaks on Chrs 
1 (LRS 9) and 19 (LRS 9.2). (B) Adjusting BLA volume for brain weight reduces QTL 
on Chr 8 but linkage remains above suggestive threshold (LRS 10.7). (C) Adjusting 
BLAc volume for effect of body weight increases QTL on Chr 8 (LRS 15). Blue plot: 
LRS; green plot indicates positive additive effect for D allele and red plot indicates 
positive additive effect for B allele; yellow histogram: frequency of peak LRS; pink 
horizontal line: significant LRS threshold at genome-wide p " 0.05; grey horizontal line: 
suggestive LRS threshold at genome-wide p " 0.63. 
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Figure 2-3 QTL analysis of BLA cell counts 
(A) BLA neuron density has a suggestive linkage on Chr 13 (LRS 11.4). (B) Glial cell 
density in the BLA has suggestive linkages on Chrs 11 (LRS 11.4) and 13 (LRS 10.3). 
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both neuron and glial cell densities and is estimated to increase the neuron density by 
12% and the glial density by more than 35%. 
 
Another suggestive association is observed for the density of glial cells on distal 
Chr 11. The suggestive LRS peaks at ~11.4 between 90 and 105 Mb. Glial density, after 
correction for the effect of brain weight, maps to this locus at a nearly significant LRS of 
14.8. The LRS peaks almost precisely over the NeuroD2 gene located at ~98 Mb. The B 
allele at this locus is estimated to increase the glial cell density by more than 25%. Other 
then the effect of increasing the peak over NeuroD2, regression of the cell counts data 
against brain weight and body weight do not cause major alterations in the linkage maps. 
 
 
2.4.4 QTL Specificity 
 
Brain weight and body weight are the two most significant predictors of the BLA 
structure. A genome wide linkage analysis was performed for brain weight (Figure 2-4A) 
and body weight (Figure 2-4B) to identify any genetic loci that may primarily modulate 
these global traits but are also linked with the size or cell populations of a specific brain 
structure such as the BLA. This is a cautionary step to avoid erroneous identification of a 
more general QTL with widespread effects as being specific for the BLA. 
 
The brain weight variation is associated with a suggestive QTL on Chr 19. For the 
body weight, suggestive linkages occur on Chrs 7, 10, and 19. This indicates the linkage 
interval on Chr 19 to primarily modulate gross structures, with a non-specific association 
with the BLA. Both brain weight and body weight also have linkage peaks of Chr 1, and 
though both are below the suggestive thresholds, these linkage peaks may account for the 
suggestive LRS on Chr 1 for the BLA volume that was weakened by regression against 
brain weight and body weight. 
 
 
2.4.5 Correlations between BLA Volume and Cell Populations 
 
The strongest correlation among the BLA neuroanatomical traits is between its 
volume and glial number (Figure 2-5A) with a positive Pearson’s product correlation r = 
0.5, p = 0.0007. Weaker but significant positive correlations exist between the volume 
and glial cell density (Figure 2-5B; r = 0.4, p = 0.03), and volume and neuron number 
(Figure 2-5C; r = 0.4, p = 0.02). Neuron density in the BLA has the tendency to correlate 
negatively with volume, and though this does not reach statistical significance (Figure   
2-5D; r = -0.3, p = 0.1), the negative association indicates that smaller BLA will have 
slightly higher neuronal density. As expected, strong positive correlations relate cellular 
densities with number. This is especially true for the near perfect correlation between the 
density and number of glial cells (Figure 2-5E; r = 0.9). Correlation between the number 
and density of neurons is also highly significant but less stringent compared to glial cells 
(Figure 2-5F; r = 0.7, p = 1.2x10-6). 
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Figure 2-4 QTL maps of brain and body weight 
Genome-wide linkage map for (A) brain weight: suggestive linkage on Chr 19; and (B) 
body weight: suggestive linkages on Chrs 7, 8, 19. The linkage on Chr 19 overlaps with 
the suggestive linkage for the BLA volume on Chr 19.
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To provide an overview of linkage intervals that may be common for the BLA 
neuroanatomical traits, a cluster map was generated for, from rows 1 to 6, the raw 
volume, body weight adjusted volume, glial number, glial density, neuron number, and 
neuron density (Figure 2-5G). In addition to the overlapping linkage interval of Chr 
13for the neuron and glial cell populations, closely aligned linkage intervals can be 
detected on Chr 1 for all traits, on Chr 3 for the neurons and glial cells, on Chr 5 for the 
volume and glial cells, and on Chr 6 for the volume and neuron number. These linkages 
are below the significant threshold but may indicate potential shared QTLs. 
 
The complex trait analysis of the BLA uncovered only one significant QTL, 
Vol8a, associated with its volume, and two suggestive linkage intervals on Chr 11 and 
Chr 13 associated with the cellular traits. 
 
 
2.4.6 Neuroanatomical Correlates of BLA and Comparative QTL Analysis 
 
GN maintains an archive of diverse phenotypes (BXD Published Phenotypes 
database) previously collected from the BXD strains by different researchers. This makes 
it possible to search for traits with significant covariance with the BLA. The “Trait 
Correlation” tool was use to compute correlations between the BLA structural traits and a 
variety of other BXD phenotypes that range from physiology, neuroanatomy of other 
brain regions, to behavior. This analysis showed that the top 15 strongest correlates are 
all neuroanatomical traits. The strongest association is between the BLA volume and the 
volume of the hippocampus proper (Figure 2-6A; r = 0.7, p = 4.5x10-6, N = 34) and its 
sub-regions such as the dentate gyrus (r = 0.5, p = 0.001) and pyramidal cell layer (r = 
0.5, p = 0.003). The volume of the BLA also correlates significantly with the sizes of the 
striatum (Figure 2-6B; r = 0.6, p = 1.2x10-5, N = 36), and the lateral geniculate nucleus 
(Figure 2-6C; r = 0.5, p = 4.5x10-3, N = 35). 
 
To determine if the linkage intervals identified in this study are specific for the 
BLA, or if common QTLs may be involved in modulating the sizes of different brain 
structures, we retrieved the volumetric data for the cerebellum and internal granular layer 
(IGL) (Airey et al., 2001), total hippocampus, hippocampus proper, dentate gyrus and 
pyramidal cell layer of the hippocampus (Lu et al., 2001; Peirce et al., 2003), LGN 
(Seecharan et al., 2003), striatum (Rosen et al., 2009), and olfactory bulb weight 
(Williams et al., 2001a), and performed multiple QTL mapping for these traits. To 
display the overlapping linkage intervals, a cluster QTL map was generated for, from 
rows 1 to 10, the IGL, IGL adjusted for brain weight, striatum, hippocampus proper, 
dentate gyrus, BLA, LGN, olfactory bulb weight, BLA neuron density, and BLA glial 
density (Figure 2-6D). This analysis confirms Vol8a as a major neuroanatomical QTL 
but makes it less specific for the BLA. Vol8a is linked to the volumes of the IGL and the 
whole cerebellum, striatum, and hippocampus proper, but not with the volumes of the 
dentate gyrus, and LGN. A hint of linkage is also visible between the olfactory bulb 
weight and Vol8a. In all these cases, it is the D allele in Vol8a that has the positive 
additive effect. The Cbs8a QTL reported previously (45 cM; Airey et al., 2001) lies only  
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slightly distal to Vol8a. After the cerebellum and IGL volumes are adjusted for brain 
weight, their linkage interval is shifted from Vol8a to Cbs8a. It is uncertain if Vol8a and 
Cbs8a are two separate QTLs with Cbs8a specific for the cerebellum, or if they represent 
the same QTL but appear separate due to low mapping resolution. If the later is the case, 
then there is consensus for the linkage interval to be located on Vol8a. Vol8a may be 
selectively modulating the sizes of more than one brain structure but not of other brain 
structures such as the LGN and the dentate gyrus. 
 
 
2.4.7 Behavioral Correlates of BLA and Comparative QTL Analysis 
 
After the neuroanatomical traits, another category of phenotypes that show 
significant covariance with the BLA structure is behavioral phenotypes related to 
addiction, and locomotor activity (Table 2-2; Figure 2-7A). Among these, cocaine open 
field center time behavior (GN trait ID 10333), which assesses the effect of an addictive 
substance on a behavioral measure of locomotor activity and emotionality, shows the 
most significant correlation with the BLA volume, and the same trait also correlates 
significantly with the neuron number (r = -0.5, p = 0.02, N = 23). To search for possible 
common QTLs shared between the BLA and its correlated behavioral phenotypes, a 
cluster QTL analysis was performed and the most striking overlap of QTLs was found 
between the BLA volume and the cocaine open field behavior. Another correlated 
behavior that shares a linkage interval on Vol8a is the locomotor behavioral response 
measured by Palmer et al. (2002; GN trait ID 10453). A multiple QTL map was 
generated for these three traits (Figure 2-7B; red: cocaine open field, green: locomotor 
response, blue: BLA volume). Three overlapping linkage peaks are observed for BLA 
volume and cocaine open field behavior: (1) though the LRS is only of suggestive 
strength, the cocaine open field behavior has a linkage overlapping Vol8a, (2) significant 
peak for the behavioral trait on mid-proximal Chr 1 overlaps the peak that was observed 
for the BLA traits on Chr 1, (3) though below the suggestive threshold for both traits, 
another shared peak in LRS is observed on proximal Chr 5. Another region of overlap, 
but with a much weaker LRS is observed on the distal end of Chr 18. A peak on Vol8a is 
also present for the trait 10453, which measures the effect of 2-hydroxypropyl-beta-
cyclodextrin on locomotor activity (Palmer et al., 2002). 
 
Other significant correlates of the BLA volume are: distance traveled in open field 
(r = 0.6, p = 0.003, N = 17; trait ID 10843; Yang et al., 2008); conditioned place 
preference (r = –0.6, p = 0.003, N = 22; GN trait ID 10093, Cunningham, 1995); baseline 
locomotor activity in grid test (r = –0.5, p = 0.02, N = 26; GN trait ID 10503, Phillips et 
al., 1996); saccharin preference (r = –0.5, p = 0.02, N = 22; GN trait ID 10550, Risinger 
et al., 1998); pentylenetetrazol induced seizure (r = –0.5, p = 0.02, N = 24; GN trait ID 
10614, Wakana et al., 2000); ethanol induced locomotor response (r = 0.4, p = 0.02, N = 
28; GN trait ID 10790; Demarest et al., 2001); ethanol intake (r = 0.5, p = 0.03, N = 19; 
GN trait ID 10074, Crabbe et al., 1983). 
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Table 2-2 Behavioral correlates of BLA 
 
X-Axis 
BLAc Traits 
Y-Axis 
Behavioral Traits 
 
r 
 
p 
 
N 
     
Volume     
10674 10333: Cocaine open filed-center time 
(Jones et al., 1999) 
-0.6 0.001 23 
10674 10095: Locomotor activity (Cunningham, 
1995) 
-0.6 0.002 22 
10674 10490: Cocaine induced sensitization of 
locomotor response (Phillips et al., 1998) 
0.5 0.01 27 
10674 10453: Locomotor response (Palmer et al., 
2002) 
0.5 0.005 26 
Glial cells     
10879 10038: Distance traveled (Bolivar & 
Flaherty, 2003) 
0.6 0.002 27 
10879 10783: Novel food preference (Bolivar & 
Flaherty, 2004 
-0.5 0.009 26 
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2.4.8 Candidate Genes 
 
To narrow the search for candidate genes located within a linkage interval, we 
selected only those genes that have SNPs between the parental alleles and whose whole-
brain expression levels correlate significantly with the BLA traits. Cis-acting genes, 
which self-regulate their own expression, are considered to be stronger candidates for 
complex traits as the association between trans-acting genes and complex traits tends to 
be more complicated (Chesler et al., 2003; Chesler et al., 2005; Kempermann et al., 
2006). A criterion for cis-regulated genes is that the genome-wide linkage maps for the 
expression levels of these genes should have a significant LRS peak within 10 Mbs of its 
chromosomal location (Chesler et al., 2003; Bystrykh et al., 2005; Chesler et al., 2005). 
 
Several cis-acting genes located in Vol8a correlate with the BLA size and cell 
counts. Of these, Large (like-glycosyltransferase) shows a very high expression 
specifically in the BLA (referred to Allen Brain Atlas, Figure 2-1B). It is implicated in 
the glycosylation of extracellular matrix (ECM) components such and the Large mutant 
mouse serves as a model for muscular dystrophy and exhibits abnormalities in neuronal 
migration (Brockington et al., 2005). Other Vol8a candidates include Ssbp4, Zfp617, 
Sfrs14, and Fcho1. Proteoglycan components of the neural ECM are considered to 
provide the supporting microenvironment vital for proliferation, migration and 
differentiation of cells in the nervous system (Oohira et al., 2000; Ida et al., 2005). 
Chondroitin sulfate proteoglycan 3 (Cspg3) or Neurocan, and Spock3 or Testican3, are 
two such neural proteoglycan genes located in Vol8a. Both Cspg3 and Spock3 are 
expressed in the BLA (ABA), and though neither are cis-acting genes, they are also 
considered as possible candidates. 
 
The expression of NeuroD2 (neurogenic differentiation 2) correlates significantly 
with all aspects of the BLA structure though it is only the glial cell population that maps, 
at a suggestive LRS, to its locus on Chr 11. The whole-brain expression level of NeuroD2 
correlates significantly with the density of neurons (r = 0.5, p = 0.002, N = 29; Figure   
2-8A), density of glial cells (r = 0.5, p = 0.007, N = 29; Figure 2-8B), and volume of 
BLA (r = 0.4, p = 0.03, N = 29; Figure 2-8C). NeuroD2 belongs to the bHLH 
transcription factor family, and these transcription factors have been implicated in 
guiding neuron versus glial fate choice of cortical cells (Cai et al., 2000). Specific loss of 
the BLA has been shown in NeuroD2-null mice and the heterozygotes develop smaller 
BLA and exhibit aggressive and lowered anxiety behaviors (Lin et al., 2005). The top 
four transcripts that correlate with BLA volume all belong to GH (Growth Hormone) 
located on Chr 11 at ~106 Mb (r = 0.7, p = 0.0000009). This may be significant as this is 
only ~8 Mb from NeuroD2. However, NeuroD2 does not appear to be cis-regulated, and 
other genes located within this interval also correlate with the BLA traits. These include 
Dlgh4, Thra, Igf2bp, and Plxdc1. Based on a higher SNP density and a tendency for cis-
regulation, Thra (thyroid hormone receptor alpha), which lies within 1 Mb of NeuroD2, 
is also a prime candidate gene. Thra is strongly expressed in the BLA (ABA) and animals 
with mutant Thra have been reported to have anxiety, memory, and locomotor 
impairments (Venero et al., 2005), and abnormal fear and open field behaviors (Guadaño-
Ferraz et al., 2003). 
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Figure 2-8 Correlations between NeuroD2 and BLA traits 
Whole-brain expression levels of NeuroD2 (x-axis) correlates significantly with BLA (A) 
neuron density (y-axis) (r = 0.5, p = 0.002, N = 29), (B) glial density (y-axis) (r = 0.5, p = 
0.007, N = 29), and (C) volume (r = 0.4, p = 0.03, N = 29). 
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2.5 Discussion 
 
 
2.5.1 Summary 
 
We evaluated the genetic modulation of anatomical variation of the BLA using a 
diverse panel of strains. Variation for many key parameters among normal strains is often 
2-fold or greater. We uncovered a significant QTL on mid-Chr 8 (Vol8a) strongly linked 
to BLA volume. This region of Chr 8 also contains loci that modulate volume of the 
cerebellum, striatum, and several hippocampal regions (e.g., the pyramidal cell layer), but 
not the size of the hippocampal dentate gyrus or the LGN. The most parsimonious 
explanation is that a single gene variant modulates the size of several regions, but given 
the size of the Chr 8 QTL interval (~10 Mb) and the large number of candidate genes, 
this may be a chance colocalization of a set of gene variants with independent 
mechanisms of affecting the volume of diverse brain regions. A suggestive linkage 
interval on Chr 13 that may modulate neuron and glial populations in the BLA also 
overlaps a hippocampal volume QTL (HipV13a). 
 
The most BLA-specific linkage interval is on Chr 11 and it associates specifically 
with the glial cell population, but the linkage is only suggestive. However, this locus is 
particularly interesting because it overlaps the chromosomal location of NeuroD2, a gene 
that is already known to control the BLA development (Lin et al., 2005). Expression of 
this gene also correlates significantly with the volume of the BLA and its glial and 
neuronal cell populations. 
 
 
2.5.2 Technical Issues 
 
Estimates of glial cell and endothelial cell numbers have comparatively high 
errors—CE averaging at 0.3 and 0.2 respectively. While there is the possibility that the 
higher CE reflects greater intra-strain variation among isogenic mice, it may also indicate 
technical limitations in accurate data collection. A possible factor may be the lower 
average packing density and cell count of the glial and endothelial cell populations 
relative to the neuron population. The glial and endothelial cells are also considerably 
smaller in size than the neurons. Despite these differences, we used the same counting 
criteria for all three cell-types. Thus the volume of tissue through which counts were 
taken may provide a less adequate representation of the glial and endothelial cell 
distribution in the BLA because fewer of these cells would be included, and this may 
have resulted in higher sampling variance. A count box of larger dimensions would have 
reduced the variance observed in these data (Rosen & Williams, 2001).  
 
Another factor that may have contributed to the high CE is the low sample sizes 
from which the cell counts were collected. Adding more subjects would have provided a 
better representation of a strain’s average trait and have lowered the error rate. We used 
only the coronal sections for stereological measurements as the cell counting process 
required a more discrete identification of the sub-nuclear regions within the BLA and this 
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proved to be a difficult task with the horizontal sections. Despite the low sample size, the 
error rate is low for the neuron data with a CE of only 0.06. Nevertheless, we consider the 
volumetric measurements to be the most reliable trait data we have gathered for the BLA, 
and it is the linkage map and the QTL yielded by this data that we place more confidence 
on. However, a concern with the volumetric data is the use of both coronal and horizontal 
sections. Unlike the cell counting process, the volumetric measurements required the 
identification of the gross outline of the amygdala from multiple serial sections and 
summing of these areas to obtain the volume, and measurements could be taken from 
both coronal and horizontal sections. More coronal sections than horizontal sections were 
used because the BLA structure is more clearly distinguishable in the coronal sections, 
but for the final data, strain means were calculated from both types of sections. The 
regression analysis does not indicate the inclusion of horizontal sections to have a 
significant effect on the volume data. 
 
 
2.5.3 Interactions between QTLs 
 
Are genetic effects on BLA volume and cell populations specific to this region or 
are they merely secondary effects of variance in brain weight?  Variation in volume of 
specific brain regions may correlate with variation in brain weight. For example, overall 
BLA volume correlates with brain weight (explained variance of 16%). At a finer grain 
of analysis, we can now begin to resolve the sources of this type of covariance. The 
strongest and most significant BLA volume locus, Vol8a, also modulates the volumes of 
the cerebellum and hippocampus, but does not appear to modulate total forebrain volume 
(Beatty & Laughlin, 2006). This suggests that the covariance between BLA volume and 
brain weight can actually be decomposed into an amygdala-hippocampus-cerebellum 
shared QTL. 
 
An interesting point from this analysis is the quantitative effects of the B and D 
alleles on the size of the BLA. In the case of Vol8a, the D allele has the positive additive 
effect and contributes to a larger BLA. In contrast, the suggestive linkage on Chr 19 has 
the B allele with a positive additive effect for both the BLA size and brain weight. This 
may be reflected by the larger brain weight and the generally higher BLA trait values in 
B6 compared to D2 mice (Table 2-1). However, it is worth noting that after regression 
correction for brain weight, the relative volume of B6 BLA is actually smaller than that 
of D2, though this difference does not reach statistical significance. This trend is 
consistent with the surprising finding that despite having a much smaller brain than B6, 
the area of the neocortical barrel field (rostral and dorsolateral neocortex) of D2 is 
significantly larger than that of B6 (Airey et al., 2005; Li et al., 2005). 
 
Linkage of variation in glial cell density to Chr 11 appears to be more BLA 
specific. In contrast to most other traits, regression of this trait against brain weight 
strengthens the LRS. 
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2.5.4 Relations with Other CNS Structures 
 
The amygdala and hippocampus are two closely associated limbic structures and 
the covariance in their sizes and possible common genetic linkages is not unexpected. 
However, the most intense linkage of Vol8a is with the sizes of the BLA and the raw 
IGL, and Vol8a lies only slightly proximal of Cbs8a (Airey et al., 2002). Although the 
cerebellum is not a limbic structure, it has been attributed with emotion-related cognitive 
functions and shares connections with the limbic system (Lee et al., 2004). In addition, 
both the amygdala and cerebellum have been implicated in the etiology of autism (Abell 
et al., 1999). Interestingly, in a study on the coordinated evolution of functionally and 
neuroanatomically related brain regions, the amygdala and cerebellum were the two 
structures that were unexpectedly indicated to have undergone correlated evolutionary 
changes in size across animal species (Barton & Harvey, 2000). These observations point 
to a more intimate relation between the amygdala and cerebellum. 
 
 
2.5.5 Implications for Behavioral Phenotypes 
 
A large literature implicates the amygdala in a range of behavioral processes 
(McIntyre et al., 2003; McGaugh, 2004), and mediation of behavioral responses to drugs 
of abuse (Ryabinin et al., 1999; Floyd et al., 2003; Sharpe et al., 2005).  Of particular 
salience to the present findings, Lin et al. (2005) recently found that mutant mice lacking 
NeuroD2 have reduced cell number and volume of the BLA, but not other amygdala 
nuclei. These mice also exhibit low levels of anxiety and impaired emotional learning. 
This provides an example of how genetically-driven abnormalities in BLA volume may 
translate to disturbances in complex behavioral phenotypes (Rosvold et al., 1954; Prather 
et al., 2001). In this context, a correlative analysis of BLA traits with a range of 
behavioral phenotypes catalogued in GN highlights significant associations between BLA 
and responses to drugs of abuse, and emotionality. The association is especially 
significant between the BLA volume and cocaine induced behavioral responses as 
measured by the open field behavior (Jones et al., 1999; GN trait 10333). The shared 
linkage intervals between the brain structure and behavioral phenotype signify multiple 
genetic loci that may modulate the formation and structure of a neural substrate, which, in 
turn, underlies a complex behavior. Several studies have underscored the role of the BLA 
in chronic addiction to drugs of abuse and cocaine seeking behavior (See et al., 2003; 
Fuchs et al., 2006), and psychostimulants which alter locomotor activity levels in animals 
have been shown to have specific effects on the basolateral complex (Trinh et al., 2003). 
A genetic dissection of the amygdala may provide further insights into genetics of these 
behaviors. 
 
 
2.5.6 Conclusion  
 
In this study we combined three complimentary methods to study the BLA: (1) a 
classic quantitative dissection of the BLA; (2) an analysis of gene expression across the 
same BXD strains, as well as high resolution spatial data on gene expression using in situ 
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gene expression data provided by ABA; and (3) a correlative analysis using 30 years of 
studies on the BXD strains. On the basis of transcript expression covariance with the 
BLA size and cell populations, and the presence of SNPs, the following three genes are 
prime candidates: Large, NeuroD2, and Thra. 
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CHAPTER 3. VARIATION IN MOUSE BASOLATERAL AMYGDALA 
VOLUME IS ASSOCIATED WITH DIFFERENCES IN STRESS REACTIVITY 
AND FEAR LEARNING
*
 
 
 
3.1 Synopsis 
 
A wealth of research identifies the amygdala as a key brain region mediating 
negative affect, and implicates amygdala dysfunction in the pathophysiology of anxiety 
disorders. Although there is a strong genetic component to anxiety disorders such as 
posttraumatic stress disorder (PTSD) there remains debate about whether abnormalities in 
amygdala function predispose to these disorders. In the present study, groups of C57BL/6 
x DBA/2 (B x D) recombinant inbred strains of mice were selected for differences in 
volume of the basolateral amygdala complex (BLA). Strains with relatively small, 
medium, or large BLA volumes were compared for Pavlovian fear learning and memory, 
anxiety-related behaviors, depression-related behavior, and glucocorticoid responses to 
stress. Strains with relatively small BLA exhibited stronger conditioned fear responses to 
both auditory tone and contextual stimuli, as compared to groups with larger BLA. The 
small BLA group also showed significantly greater corticosterone responses to stress than 
the larger BLA groups. BLA volume did not predict clear differences in measures of 
anxiety-like behavior or depression-related behavior, other than greater locomotor 
inhibition to novelty in mice with smaller BLA. Neither striatal, hippocampal nor 
cerebellar volumes correlated significantly with any behavioral measure. The present data 
demonstrate a phenotype of enhanced fear conditioning and exaggerated glucocorticoid 
responses to stress associated with small BLA volume. This profile is reminiscent of the 
increased fear processing and fear reactivity that is associated with amygdala excitability 
and reduced amygdala volume in humans carrying loss of function polumorphism in the 
serotonin transporter and monoamine oxidase A genes. Our study provides a unique 
example of how natural variation in amygdala volume associates with specific fear- and 
stress-related phenotypes in rodents, and further supports the role of amygdala 
dysfunction in anxiety disorders such as PTSD. 
 
 
3.2 Introduction 
 
The past decade has seen great advances in understanding how genetically driven 
individual differences in the anatomy and function of specific brain regions confer risk 
for a variety of neuropsychiatric diseases (Caspi & Moffitt, 2006; Hariri et al., 2006). 
This literature is based upon the assumption that associations between genes, neural 
function, and clinical end points are causative in nature. However, associations between 
clinical symptoms and measures of neural activation are invariably made a posteriori: 
                                                
*
 Adapted with permission from Nature Publishing Group. Yang RJ, Mozhui K, Karlsson 
RM, Cameron HA, Williams RW, Holmes A (2008). Variation in mouse basolateral 
amygdala volume is associated with differences in stress reactivity and fear learning. 
Neurophychopharmacology 22:2595–2604. 
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that is, after the phenotype is observed. By contrast, there has been little demonstration 
that variation in a brain region of interest can successfully predict, a priori, the likely 
prevalence of a clinical or behavioral trait. 
 
A pertinent case in point is posttraumatic stress disorder (PTSD). There is a 
significant genetic component to risk for PTSD (Kendler, 2001), as well as neurological 
abnormalities in unaffected probands that are suggestive of antecedent genetic or familial 
risk factors (Gurvits et al., 2006). Functional neuroimaging studies have identified 
hyperactivityof the amygdala as a neural correlate for the clinical symptoms seen in 
PTSD (Rauch et al., 2006; Shin et al., 2006). In addition, some but not all structural 
imaging and postmortem studies have found a trend for smaller left amygdala volume in 
patients with the disorder (Bremner et al., 1997; Bonne et al., 2001; De Bellis et al., 2001, 
2002; Fennema-Notestine et al., 2002; Lindauer et al., 2004; Wignall et al., 2004; Karl et 
al., 2006). Taken together, these findings suggest that amygdala dysfunction may 
predispose individuals to PTSD and other stress-related disorders. However, while there 
are data showing that smaller hippocampal volume can precede the development of 
PTSD (Gilbertsob et al., 2002), the hypthesis that variation in amygdala anatomy can lead 
to PTSD has not been directly tested. 
 
A major role for the amygdala in PTSD is consistent with a large corpus of data 
from animal models demonstrating amygdala mediation of a spectrum of behavioral and 
mnemonic functions that include, but are not limited to, the regulation of emotion and 
negative affect (Davis & Whalen, 2001; Robbins & Everitt, 2002; Fanselow & Poulos, 
2005; Phelps & LeDoux, 2005). Ablation of specific subnuclei of the rat amygdala 
produces alterations in certain fear-, anxiety-, and stress-related behaviors. Specifically, 
the basolateral amygdala complex (BLA) appears necessary for the formation and/or 
expression of associative fear memories. This has led to a model in which the lateral 
nucleus within BLA serves as a convergence site for sensory and aversive information 
that is relayed eitherdirectly or via the basal nucleus to the major output center of the 
amygdala, the central nucleus (CeA), to drive fear-related behaviors (Fanselow & 
LeDoux, 1999; Maren & Quirk, 2004). Thus, rodents receiving pre-training lesions of the 
lateral, but not basal, nucleus fail to form fear memories (Goosens & Maren, 2001; Nader 
et al., 2001; Koo et al., 2004), while post-training lesions of the basal nucleus prevent the 
expression of fear memory but not the ability to acquire new memories (Anglada-
Figueroa & Quirk, 2005). These findings provide clear evidence that the BLA is 
necessary for certain forms of learned fear behavior. They do not, however, address the 
issue of whether natural variation in amygdala anatomy and function is sufficient to 
predict differences in these behaviors. 
 
In the present study, we sought to address this issue by utilizing a genetically 
defined panel of C57BL/6 x DBA/2 (BXD) recombinant inbred strains that we have 
recently shown to exhibit up to 2-fold variation in BLA volume in large sample of 37 RI 
lines (Mozhui et al., 2007). BXD RI mice are inbred strains derived from C57BL/6 and 
DBA/2 (Taylor, 1989; Chesler et al., 2003) that have been used to identify chromosomal 
loci underlying fear- and anxiety-related phenotypes (Caldarone et al., 1997; Owen et al., 
1997; Wehneret et al., 1997; Valentinuzzi et al., 1998), as well as volume and cell 
 37 
number variation in various brain regions (Neumannet et al., 1993; Airey et al., 2001, 
2002; Lu et al., 2001; Rosen &Williams, 2001; Williams et al., 2001a; Seecharan et al., 
2003). We selected 17 BXD RI lines and assigned them to subgroups with relatively 
small, medium, and large BLA volume. Our objective was to test whether a priori 
categorization of mice according to BLA volume differences within a natural range was 
sufficient to predict differences in fear-, anxiety-, and stress-related phenotypes. The 
results obtained provide some of the strongest evidence to date that genetically driven 
variation in amygdala volume is sufficient to predict the magnitude of fear- and stress-
related phenotypes. 
 
 
3.3 Materials and Methods 
 
 
3.3.1 Histology 
 
Histological analysis of the BXD RI lines was performed previously at the 
Department of Anatomy and Neurobiology, University of Tennessee Health Science 
Center, and is described in detail by Mozhui et al. (2007). Briefly, the BLA complex was 
defined as the portion between the external capsule and the amygdalar capsule, as 
described by Swanson and Petrovich (1998). This includes the lateral and basolateral, but 
not basomedial, nuclei (Figure 3-1A). Images from bilateral 30 mm thick serial sections 
were captured from a Zeiss light microscope to a computer and the BLA was manually 
traced to determine cross-sectional area (mm
2
) along the entire rostrocaudal thickness of 
the BLA (B6–9 sections for each brain). Volume was calculated by multiplying the 
interval thickness between serial sections (which was 300 mm) and correcting for 
volumetric shrinkage caused by the histological process ((measured values/total brain 
volume) x expected brain volume for given brain weight). Post-processing total brain 
volume was determined by the point-counting method described by Williams (2000). 
These data can be viewed at an anatomical database at http://www.genenetwork.org. 
 
 
3.3.2 Selection of BXD RI Lines and Assignment to BLA Volume Groups 
 
In an earlier study, we conducted a comprehensive analysis of 35 BXD RI lines 
(plus the C57BL/6J and DBA/2J parental lines) for BLA volume (Mozhui et al., 2007). 
This revealed up to 2-fold variation in BLA volume across this panel of RI lines. In the 
current study we obtained a subset of this larger panel. We selected lines on the basis of a 
desire to obtain a range of relatively small, medium, and large BLA volumes; but this 
was limited by the availability of lines from a single commercial vendor (The Jackson 
Laboratory, Bar Harbor, ME), which was necessary to avoid a potentially confounding 
source of variability (ie supplier). Of the 15 BXD RI lines (plus the C57BL/6J and 
DBA/2J parental lines) obtained, we cross-referenced with the dataset (Mozhui et al., 
2007) to assign an approximately equal number of lines to ‘small,’ ‘medium,’ and ‘large’ 
groups. This resulted in five lines in the small group (BXD13, BXD21, BXD28, BXD38,  
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Figure 3-1 Basolateral amygdala volume differences in BXD RI lines 
(A) Neuroantomical definitions of the BLA complex. (B) BLA volume differences in 
mice selected for relatively small (S), medium (M), and large (L) BLA. (C) Dorsal 
striatal, total hippocampal, and total cerebellar volume differences in mice selected for 
BLA volume differences (n = 24–34 per volume group). 
**
p < 0.01 vs L, 
##
 p < vs M. 
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and BXD39), seven lines in the medium group (BXD8, BXD11, BXD12, BXD23, 
BXD31, BXD34, and DBA/2J), and five lines in the large group (BXD16, BXD19, 
BXD22, BXD32, and C57BL/6J). Next, we took the BLA volume data for each line (an 
average of n = 4–8 mice per line) from the dataset (Mozhui et al., 2007) and calculated 
the mean average and within-group variance of BLA volume within each of our three 
volume groupings. Volume differences between the subgroups were then analyzed using 
one-way analysis of variance (ANOVA) followed by Newman–Keuls post hoc analysis. 
This showed that the subgroups differed significantly from one another (main effect of 
volume group: F2, 14 = 18.58, post hoc comparisons: all p < 0.01). For depiction of mean 
differences and within-group variance as measured by standard error, see Figure 3-1B. 
 
To determine whether BLA volume differences in our groups generalized to other 
brain regions, we obtained the volume values for dorsal striatum (caudate putamen), total 
hippocampus, and total cerebellum in each of the RI lines we tested from 
http://www.genenetwork.org. These data were originally described in the following 
sources: for dorsal striatum, Rosen and Williams (2001) and Lu et al. (2001); for 
hippocampus, including dentate gyrus, excluding subiculum, Peirce et al. (2003); and for 
cerebellum, Airey et al. (2001). One-way ANOVA and post hoc tests showed that the 
subset of RI lines we designated as the large BLA groups also had significantly greater 
striatal volume than the group designated as the small BLA group (main effect of group: 
F2, 14 = 3.78, p < 0.05, post hoc comparison: p < 0.05; Figure 3-1C). ANOVA showed 
that the BLA subgroups did not significantly differ in either total hippocampal or 
cerebellar volume (Figure 3-1C). 
 
 
3.3.3 Animal Husbandry and Behavioral Phenotyping 
 
Mice were bred at The Jackson Laboratory and transported to the NIH at ~8 
weeks of age and housed 1–4 per cage in same-strain groupings in a temperature- and 
humidity-controlled vivarium under a 12 h light–dark cycle (lights on 0600 hours). There 
were a total of 190 male mice at the start of the study, with at least n = 8–12/RI line 
except for BXD28 (n = 5). This resulted in a total of 47 mice in the small BLA group, 82 
in the medium BLA group, and 61 in the large BLA group. Behavioral testing was 
conducted during the light phase between 0900 and 1700 hours. Given evidence of 
qualitative differences between rodent tests for anxiety-like behavior (Holmes et al., 
2003), three separate tests were employed. Mice were tested on a battery of tests in the 
following order with the putatively more stressful assays at the end of the sequence and at 
least 1 week between tests: exploratory and anxiety-like behavior (novel open-field, 
elevated plus-maze, light–dark exploration tests), Pavlovian fear conditioning, 
depression-related behavior (forced swim test, FST), hot plate (as a control for pain 
perception in fear conditioning), and glucocorticoid responses to stress (corticosterone 
levels following swim stress). All experimental procedures were performed in accordance 
with the National Institutes of Health Guide for Care and Use of Laboratory Animals and 
were approved by the local Animal Care and Use Committee. 
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3.3.4 Pavlovian Fear Conditioning 
 
Pavlovian fear conditioning (Kim & Fanselow, 1992) was conducted in a chamber 
with transparent walls and a metal rod floor based on methods described previously 
(Wellman et al., 2007). To provide a distinctive olfactory environment, the chamber was 
cleaned between subjects with a 79.5% water/19.5% ethanol/1% vanilla extract solution. 
After an initial 120 s acclimation period, the mouse received three pairings (60–120 s 
interval after each pairing) between the conditioned stimulus (CS; 30 s, 80 dB, 3 kHz 
tone) and the unconditioned stimulus (US; 2 s, 0.6mA scrambled footshock), in which the 
US was presented during the last 2 s of the CS. The presentation of stimuli was controlled 
by a San Diego Instruments (San Diego Instruments, San Diego, CA) or Med Associates 
fear conditioning system (Med Associates, Burlington, VT). 
 
After 24 h, expression of the fear memory for the CS was tested in a novel 
context, in a different room from training. The novel context had black/white checkered 
walls and a solid Plexiglas, opaque floor. This chamber was cleaned between subjects 
with a 50% ethanol/50% water solution. After an initial 180 s acclimation period, the CS 
was continuously presented for 180 s. After 24 h, expression of the fear memory for the 
conditioned context was tested in the same room as conditioning by placing the mouse in 
the training chamber for 5 min. Freezing was defined as absence of any visible movement 
except that required for respiration, and was scored at 5 s intervals by an observer who 
was blind to BXD line. The number of observations scored as freezing was converted to a 
percentage ((number of freezing observations/total number of observations) x 100) for 
analysis. 
 
The hot plate test was conducted as a control for group differences in pain 
perception (Boyce-Rustay & Holmes, 2006). The apparatus was a flat plate (Columbus 
Instruments, Columbus, OH) heated to 551C on which the mouse was placed. The 
latency to show a hind paw shake or lick was timed by an observer, with a maximum 
response latency of 30 s. 
 
 
3.3.5 Depression-Related Behavior and Glucocorticoid Responses to Stress 
 
The FST was conducted as previously described (Porsolt et al., 1978; Hefner & 
Holmes, 2007). The apparatus was a transparent Plexiglas cylinder (25 cm high, 20 cm 
diameter) filled halfway with water (24 ± 1° C) into which the mouse was gently lowered 
for a 10 min trial. The presence/absence of immobility (cessation of limb movements 
except minor involuntary movements of the hind limbs) was manually observed using an 
instantaneous sampling technique every 5 s during the last 8 min and expressed as a 
percentage of total observations. The result was converted to a percentage ((number of 
immobility observations/total number of observations) x 100) for analysis. 
 
Glucocorticoid responses to stress were measured after a 4-week rest period 
following the FST described above. The mouse was subjected to a 10 min forced swim 
stress trial and then returned to the home cage. After 30 min, mice were killed via rapid 
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cervical dislocation and decapitation to collect trunk blood. Nonstressed controls were 
killed within 30 s of removal from the home cage. To minimize disturbance of 
nonstressed controls, all mice were individually housed 24 h prior to killing. Blood 
samples were centrifuged at 13 000 r.p.m. for 30 s. Serum was extracted and assayed for 
total corticosterone (bound and free) using the Coat-a-Count RIA TKRC1 kit (limit of 
detection 5.7 ng/ml; Diagnostic Products Corp, Los Angeles) as previously described 
(Boyce-Rustay et al., 2007). 
 
 
3.3.6 Anxiety-Related Behavior 
 
The novel open-field test was conducted as previously described (Wiedholz et al., 
2007). The apparatus was a square arena (39 cm x 39 cm x 35 cm) with opaque white 
Plexiglas walls and floor that was evenly illuminated to B20 lux. The mouse was placed 
in a corner and allowed to freely explore for 30min. Distance traveled, time spent 
moving, time spent in the (20 cm x 20 cm) center, and entries into the center were 
measured using the Ethovision videotracking system (Noldus Information Technology 
Inc., Leesburg, VA). The apparatus was cleaned with 70% EtOH (v/v) and dried between 
subjects. 
 
The elevated plus-maze test was conducted as previously described (Handley & 
Mithani, 1984; Boyce-Rustay & Holmes, 2006). The apparatus consisted of two open 
arms (30 cm x 5 cm; 55 lux) and two closed arms (30 cm x 5 cm x 15 cm; 5 lux) 
extending from a 5 cm x 5 cm central area and elevated 20 cm from the ground (San 
Diego Instruments). The walls were made from black ABS plastic and the floor from 
white ABS plastic. A 0.5 cm raised lip around the perimeter of the open arms prevented 
mice from falling off the maze. The mouse was placed in the center facing an open arm 
and allowed to explore the apparatus for 5 min. Time spent in the open arms, and entries 
into the open and closed arms were measured by the Ethovision videotracking system 
(Noldus Information Technology Inc.). The apparatus was cleaned with 70% EtOH (v/v) 
and dried between subjects. 
 
The light–dark exploration test was conducted as previously described (Crawley, 
1981; Boyce-Rustay & Holmes, 2006). The apparatus consisted of two compartments 
(each 17 cm x 13 cm x 13 cm), one with white Plexiglas walls and clear Plexiglas floor 
(40 lux) (‘light’ compartment) and the other with black Plexiglas walls and clear 
Plexiglas floor (0 lux) (‘dark’ compartment), which were connected by a partition at floor 
level with a small opening (5 cm) (Med Associates, Georgia, VT, Model ENV-3013). 
The mouse was placed into the dark compartment facing away from the aperture and 
allowed to explore the apparatus for 10 min. Time spent and full-body transitions into the 
light compartment, and total full-body transitions between the light and dark 
compartments were measured by photocells connected to Med Associates software. The 
apparatus was cleaned with 70% EtOH (v/v) and dried between subjects. 
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3.3.7 Statistics 
 
BLA group effects were analyzed using ANOVA and Newman–Keuls post hoc 
tests where appropriate. One mouse was an extreme outlier (45 standard deviation from 
the mean) for preconditioning freezing and was excluded from the study. Genetic 
correlations were performed (treating each of the 17 strains as an individual data point) 
between BLA, dorsal striatal, total hippocampal, and cerebellar volume, and behavioral 
and neuroendocrine measures using Spearman’s test. The threshold for statistical 
significance was set at p < 0.05.  
 
 
3.4 Results 
 
 
3.4.1 Pavlovian Fear Conditioning 
 
There was no significant difference between BLA groups for percent freezing 
during the (2-min) preconditioning or (2-min) postconditioning periods (Figure 3-2A). 
BLA groups significantly differed in percent freezing to the CS (F2, 158 = 7.74, p < 0.01) 
and context (F2, 159 = 5.37, p < 0.01). The small BLA group froze more in response to the 
CS (Figure 3-2B) and to the context (Figure 3-2C) than the medium or large groups. 
There was a significant genetic correlation between freezing to CS and volume of BLA, 
but not striatum, hippocampus, or cerebellum (Table 3-1). 
 
There were no group differences in the hot plate test for nociception (mean ± 
SEM latency to respond: small = 6.42 ± 0.47 s, medium = 7.39 ± 0.48 s and large = 6.14 
± 0.37 s). 
 
 
3.4.2 Depression-Related Behavior and Glucocorticoid Responses to Stress 
 
There was no effect of BLA group on percent immobility in the FST (Figure      
3-3A). Corticosterone levels were affected by stress in a BLA group-dependent manner 
(stress x group interaction: F2, 41 = 3.41, p < 0.05). While there were no group differences 
in corticosterone in nonstressed mice, corticosterone levels following stress were 
significantly greater in the small BLA group than the medium or large groups (Figure   
3-3B). There was a significant baseline correlation between nonstressed corticosterone 
and striatal, but not BLA, hippocampus, or cerebellar, volume (Table 3-1). 
 
 
3.4.3 Tests for Anxiety-Related Behavior 
 
There was a significant effect of BLA group on distance traveled (F2, 186 = 8.21, p 
< 0.01), but not percent time in the center in the novel open-field test. The small BLA 
volume group traveled less than the medium or large BLA volume groups (Figure 3-4A), 
while percent time in the center was no different between groups (Figure 3-4B). There  
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Figure 3-2 Pavlovian fear conditioning in mice differing in BLA volume 
(A) There were no differences in freezing during the preconditioning and immediate 
postconditioning periods between mice with relativel small (S), medium (M), or large (L) 
BLA volume. The small BLA group froze more than medium or large BLA groups 
during exposure to the conditioned stimulus (CS) (B) and conditioned context (C) (n = 
35–75 per volume group). 
**
p < 0.01, 
*
p < 0.05 vs L, 
##
p < 0.01 vs. M. 
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Table 3-1 Genetic correlations between BLA, striatum, hippocampus, 
cerebellum and behavior. 
 
Behavior BLA Striatum Hippocampus Cerebellum 
     
Pavlovian fear conditioning     
Preconditioning freezing –0.23 –0.04 –0.33 0.52 
Postconditioning freezing –0.03 –0.05 –0.17 0.20 
Freezing to conditioned cue –0.50* –0.21 –0.42 –0.03 
Freezing to conditioned 
context 
–0.29 0.06 –0.06 0.21 
     
Forced swim test     
Immobility –0.13 –0.30 0.02 –0.25 
     
Corticosterone     
Baseline –0.10 –0.42* –0.24 – 
Poststress –0.49 0.18 0.18 0.37 
     
Novel open field     
Distance traveled 0.50* 0.04 0.30 –0.41 
Center time 0.34 0.18 0.39 –0.12 
     
Elevated plus maze     
Time in open arms 0.04 –0.47 –0.31 –0.12 
Time in center square 0.65* 0.43 0.16 –0.05 
Total arm entries 0.38 0.21 –0.02 –0.07 
Open arm entries 0.02 –0.35 –0.06 –0.23 
Closed arm entries 0.43 0.42 0.06 0.22 
     
Dark-light exploration     
Time in light 0.37 –0.12 0.27 –0.24 
Light-dark transitions 0.34 –0.20 0.11 –0.24 
      BLA, basolateral amygdala complex, *p < 0.05 
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Figure 3-3 Depression-related behavior and glucocorticoid responses to stress in 
mice differing in BLA volume 
(A) BLA volume was not associated with differences in percent immobility in the forced 
swim test (n = 25–49 per volume group). (B) Mice with relatively small (S) BLA showed 
normal baseline corticosterone, but higher corticosterone responses to swim stress than 
medium (M) or large (L) BLA groups  (n = 5–ß11 per volume group per stress 
condition). 
**
p < 0.01, 
*
p < 0.05 vs. L. 
 
 46 
 
 
Figure 3-4 Exploratory- and anxiety-like behaviors in mice differing in BLA 
volume 
Mice with relatively small (S) BLA traveled less distance than mice with medium (M) or 
large (L) BLA (A) while groups showed equivalent percent center time (B). Small and 
medium BLA groups spent less time in the center square but not open arms (C) and made 
fewer total and closed but not open arm entries (D) in the elevated plus-maze than the 
large BLA group. Small and medium BLA groups spent less time in the light 
compartment (E) and made fewer light–dark transitions (F) in the light–dark exploration 
test than the large BLA group (n = 35–84 per volume group). 
**
p < 0.01, 
*
p < 0.05 vs. L,
 
##
p < 0.01, 
#
p < 0.05 vs. M. 
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was a significant genetic correlation between distance traveled and volume of BLA, but 
not striatum, hippocampus or cerebellum (Table 3-1). 
 
There was a significant effect of BLA group on total (F2, 183 = 4.24, p < 0.05) and 
closed arm entries (F2, 183 = 6.93, p < 0.01) and percent time in the center square (F2, 183 = 
8.28, p < 0.01), but not percent open arm time or open arm entries in the elevated plus-
maze. The medium and small BLA groups spent less time in the center square (Figure   
3-4C) and made fewer total and closed arm entries (Figure 3-4D) than the large BLA 
volume group. There was a significant genetic correlation between percent center time 
and volume of BLA, but not striatum, hippocampus, or cerebellum (Table 3-1). 
 
There was a significant effect of BLA group on percent time in the light 
compartment (F2, 175 = 4.14, p < 0.05) and light–dark transitions (F2, 175 = 13.16, p < 0.01) 
in the light–dark exploration test. The medium and small BLA groups spent less time in 
the light compartment (Figure 3-4E) and made fewer light–dark transitions (Figure       
3-4F) than the large BLA volume group, while the medium group made fewer transitions 
than the large group. Neither measure significantly correlated with volume of BLA, 
striatum, hippocampus, or cerebellum (Table 3-1). 
 
 
3.5 Discussion 
 
The major finding of the present study was that variation in volume of the BLA 
complex in a panel of BXD RI inbred strains was associated with differences in specific 
measures of mouse fear-, anxiety-, depression-, and stress-related phenotypes. 
 
There is compelling evidence that the BLA is necessary for the formation and 
expression of associative fear memories, as typically evidenced by the effects of lesions 
on the type of Pavlovian fear conditioning task employed in our study (Davis & Whalen, 
2001; Fanselow & Poulos, 2005; Phelps & LeDoux, 2005). The present findings 
reinforce and extend this literature by showing that mice with naturally occurring 
variation in BLA volume exhibit significant differences in fear conditioning. BXD RI 
strains selected for BLA volumes that were relatively small showed significantly greater 
levels of conditioned freezing than strains with a larger BLA. There were no differences 
in levels of freezing immediately prior to or immediately after conditioning, 
demonstrating that differences between BLA groups in the recall/expression of fear 
memory were not due to differences in unconditioned freezing or in capacity to express 
short-term fear memory. Moreover, pain perception measured in the hot plate test did not 
differ between the groups, excluding variation in pain perception as a confounding 
influence. 
 
Differences in fear expression between BLA volume groups were found both for 
conditioned fear to discrete (auditory cue) and compound (context) stimuli, which is 
consistent with the ability of BLA lesions (Goosens & Maren, 2001) and gene knockout-
induced gross disruption of BLA (Lin et al., 2005) to impair both forms of associative 
fear memory. Interestingly however, there was a significant genetic correlation between 
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BLA volume-varying BXD lines and cued, but not contextual, conditioned fear. A 
relatively greater correlation for cued conditioning is in agreement with evidence from 
lesion studies demonstrating the importance of the BLA for cued relative to contextual 
fear conditioning, the latter involving greater recruitment of additional structures, notably 
the hippocampus (Maren & Quirk, 2004). These data also concur with gene-mapping 
studies in BXD RIs indicating that cued and contextual conditioning are under partly 
dissociable genetic control (Owen et al., 1997; Wehner et al., 1997). Finally, the fact that 
we were able to detect two correlating phenotypic traits (BLA volume and fear memory) 
across two laboratories (University of Tennessee, NIH) speaks both to the strength and 
replicability of the underlying genetic component (Wahlsten et al., 2006). 
 
BLA volume-related variation in fear conditioning was dissociated from 
differences in anxiety-like behavior. The small BLA volume group showed less 
locomotor exploration in the novel open-field and elevated plus-maze than the larger 
BLA groups, but there were no differences in the principal measures of anxiety-like 
behavior (open-field center time, elevated plus-maze open arm exploration). In a third 
test of anxiety-like behavior, the light–dark exploration test, the small and medium BLA 
groups spent less time in the light compartment and made fewer light–dark 
intercompartment transitions than the large BLA group. Different mouse tests for anxiety 
likely measure different forms of behavior controlled by distinct genetic factors (Turri et 
al., 1999; Holmes et al., 2003; Kliethermes & Crabbe, 2006) and it is possible that the 
profile of the small and medium BLA groups in the light–dark exploration test reflects a 
high anxiety-like phenotype that is not seen in the other tests. Taken together however, 
the differences between BLA volume groups on the anxiety-related assays (particularly 
the open-field and light–dark exploration tests) were marginal and are most 
parsimoniously interpreted as modest locomotor inhibition in response to novelty rather 
than a clear high anxiety-like phenotype in mice with smaller BLA volumes. Indeed, the 
absence of anxiety-related differences would be consistent with the lack of effects of 
BLA lesions or temporary inactivation on anxiety-like behaviors in rats tested under the 
standard task conditions used in the current study (Decker et al., 1995; Moller et al., 
1997; Herry et al., 2007; Moreira et al., 2007). 
 
To our knowledge, there has been little investigation of the role of BLA in rodent 
depression-related behaviors; with one study finding no effect of BLA lesions in the rat 
FST for depression-related behavior (Shimazoe et al., 1988). The present data found no 
link between variation in BLA volume and immobility in the mouse FST. By contrast, 
BLA groups differed markedly in their glucocorticoid responses to swim stress. Thus, 
while baseline levels of corticosterone were no different between the groups, 
corticosterone levels following swim stress were significantly greater in small BLA mice 
than in the larger BLA groups. 
 
A pathway from the main output nucleus of the amygdala, the CeA, to the 
paraventricular nucleus of the hypothalamus (Swanson & Petrovich, 1998) is thought to 
modulate hypothalamic–pituitary–adrenal (HPA) axis responses to stress (reviewed in 
Herman et al., 2005). Lesions encompassing the CeA can inhibit HPA-axis responses to 
at least some forms of stress (Beaulieu et al., 1986; Van de Kar et al., 1991), whereas 
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amygdala stimulation can increase glucocorticoid release (Redgate & Fahringer, 1973; 
Dunn & Whitener, 1986). As such, the relatively greater HPA-axis response in small 
BLA mice could be another manifestation of abnormal amygdala function. 
 
Corticosterone also exerts effects within the amygdala via glucocorticoid 
receptors (Aronsson et al., 1988). Of particular interest in this context, BLA has been 
identified as a critical site of action through which glucocorticoids modulate associative 
fear memory, (for example) glucocorticoid receptor agonists administered systemically or 
directly into the BLA enhance fear conditioning in rats (Zorawski & Killcross, 2002; Hui 
et al., 2004; Roozendaal et al., 2006). This raises the possibility that increased 
glucocorticoid receptor activity in smaller BLA mice may be a factor driving enhanced 
fear conditioning, although this remains to be tested. A related issue is whether BLA 
variation is a consequence rather than cause of differences in stress reactivity. While we 
do not discount this possibility it seems unlikely given evidence that chronic stress 
increases rather than decreases spine density and dendritic arborization in rats and mice 
(Vyas et al., 2002; Mitra et al., 2005; Govindarajan et al., 2006). On the other hand, 
because stress causes dendritic shrinkage in rodent ventromedial prefrontal cortex 
(vmPFC) (Wellman, 2001; Izquierdo et al., 2006; Radley et al., 2006), it would be of 
interest to examine vmPFC and fear-related behaviors mediated by vmPFC such as fear 
extinction (Quirk & Mueller, 2007) in mice with different BLA volumes. 
 
BLA groups were selected for differences in BLA volume; and the fact that 
groups comprised multiple RI strains, each with a unique genotype, reduces the 
likelihood that differences in fear conditioning and stress reactivity were due to spurious 
idiosyncrasies (for example poor vision, hearing, nociception) of specific strains. 
However, this approach cannot exclude the potential contribution of other phenotypic 
traits that covary with BLA volume. We have recently shown that a common genetic 
locus may underlie the structures of multiple forebrain regions including amygdala, 
cerebellum, dorsal striatum, and portions of the hippocampus (Mozhui et al., 2007). 
Analysis of the volume of these three structures in our three BLA volume groups 
indicated volume differences in dorsal striatal but not hippocampal or cerebellar volume, 
raising the possibility that striatal volume variation contributed to behavioral differences 
between BLA groups, (for example via affects on motor function). Arguing against this 
possibility, however, there were no significant correlations between striatal volume and 
any behavioral measure (c.f. baseline corticosterone), while BLA volume significantly 
correlated with novel open-field locomotion. Moreover, BLA volume predicted 
corticosterone responses to stress, unlikely to be influenced by locomotion, while other 
measures predicted to be affected by locomotor differences, such as FST immobility, 
were unrelated to BLA volume. Nonetheless, although present data suggest a specific 
influence of amygdala function on fear conditioning and stress reactivity, we cannot rule 
out the possible contribution of differences in other brain regions or other, as yet 
undetermined, traits genetically correlated with BLA volume. In fact, given the highly 
integrated nature of the neural circuitry subserving stress, fear, and anxiety behaviors 
(Amat et al., 2005; Hariri & Holmes, 2006; Quirk & Mueller, 2007; Ressler & Mayberg, 
2007; Wellman et al., 2007), it is unlikely that the amygdala would act in isolation to 
mediate these complex functions. 
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The finding that relatively smaller BLA is associated with increased fear and 
stress reactivity may at first appear counterintuitive given the effects of amygdala lesions, 
but this is in fact entirely consonant with recent findings from genetic studies in humans. 
For example, functional neuroimaging studies of two gene variants implicated in stress-
related disorders, the low-expressing forms of the serotonin transporter and monoamine 
oxidase A, demonstrate that these variants produce exaggerated amygdala reactivity 
during fear processing and that this is coupled with lesser amygdala volume (Pezawas et 
al., 2005; Meyer-Lindenberg et al., 2006). The volume differences underlying these fear-
related phenotypes were modest, as they were in our mouse sample. Thus, it appears that 
relatively modest variation in BLA volume is sufficient to determine fear- and stress-
related phenotypes. 
 
Elucidating the molecular and physiological factors associated with volume 
differences is likely to be key to understanding this relationship between BLA volume 
and behavior. A pertinent observation in this regard is that the total number of neurons 
(and non-neuronal cells) in BLA was equivalent across BLA volume groups (Mozhui et 
al., 2007), indicating that rather than having a relative loss of neurons, the smaller BLA 
mice had a slightly denser packing of neurons (Mozhui et al., 2007). An important 
question for future studies will be how variation in this and other intrinsic properties of 
BLA, such as neuronal morphology and the ratio of excitatory over inhibitory cells, 
might contribute to the behavioral differences between BLA volume groups. Another 
interesting question is whether phenotypic differences between BLA groups are localized 
to specific subnuclei within the BLA complex. For example, akin to the small BLA 
phenotype observed in our study, lesions of the lateral nucleus prior to fear conditioning 
block acquisition (Goosens & Maren, 2001; Nader et al., 2001; Koo et al., 2004), 
postconditioning lesions of the basal nucleus (corresponding to basolateral nucleus in 
Figure 3-1A) impair the expression, but not acquisition, of fear memory (Anglada-
Figueroa & Quirk, 2005). 
 
In summary, the present study has shown that variation in BLA volume is 
associated with differences in fear memory, glucocorticoid responses to stress, and 
locomotor inhibition in response to novelty. The present findings also provide parallels 
with clinical data, to the extent that PTSD patients also exhibit enhanced fear memory 
(American Psychiatric Association, 1994; Peri et al., 2000) and exaggerated 
glucocorticoid responses to stress (Yehuda, 2002; de Kloet et al., 2006), as well as 
amygdala hyperactivity and possibly smaller amygdala volume (Bremner et al., 1997; 
Wignall et al., 2004; Karl et al., 2006; Rauch et al., 2006; Shin et al., 2006), relative to 
controls. Thus, the present study not only provides a novel extension to the literature 
linking the amygdala with fear- and stress-related processing with possible implications 
for understanding amygdala dysfunction in PTSD, but also provides one of the first 
examples of how structural variation in a specific brain region can successfully predict 
differences in specific phenotypic traits in the rodent. 
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CHAPTER 4. GENETIC VARIATION IN STRESS SUSCEPTIBILITY IS 
ASSOCIATED WITH DIVERGENT CORTICOLIMBIC GENE EXPRESSION 
 
 
4.1 Synopsis 
 
Genetic factors have significant influence in determining an individual’s 
susceptibility to the adverse effects of stress. In this study, we used diverse inbred mouse 
strains as models to examine the genotype dependent effect of stress. Seven different 
inbred strains—129/SvImJ, A/J, BALB/cJ, BALB/cByJ, C57BL/6J (B6), DBA2/J (D2), 
and FVBN/J—were subjected to repeated restraint stress. Their relative vulnerability to 
stress was then assessed using different behavioral and physiological indices. We found 
significant strain differences in anxiety- and depression-like phenotypes, and differences 
in blood corticosterone level in response to stress. Of particular interest was the 
behavioral divergence between B6 and D2. D2 showed a much higher basal anxiety-like 
behavior than B6, and anxiety level was heightened by restraint stress. In contrast, B6 
appeared more resilient to stress and did not show a significant difference in anxiety-like 
behavior before and after the restraint treatment. We further assayed global gene 
expression in the prefrontal cortex, amygdala, and hippocampus of B6 and D2 mice. Our 
analysis detected substantial expression difference between B6 and D2 in all three 
regions. We also identified a large set of genes that showed expression change in 
response to restraint stress, including several genes that have been associated with 
psychiatric illnesses in human (e.g., Homer1, Nr4a2, Gal). In addition, several clock 
genes involved in regulating the circadian rhythm (Per1, Per2, Per3, Dbp) showed an 
upregulation following restraint, suggesting possible links between the molecular 
mediators of stress and the sleep cycle. 
 
 
4.2 Introduction 
 
Stress is a known major risk factor for neuropsychiatric diseases ranging from 
mood and anxiety disorders to schizophrenia and drug addiction. Susceptibility to stress 
varies considerably between individuals and is under the influence of genetic factors 
(Caspi & Moffitt, 2006; Hariri & Holmes, 2006; Yehuda & LeDoux, 2007; Uher & 
McGuffin, 2008). However, despite being the subject of enormous research efforts, the 
specific genes underlying vulnerability and resilience to stress have not yet been well 
established. This is in part due to the complexity that arises from multiple genetic, 
lifestyle and environmental factors in human populations.  
 
Rodents provide important model systems for identifying genetic factors that 
influence vulnerability to stress (Ramos & Mormede, 1998; Cryan & Holmes, 2005). Of 
considerable value are inbred mouse strains. A panel of inbred strains can represent a 
restricted degree of environmental variance, within which each individual strain provides 
a stable genetic pool. Previous studies have shown that inbred strains differ in their 
responses to stress on various neural, neuroendocrine and behavioral measures. For 
example, acute exposure to stress produces heightened anxiety-like behavior and 
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hypothalamic-pituitary-adrenal (HPA)-axis activation in some strains, such as BALB/cJ 
and D2, but less so or not at all in others, such as B6 (Belzung & Griebel, 2001; Anisman 
& Matheson, 2005; Jacobson & Cryan, 2007; Millstein & Holmes, 2007). Inbred mouse 
strains have also been shown to differ in their responses to repeated stress exposure 
(Tannenbaum & Anisman, 2003; Anisman & Matheson, 2005; Mineur et al., 2006), 
although there have been surprisingly few studies of this kind to date. This differential 
sensitivity to repeated stress is particularly pertinent to attempts at modeling human 
neuropsychiatric diseases because risk for these disorders is often associated with history 
of repeated trauma (Caspi et al., 2002; Berton & Nestler, 2006; Yehuda & LeDoux, 2007; 
Holmes & Wellman, 2009). 
 
In the present study, we surveyed anxiety-, depression- and HPA-axis responses 
following repeated stress in genetically diverse inbred mice. This multiple strain 
comparison was done using a panel of seven inbred mice. The aim was to identify strains 
that differ in anxiety-related traits and sensitivity to repeated stress. To this end, we 
employed a repeated restraint stress protocol that has been shown to cause significant 
alterations in the morphology of principal neurons in three key corticolimbic regions 
known to mediate the effects of stress: medial prefrontal cortex (mPFC), amygdala and 
hippocampus (e.g., Vyas et al., 2002; Vyas et al., 2003; Govindarajan et al., 2006; 
Bennur et al., 2007; Shansky et al., 2009). Based on the results obtained, our second 
major aim was to examine gene expression in mPFC, amygdala and hippocampus in two 
strains (B6 and D2) that differed in anxiety-like behavior before and after restraint. 
 
 
4.3 Materials and Methods 
 
 
4.3.1 Subjects 
 
Subjects were male mice of the 129/SvImJ (129S1), A/J, BALB/cJ, BALB/cByJ, 
C57BL/6J (B6), DBA2/J (D2), and FVBN/J inbred strains. These strains were selected on 
the basis of 1) their frequent use in behavioral neuroscience and as genetic backgrounds 
for mouse mutant lines, 2) inclusion as "group A" priority strains in the Mouse Phenome 
Project, an international effort to provide the biomedical research community with 
phenotypic data on the most commonly used mouse strains 
(http://www.jax.org/phenome), and 3) prior studies demonstrating differential trait 
anxiety- and depression-related and stress-sensitivity phenotypes (Anisman & Matheson, 
2005; Millstein & Holmes, 2007). Mice were obtained from The Jackson Laboratory (Bar 
Harbor, ME) to reduce a potential source (i.e., supplier) of genetic and behavioral 
variation. Mice were aged 8-9 wks at the start of the study, housed 2/cage (by strain and 
stress condition), with cages placed side-by-side in a temperature- (72 ± 5° C) and 
humidity- (45 ± 15%) controlled vivarium under a 12 hour light/dark cycle (lights on 
0600 hour). Testing was conducted in a manner counterbalanced for strain and stress 
condition. The number of mice used is given in the figure legends. All experimental 
procedures were approved by the National Institute on Alcohol Abuse and Alcoholism 
Animal Care and Use Committee and followed the National Institute of Health guidelines 
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outlined in ‘Using Animals in Intramural Research’ and the local Animal Care and Use 
Committees. 
 
 
4.3.2 Repeated Restraint Stress 
 
Previous studies have shown that 10 days of immobilization in ‘immobilization 
bags’ produces significant changes in neuronal morphology in the mPFC, basolateral 
amygdala and CA3 region of the hippocampus in rats and mice (Vyas et al., 2003; 
Govindarajan et al., 2006; Shansky et al., 2009). We adopted a modified version of this 
protocol in which mice were placed in ventilated 50 mL Falcon tubes for 2 hour/day 
(1000 – 1200 hr) for 10 consecutive days. To be consistent with earlier studies using this 
stressor in rats and mice (Vyas et al., 2002; Govindarajan et al., 2006; Shansky et al., 
2009), non-stressed controls remained in the home cage. We reasoned that restraint in 
tubes would be a less severe stressor than restraint in immobilization bags and would 
therefore allow us to better detect differential sensitivity to stress across strains than a 
severe stressor that might cause profound changes across all strains. 
 
 
4.3.3 Effect of Repeated Restraint on Body Weight 
 
To obtain a systemic measure of the effects of restraint, we measured reductions 
in body weight (Willner et al., 1996; Pothion et al., 2004; Krishnan et al., 2007; Shansky 
et al., 2009). Changes in body weight over the 10-day restraint period were compared 
between restrained and non-restrained groups. Statistical significance for this and all 
other analyses was set at p ! 0.05. 
 
 
4.3.4 Effect of Repeated Restraint on Anxiety-Related Behavior 
 
Twenty-four hours after the final restraint, mice were tested for anxiety-like 
behavior using the dark-light emergence test, modified from a procedure previously 
described (Holmes et al., 2003). We employed this task rather than more commonly used 
tests for anxiety-like behavior, such as the elevated plus-maze (Cryan & Holmes, 2005), 
because under baseline conditions in our laboratory, B6 mice typically display lesser 
anxiety-like behavior in the emergence test (~25% time out of shelter (e.g., this study) 
than in the elevated plus-maze (~10% open arm time (e.g., Norcross et al., 2008). Thus, 
we predicted that emergence test would facilitate the detection of increases in anxiety-
like behavior caused by stress by avoiding a ‘floor effect.’ 
 
The mouse was placed in an opaque black Plexiglas shelter (39 x 13 x 16 cm) 
with a 13 x 8 cm aperture at floor level that opened onto a large white Plexiglas square 
arena (39 x 39 x 35 cm) illuminated to ~90 lux. Latency to first exit the shelter, the 
number of shelter exits (defined as all 4 paws out of the shelter) and time spent out of the 
shelter in the open field over a 15 min session was recorded by an observer using 
Hindsight (Hindsight, Services, Wokingham, UK). To dissociate the anxiety-related and 
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general exploratory phases of the test session, data were separately analyzed during the 
first 5 min and last 5 min, respectively. The effects of strain and stress were analyzed 
using 2-factor analysis of variance (ANOVA) followed by Newman Keuls post hoc tests. 
 
Given the high number of strains tested and the resultant reduction of power in 
our analysis, we conducted planned post hoc comparisons of strain and/or stress effects in 
the presence of significant ANOVA main effects regardless of whether a significant 
strain x stress interaction effect was also found. 
 
 
4.3.5 Effect of Repeated Restraint on Depression-Related Behavior 
 
Twenty-four hours after the emergence test, mice were assessed for depression-
related behavior in the forced swim test (Porsolt et al., 1977; Cryan & Holmes, 2005). 
Mice were gently lowered into a transparent Plexiglas cylinder (20 cm diameter) filled 
halfway with water (24 ± 1ºC) for a 6 min session, as previously described (Boyce-
Rustay & Holmes, 2006). The presence/absence of immobility (cessation of limb 
movements except minor involuntary movements of the hind limbs) was manually 
observed using an instantaneous sampling technique every 5 sec during min 2-6 and 
expressed as a percentage of total observations. The effects of strain and stress were 
analyzed using 2-factor ANOVA followed by Newman Keuls post hoc tests. 
 
 
4.3.6 Effect of Repeated Restraint on Swim Stress Activation of HPA-Axis 
 
Mice exposed to repeated social defeat stress exhibit an augmented HPA-axis 
response to swim stress (Krishnan et al., 2007). We tested whether repeated restraint 
stress similarly sensitized the HPA-axis response to swim stress. Restraint stressed mice 
and non-restrained controls were returned to the home cage after the forced swim stress 
session described above. Thirty min later, mice were sacrificed via rapid cervical 
dislocation and decapitation to collect trunk blood. An additional set of experimentally-
naïve mice were sacrificed at the same time to provide non-swim-stressed baseline 
corticosterone data. Blood samples were centrifuged at 13,000 rpm for 30 sec. Serum was 
extracted and assayed for total corticosterone (bound and free) using the Coat-a-Count 
RIA TKRC1 kit (limit of detection: 5.7 ng/ml; Diagnostic Products Corp, Los Angeles) 
as previously described (Boyce-Rustay et al., 2007). The effects of strain and stress were 
analyzed using 2-factor ANOVA followed by Newman Keuls post hoc tests. 
 
 
4.3.7 Sample Preparation for Expression Analysis 
 
We next performed genome-wide gene expression analysis of B6 and D2 mice in 
order to compare changes in gene expression following restraint stress in the two strai. 
Mice were exposed to repeated restraint (as above), and then sacrificed via cervical 
dislocation and rapid decapitation 4 hour after the final restraint stress. A set of naïve D2 
and B6 mice was also sacrificed at the same time. Brains were quickly removed and 
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stored in RNAlater (Ambion, Austin, TX). Three corticolimbic brain regions mediating 
stress- emotion-related behaviors, the medial prefrontal cortex (mPFC), amygdala 
(principally the basolateral nucleus) and hippocampus, were microdissected within 48 
hour of brain collection. The brain was placed in a coronal matrix and sectioned 1.4-2.4 
mm from Bregma to obtain the mPFC (tissue medial to the forceps minor, mainly 
comprising the infralimbic and prelimbic cortices), and 1.0-2.0 mm from Bregma to 
obtain the amygdala and hippocampus. The amygdala was visualized under dark-field 
microscope and dissected using the external and internal capsules as a guide to obtain the 
basolateral nucleus (although we cannot exclude some inclusion of tissue from the central 
nucleus and striatum). The whole hippocampus was then dissected. 
 
Tissue was immediately frozen and stored at -80° C. Samples from each mouse 
were stored and analyzed separately (i.e., no pooling). Total RNA was isolated using 
RNAqueous Micro kit (Ambion, Austin, TX). RNA purity and concentration was 
evaluated with a spectrophotometer using a 260/280 nm absorbance ratio, and RNA 
quality was checked using Agilent Bioanalyzer 2100 (Agilent Technologies, Santa Clara, 
CA). Samples were processed according to the manufacturer’s instructions and 
hybridized onto a total of 36 Illumina Mouse–6.1 arrays (Illumina, Inc, San Diego, CA). 
Samples that differed by strain, region, and treatment were interleaved on arrays on the 
same slide (6 arrays per slide) to avoid batch confounds. Raw microarray data were 
normalized using the rank invariant and background subtraction protocols provided by 
Illumina as part of its BeadStation software suite. We log-transformed the expression 
values and stabilized the variance of each array. The Illumina Mouse–6.1 array consists 
of > 46,000 probes. We extensively re-annotated these probes and the improved 
annotations were incorporated into the data analysis for the current study. 
 
 
4.3.8 Microarray Data Analysis 
 
Probes were initially filtered by expression: i.e., expression signals below 
background in half or more of the samples were excluded resulting in 25,908 probes for 
analyses. This set of expressed genes was analyzed by hierarchical clustering, using the 
TM4 MeV software (Saeed et al., 2003), to sort the samples based on global expression 
patterns. Baseline strain effects were defined as gene expression values in non-restrained 
B6 mice that showed both a fold-difference " 1.3 and a significant difference as 
determined by Student’s t-test relative to values in non-restrained D2 mice. Restraint 
effects were defined as gene expression values in restrained vs. non-restrained mice of 
the same strain that showed both a fold-difference " 1.3 and a significant difference as 
determined by Student’s t-test.  
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4.4 Results 
 
 
4.4.1 Effect of Repeated Restraint on Body Weight 
 
We measured loss of body weight as a systemic measure of the stress caused by 
repeated restraint. ANOVA revealed a significant strain x restraint interaction for change 
in body weight over the 10-day stress period (F6,84 = 3.57, p < 0.01). Post hoc tests 
showed that all strains except 129S1 and D2 showed a significant difference in body 
weight change between the restrained and non-restrained groups (Figure 4-1). The lack 
of a statistically significant difference in D2 was likely due to high variability in the 
restrained D2 group in this experiment. 
 
 
4.4.2 Effect of Repeated Restraint on Anxiety-Related Behavior 
 
We measured behavior during the first 5 minutes of the dark-light emergence test 
as an assay for the effects of repeated restraint and strain differences in anxiety-like 
behavior. ANOVA found a significant stress x strain interaction (F6,98 = 2.71, p < 0.05) 
for the number of shelter exits. Post hoc analysis showed that all strains except FVBN/J 
made significantly fewer shelter exits than the reference B6 strain, while restrained D2 
and FVBN/J mice made significantly fewer exits than their non-restrained D2 and 
 
 
 
 
Figure 4-1 Differences in repeated restraint-induced changes in body weight 
Restraint stress reduced body weight in a strain-dependent manner, with significantly 
greater net reductions in BALB/cByJ and FVBN/J than the reference C57BL/6J strain   
(N = 5-9 per strain and condition). *p < 0.05 vs. non-restraint mice of the same strain, #p 
< 0.05 vs. C57BL/6J. Data are Means ± SEM. 
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FVBN/J counterparts (Figure 4-2A). There was also significant effect of strain (F6,98 
=29.64, p < 0.01), but no main effect of stress and or strain x stress interaction, for 
percent time spent out of the shelter during the first 5 min. Post hoc comparison between 
restraint and non restraint groups found that only restrained D2 spent significantly lesser 
time out of the shelter than non-restrained counterpart. Under baseline conditions, 129S1, 
A/J, BALB/cByJ, and BALB/cJ spent significantly less time, and FVB/NJ spent more 
time, out of the shelter than B6 (Figure 4-2B). Lastly, there was a significant effect of 
strain (F6,98 = 18.45, p < 0.01) but not stress, and no strain x stress interaction, for latency 
to first exit the shelter. At baseline, 129S1, A/J, BALB/cByJ, and BALB/cJ were 
significantly slower to exit the shelter than B6 (Figure 4-2C). Latency did not differ 
between restrained and non-restrained mice of any strain. 
 
We reasoned that the final 5 minutes of the 15 minutes test session would be less 
sensitive than the first 5 minutes to true-positive strain- or restraint-related effects on 
anxiety-like behavior. During this period, there was a significant effect of strain for 
shelter exits (F6,98 = 36.15, p < 0.01) and for percent time out of the shelter (F6,98 = 47.02, 
p < 0.01), but no significant main effect of stress and no strain x stress interaction for 
either measure. Post hoc comparisons showed that all strains except D2 and FVBN/J 
made significantly fewer less shelter exits and spent less time out of the shelter, as 
compared to B6. Repeated restraint had no effect on either measure in any strain during 
this period. 
 
 
4.4.3 Effect of Repeated Restraint on Depression-Related Behavior 
 
We next examined depression-related behavior using the forced swim test. There 
was a significant effect of strain (F6,98 = 58.24, p < 0.01) and stress (F1,98 = 5.61, p < 0.05) 
but no strain x stress interaction for percent immobility. Post hoc analysis showed that 
D2 and FVB/NJ showed significantly less immobility than the B6 reference strain, and 
that restrained BALB/cByJ showed significantly less immobility than non-restrained 
BALB/cByJ counterparts (Figure 4-3). 
 
 
4.4.4 Effect of Repeated Restraint on the HPA-Axis 
 
Serum corticosterone levels were measured 30 minutes after forced swim stress. 
There was a significant stress x strain interaction (F6,152 = 4.82, p < 0.01), as well as main 
effects of stress (F2,12 = 228.74, p < 0.01) and strain (F6,12 = 7.00, p < 0.01), for 
corticosterone levels. Post hoc analysis showed that swim stress significantly increased 
corticosterone in all strains as compared to non-swim baseline, regardless of prior 
repeated restraint stress (Figure 4-4). In addition, swim stress-induced corticosterone 
levels were significantly higher in BALB/cJ, B6 and D2 following repeated restraint 
relative to their non-restrained counterparts. Conversely, repeatedly restrained 129S1 
showed a significantly lesser corticosterone response to swim stress than non-restrained 
129S1. 
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Figure 4-2 Differences in anxiety-like behavior in emergence test 
(A) All strains except FVBN/J made significantly fewer shelter exits than the reference 
C57BL/6J strain, irrespective of stress. DBA/2J and FVBN/J mice, but no other strain, 
showed significantly fewer shelter exits following repeated restraint, as compared to non-
restrained mice. (B) DBA/2J mice, but no other strain, spent significantly less time out of 
the shelter following repeated restraint, as compared to non-restrained DBA/2J mice. (C) 
There was no difference between restraint and non-restraint groups in latency to first exit 
shelter. 129S1, A/J, BALB/cByJ, and BALB/cJ were significantly slower to exit the 
shelter than B6. N = 7–9 per strain and condition. *p < 0.05 vs. non-stressed controls of 
same strain; #p < 0.05 vs. C57BL/6J. Data are Means ± SEM. 
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Figure 4-3 Differences in depression-related behavior 
DBA/2J and FVBN/J mice were significantly less immobile than the reference C57BL/6J 
strain, regardless of stress. BALB/cByJ mice, but no other strain, showed significantly 
less immobility as compared to non-restrained BALB/cByJ mice. N = 7-9 per strain and 
condition. *p < 0.05; #p < 0.05 vs. C57BL/6J. 
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Figure 4-4 Differences in corticosterone responses to swim stress 
Exposure to swim stress significantly increased serum corticosterone levels, relative to 
non-swim/non-restraint baseline, in all strains regardless of repeated restraint stress 
history. Swim stress-induced corticosterone levels were significantly lower in 129S1 and 
significantly higher in BALB/cJ, C57BL/6J and DBA/2J mice following repeated 
restraint, as compared to non-restrained counterparts. N = 5–15 per strain and condition. 
*p < 0.05 vs. non-restrained of same strain; †p < 0.05 vs. non-restrained and swim 
stressed of same strain. 
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4.4.5 Corticolimbic Gene Expression in B6 and D2 
 
Our behavioral analyses showed that B6 and D2 exhibited differences in anxiety-
like behavior, consistent with previous studies (Millstein & Holmes, 2007). These 
differences further diverged following exposure to repeated restraint. On the basis of 
these observations, we conducted a genome-wide analysis of baseline gene expression 
differences between B6 and D2 in the amygdala, mPFC and hippocampus, as well as 
gene expression changes in each strain following repeated restraint. 
 
Hierarchical cluster of all probes with gene expression signal above background 
showed that gene expression data segregated as a function of brain region, with relatively 
greater similarity in the amygdala and mPFC than the hippocampus (Figure 4-5). Within 
each brain region, samples segregated by strain and, to a lesser extent, restraint, 
demonstrating a stronger effect of strain than restraint on gene expression.  
 
Basal gene expression differed markedly between B6 and D2 in all 3 regions, 
albeit with a greater number of differences in the hippocampus (2540 probes representing 
2154 known genes) followed by the amygdala (1786 probes/1524 known genes) and then 
the mPFC (1712/1491 known genes) (Figure 4-6A). There was also considerable overlap 
across regions in the genes differentially expressed by the 2 strains, with 560 probes 
detecting differences common to all 3 regions. 
 
We then assessed the extent of overlap in restraint-induced expression changes in 
the three brain regions. We considered all probes that detected expression changes 
following repeated restraint and compared them across tissues (Figure 4-6B). In contrast 
to the effect of strain, only a small subset of expression changes associated with restraint 
overlapped across 2 brain regions (36 between amygdala and hippocampus, 22 between 
amygdala and mPFC, 13 between hippocampus and mPFC) and only 5 probes detected 
expression changes in all 3 regions.  Of these 5, 3 target known genes: Period 2 (Per2), D  
 
 
 
 
Figure 4-5 Hierarchical cluster analysis of expression data 
Hierarchical clustering was done using 25,908 probes that detected expression signals 
above background in at least 18 out of 36 samples. The cluster analysis was able to group 
the samples by brain region and strain. Based on global gene expression patterns, the 
samples segregated into 3 main region-specific branches—medial prefrontal cortex 
(mPFC), amygdala (Amy), and hippocampus (Hip). These further bifurcated into 
C57BL/6J (B6) and DBA/2J (D2) branches. Samples from the same treatment conditions, 
restraint-stressed (R) or non-restraint (NR), also tended to group together. 
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Figure 4-6 Differences in corticolimbic gene expression 
(A) Basal gene expression differed markedly between C57BL/6J and DBA/2J. Relatively 
more strain difference in expression traits was evident in the hippocampus than the 
amygdala and mPFC. There was significant overlap in C57BL/6J and DBA/2J 
differentially expressed genes across the 3 region in the genes. (B) Overall, in both 
C57BL/2J and DBA/2J, repeated restraint was associated with significant more gene 
expression changes in the amygdala, with significant but relatively fewer, changes in the 
hippocampus and medial prefrontal cortex (mPFC). A limited subset of expression 
changes overlapped across any 2 brain regions, and only 5 changes overlapped across all 
3 regions. (C) C57BL/6J and DBA/2J mice showed approximately equal number of 
restraint-stress induced expression changes following repeated restraint in the amygdala 
and mPFC, while C57BL/6J showed more changes in the hippocampus than DBA/2J. 
Gene expression changes associated with restraint were highly divergent between 
C57BL/6J and DBA/2J, with very few genes showing alterations in both these strains in 
any region. N = 3 per strain per condition. 
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site of albumin promoter binding protein (Dbp), and Claudin 5 (Cldn5). Notably, both 
Per2 and Dbp are circadian rhythm regulator genes and have been associated with bipolar 
disorder (Shi et al., 2008). Cldn5 codes for a component of tight junctions and this gene 
has been implicated in susceptibility to schizophrenia (Sun et al., 2004). Both Per2 and 
Dbp are consistently upregulated by stress and Cldn5 is downregulated by stress in all 
three regions (Table 4-1). 
 
We then examined gene expression changes following restraint in B6 and D2. 
This revealed significant divergence between the two strains (Figure 4-6C). In both 
strains the amygdala showed the greatest number of restraint-induced gene expression 
changes (488/447 known genes in B6, and 439 probes/408 known genes in D2) but only 
9 probes were common to both strains. In the hippocampus, B6 showed noticeably more 
expression changes after restraint than D2 (445 probes/401 known genes in B6, 205 
probes/187 known genes in D2), and only 10 of these were common to both strains. For 
both the amygdala and hippocampus in B6 and D2, there were an approximately equal 
number of upregulation and downregulation following repeated restraint. In the mPFC, 
B6 and D2 showed similar number of expression changes (221 probes/202 known genes 
in B6, 229 probes/211 known genes in D2); only 2 of these changes were in both the 
strains. In this region, there were more downregulation than upregulation for B6, but 
more upregulation than downregulation for D2. 
 
 
4.4.6 RT-PCR Analysis 
 
We used RT-PCR to confirm 16 gene expression differences associated with 
strain and/or restraint. Eight of these genes were selected on the basis of prior evidence 
linking the gene to stress-related behaviors, as in the case of Gal (Karlsson & Holmes, 
2006), Atp1a2 (Ikeda et al., 2003), Bdnf (Nestler et al., 2002), Nr4a2 (Rojas et al., 2007), 
Chrna4 (Labarca et al., 2001), Comt (Zubieta et al., 2003; Papaleo et al., 2008) Drd1a 
(Hains & Arnsten, 2008), and Rgs2 (Yalcin et al., 2004). Four genes (Grik1, Grin1, 
Gria1, and Homer1) are key components of glutamate-mediated neurotransmission and 
neural plasticity (Malenka & Bear, 2004; Szumlinski et al., 2004; Szumlinski et al., 
2005). A third set are circadian genes (Per1, Per2, Per3, and Dbp) are increasingly 
implicated in neuropsychiatric diseases, notably mania (McClung, 2007). 
 
 
Table 4-1 Restraint-stress induced upregulation of clock genes 
 
 mPFC  BLA  Hippocampus 
Gene B6 D2  B6 D2  B6 D2 
         
Per2  #2.2** #1.9*  #1.8** #1.5*  ns #1.6** 
Dbp #2.0** #1.8*  #1.8** ns  #2.5** #1.8** 
Cldn5 $1.8** ns  $1.5** ns  $1.7** $2.2** 
 *p < 0.05, **p < 0.01 
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In the amygdala, we found that basal expression of Grin1 was lower in B6 
relative to D2 (Table 4-2). In addition, basal hippocampal expression of Gria1 was 
lower, and Bdnf higher, in B6 relative to D2. As compared to D2, microarray analysis 
found that B6 hippocampal expression of Atp1a2 was lower, while RT-PCR analysis 
found that opposite pattern. As the microarray probes and RT-PCR primers do not 
perfectly target the same sequence, this inconsistency may be due to spliced variants 
(Korostynski et al., 2006). Finally, basal mPFC expression of Comt was higher, and 
expression of Chrna4 and Rgs2 lower, in B6 relative to D2. 
 
Regarding expression differences between restrained and non-restrained B6, we 
found Grik1 and Gal were downregulated, while Grin1 was upregulated in the amygdala 
following restraint (Table 4-2). In the hippocampus, expression of Nr2a2 was 
downregulated in B6 following restraint. Chrna4, Drd1a and Per2 were all upregulated 
in the mPFC after restraint in B6. Atp1a2 was upregulated according to the microarray 
analysis but downregulated according to RT-PCR, again suggesting the possibility of 
spliced variants. 
 
We confirmed 4 expression differences between restrained and non-restrained D2 
mice. In the amygdala, the expression of Per1 was upregulated in restrained relative to 
non-restrained (Table 4-1) while in the hippocampus, Dbp was upregulated and Homer1 
was downregulated following restraint. Lastly, in the mPFC of D2, Per2 was upregulated 
in after restraint. 
 
 
4.4.7 Candidate Genes in BLA Volume QTL 
 
We previously identified a significant QTL for BLA volume on mid-chromosome 
8, Vol8a (Mozhui et al., 2007). Using the BLA expression data, we searched for genes 
located in Vol8a that show significant basal expression difference between B6 and D2. 
Among the candidates that were previously identified in Mozhui et al. (2007), only 
Neurocan (Ncan or Cspg3) showed significant differential expression between B6 and 
D2 with 2.4-fold higher expression in B6 BLA than in D2 BLA (p < 0.001). Two other 
genes with substantial expression difference are sterol-C4-methyl oxidase-like (Sc4mol) 
and occluding/ELL domain containing 1 (Ocel1). While Sc4mol showed 4.3-fold higher 
expression in B6 than in D2 (p < 0.0001), Ocel1 showed 4-fold higher expression in D2 
than in B6 (p = 0.0001). These genes that have strong strain difference in expression in 
the BLA are high priority candidates for differences in BLA volume. 
 
 
4.5 Discussion 
 
In this study, we analyzed anxiety-like behavior prior to, and following repeated 
restraint in seven inbred strains of mice. The major finding of the current study was that 
different strains of mice exhibit varying levels of vulnerability to restraint stress, and such 
differences may be associated with divergent corticolimbic expression of genes  
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Table 4-2 Fold-difference scores for microarray and quantitative PCR 
 
 B6 vs. D2  B6, NR vs. R  D2, NR vs. R 
Gene Array qPCR  Array qPCR  Array qPCR 
         
Amygdala         
Grik 1 (glutamate 
receptor, ionotropic, 
kainate 1) 
– –  $2.2** $1.3*  – – 
Grin1 (glutamate 
receptor, ionotropic, 
NMDA1) 
$1.7* $2.2*  #1.9** #2.2*  – – 
Gal (galanin) #4.9** ns  $2.8** $6.6*  – – 
Per1 (period 
homolog 1) 
–   –   #1.3** #2.4** 
         
Prefrontal cortex         
Chrna4 (cholinergic 
receptor, nicotinic, 
alpha polypeptide 4) 
$1.7** $1.6*  #1.3** #1.7*  – – 
Comt (catechol-O-
methyltransferase) 
#1.6** #1.4*  #1.3** ns  – – 
Drd1a (dopamine 
receptor D1A) 
– –  #1.4* #1.4*  – – 
Per2 (period 
homolog 2) 
– –  #2.2** #1.7**  #1.9* #1.9** 
Rgs2 (regulator of G-
protein signaling 2) 
$1.5** $1.2*  –   $1.3* ns 
         
Hippocampus         
Atp1a2 (ATPase, 
Na+/K+ transporting, 
alpha 2 polypeptide) 
$2.0** #1.5**  #2.2** $1.4*  – – 
Bdnf (brain-derived 
neurotrophic factor) 
#1.9** #1.4**  $1.6* ns  – – 
Dbp (D site albumin 
promoter binding 
protein) 
–   #2.5** ns  #1.8** #2.8** 
Gria1 (glutamate 
receptor, ionotropic, 
AMPA1 (alpha 1) 
$1.4* $1.2**  #1.4** ns  – – 
Homer1 (homer 
homolog 1) 
–   $2.9** ns  $1.6** $1.3* 
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Table 4-2 (continued) 
 
 B6 vs. D2  B6, NR vs. R  D2, NR vs. R 
Gene Array qPCR  Array qPCR  Array qPCR 
Nr4a2 (nuclear 
receptor subfamily 4, 
group A, member 2) 
#1.5* ns  $1.4* $1.4**  – 1.6** 
Rora (RAR-related 
orphan receptor 
alpha) 
– –  $1.3** ns  – 1.6** 
Per3 (period 
homolog 3) 
– –  #1.2* #1.4*  #1.5* 1.6** 
*p < 0.05, **p < 0.01 
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previously implicated in stress-related behavior as well as neural plasticity and circadian 
regulation. 
 
Our initial strain survey of the effects of repeated restraint stress resulted in a 
number of important observations. As in previous studies from other laboratories using 
various repeated stressor, including ten-day restraint, in both rats and mice (e.g., Willner 
et al., 1996; Pothion et al., 2004; Krishnan et al., 2007; Shansky et al., 2009), we 
examined relative loss of body weight as an indicator of the efficacy of our stress 
regimen. As expected, restraint produced a net loss of body weight relative to non-
restrained controls and this was clearly strain-dependent. While, 129S1 mice showed 
minimal loss, BALB/cByJ and FVBN/J showed the most marked net reduction in body 
weight, as compared to B6 (which we considered our reference strain). 
 
The 129S1, A/J, BALB/cJ, and BALB/cByJ strains displayed a heightened trait 
anxiety-like phenotype in the dark/light emergence test under non-restraint 
basalconditions, as compared to the reference B6 strain, a finding largely consistent with 
a number of previous studies (for reviews, see Belzung & Griebel, 2001; Anisman & 
Matheson, 2005; Jacobson & Cryan, 2007; Millstein & Holmes, 2007). The strong basal 
phenotype in these strain did, however, prevented the detection of further increases in this 
behavior as a result of chronic restraint. By contrast, basal anxiety-like behavior in the 
FVBN/J strain was no different from B6, but unlike B6, FVBN/J mice displayed an 
anxiogenic-like profile (albeit only on one measure only—shelter exits) following 
repeated restraint, as compared to non-restrained FVBN/J mice.  Of even greater interest, 
the D2 strain showed both a higher basal level of anxiety-like behavior, as compared to 
B6, and a further increase in anxiety-like behavior following repeated restraint. Thus, D2 
and B6 showed divergent trait and restraint-induced anxiety-like behavior, suggestive of 
a susceptible and resilient phenotype, respectively. That the B6 strain displayed a 
relatively stress resilient phenotype concurs with previous reports (for reviews see, 
Anisman & Matheson, 2005; Holmes et al., 2005). 
 
In contrast to the marked trait and restraint-induced differences in emergence test 
anxiety-like behavior between strains, there were fewer clear strain- or restraint-related 
differences in depression-related behavior as measured via the forced swim test. Perhaps 
the most notable observation was a decrease in immobility in the BALB/cByJ strain 
following restraint. A decrease in immobility is similar to that seen with antidepressant 
treatment (Cryan & Holmes, 2005) and was therefore an unexpected consequence of 
restraint, especially in this characteristically high-anxiety and stress-reactive strain 
(Anisman et al., 2001; Belzung & Griebel, 2001; Dulawa et al., 2004; Norcross et al., 
2008), and additional studies will be needed to clarify the precise nature of this effect. 
 
All strains, including BALB/cByJ, showed robust HPA-axis activation, as 
measured by serum corticosterone levels, to forced swim stress. Moreover, following 
repeated restraint, both B6 and D2 showed an augmented HPA-axis response to swim 
stress, as compared to non-restrained counterparts. This is consistent with a restraint-
induced sensitization of the HPA-axis response to a novel stressor in these strains. A 
similar sensitization was recently found in B6 mice exposed to ten days of social defeat 
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(Krishnan et al., 2007). Although none of the other inbred strains we tested showed this 
effect this may simply have been due to a ‘ceiling’ level of swim-induced corticosterone 
obscuring the detection of further increases in the restrained mice. Interestingly however, 
restrained 129S1 mice actually showed a significantly decreased corticosterone response 
to swim stress relative to non-restrained counterparts. This finding is intriguing because 
there is evidence of augmented HPA-axis inhibition in patients with post-traumatic stress 
disorder (PTSD) (Yehuda, 2002), and we have recently found that the 129S1 strain has an 
impairment in fear extinction (Hefner et al., 2008); a major symptomatic characteristic of 
PTSD. 
 
Notwithstanding, the main conclusion from these analyses was that the divergent 
anxiety-related phenotypes between B6 and D2 did not generalize to measures of 
depression-related behavior or HPA-axis activation, on which the two strains did not 
diverge following repeated restraint. Krishnan and colleagues made a similar observation 
in a study of the effects of repeated social defeat (Krishnan et al., 2007). These authors 
found that a subgroup of B6 mice that showed decreased body weight and increased 
social avoidance after repeated defeat did not show abnormalities in forced swim 
immobility or swim stress-induced corticosterone. Along similar lines, Stekalova et al. 
(2004) found that C57BL/6N mice exposed to four weeks of a combination of stressors 
(rat exposure, restraint, tail suspension) had reduced body weight and increased anxiety-
like behavior (tested in the elevated plus-maze) but normal forced swim performance 
(Strekalova et al., 2004).  Taken together with the current data, these findings indicate 
that depression-related behavior measured by the forced swim test is insensitive to the 
effects of repeated stress in most mouse strains. 
 
Genome-wide analysis of gene expression in subpopulations of B6 mice classified 
as susceptible or resilient to repeated social defeat was recently used as a strategy to 
identify molecular candidates underlying these differences (Krishnan et al., 2007). We 
applied a similar strategy to explore the molecular basis of the differences in trait and 
restraint-induced anxiety-like behavior between B6 and D2 by examining patterns of 
gene expression in three key regional loci of the corticolimbic circuit mediating stress 
responses and stress-induced changes in behavior—the mPFC, amygdala, and 
hippocampus.  Consistent with previous studies (Kerns et al., 2005; Grice et al., 2007), 
our analysis detected substantial expression difference between B6 and D2 with several 
genes differentially expressed in all three regions.  
 
Amongst the differentially expressed genes confirmed with RT-PCR, B6 had 
lower amygdala levels of Grin1 (encoding the ionotropic N-methyl-D-aspartate 
(NMDAR) 1 subtype). Interestingly, reduced NMDAR function hs anxiolytic-like effects 
in rodents (Boyce-Rustay & Holmes, 2006; Cryan & Dev, 2007). In addition, B6 had 
higher hippocampal levels of Bdnf (encoding brain-derived neurotrophic factor) and 
lower levels of Gria1 (GluR1 AMPA glutamate receptor) than D2. GluR1 is a principal 
mediator of glutamatergic excitatory neurotransmission (Malenka & Bear, 2004) and 
gene knockout of GluR1 produces altered reward and schizophrenia-related disturbances 
(Bannerman et al., 2006; Wiedholz et al., 2008). A number of interesting strain 
differences were also found in the mPFC. These included relatively higher mRNA 
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expression of Comt (catechol-O-methyltransferase) and lower expression of Chrna4 (%4 
nicotinic receptor) in B6 mice. Both a high COMT activity gene variant (val158met) in 
humans (Zubieta et al., 2003) and transgenic overexpression of Comt in mice (Papaleo et 
al., 2008) are associated with reduced stress reactivity. On the other hand, a point 
mutation causing Chrna4 hypersensitivity increases anxiety-like behavior in mice 
(Labarca et al., 2001). Of further note, B6 had lower levels of Rgs2 (regulator of G-
protein signaling 2) in the mPFC. Rgs2 was recently identified a candidate gene 
underlying variation in anxiety-like behavior in both mice (Yalcin et al., 2004) and 
humans (Smoller et al., 2008). Taken together, these basal gene expression differences 
between B6 and D2 are highly convergent with previous data implicating the same genes 
in anxiety- and stress-related behaviors, and identify a number of possible candidates 
underlying the trait differences in anxiety between the two strains. 
 
Repeated restraint produced a pattern of corticolimbic gene expression differences 
that was very different from that associated with the trait anxiety-related differences 
between B6 and D2 mice.  The amygdala was by far the most stress-sensitive region in 
terms of number of expression changes produced by restraint, with a lesser although still 
significant, number of changes in the hippocampus and mPFC. Moreover, in contrast to 
the considerable regional overlap in expression difference associated with strain, there 
was a very limited set of genes differentially expressed after restraint in any two regions 
(< four percent of the total number of probes). This indicates that restraint drove the 
expression of quite unique sets of genes in the three regions we examined. An important 
additional finding was that these restraint-sensitive gene sets were (with some notable 
exceptions, see below) by and large highly divergent between the B6 and D2 strains; i.e., 
few of the same expression changes seen in B6 were also seen in D2. 
 
B6 mice showed a significant upregulation of amygdala Grin1 (encoding the 
NMDAR1 glutamate receptor subtype) and a parallel downregulation of Grik1 (kainate 1 
glutamate receptor subtype) and Gal (galanin). Numerous studies have pointed to a role 
for galanin in stress-mediation (Karlsson & Holmes, 2006), including recent work 
showing that galanin is upregulated in the ventral tegmental area by repeated social 
defeat in a ‘stress-susceptible’ subgroup of C57BL/6J mice (Krishnan et al., 2007). 
 
A striking cluster of gene expression changes associated with repeated restraint 
involved the circadian genes encoding the period homologs Per1, Per2 and Per3 and a 
modulator of their expression, Dbp (D site albumin promoter binding protein) (Ueda et 
al., 2005). The diurnal dynamics of these clock genes are modulated by intricate 
transcriptional and post-translational regulatory loops and are tightly synchronized with 
glucocorticoid levels (Maywood et al., 2007; Son et al., 2008). Several circadian genes, 
including Per1, are known to have glucocorticoid response elements in their regulatory 
regions (Reddy et al., 2007). It is plausible that in the CNS, the persistent stress-induced 
perturbations in glucocorticoid levels may be mediating the expression changes in the 
circadian genes. These circadian genes may in turn have downstream effect on the 
expression of genes such as Homer1 and the glutamate receptors (Maret et al., 2007). 
Interesting, Nr4a2, a nuclear receptor that interacts directly with the glucocorticoid 
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receptor to co-regulate gene expression (Carpentier et al., 2008), was decreased in 
expression following restraint stress in C57BL/6J. 
 
Unlike the expression changes discussed above, both strains showed significant 
upregulation in the clock genes. These changes were particularly interesting in the 
context of growing evidence linking circadian genes alcoholism and mood disorders 
(McClung, 2007; Takahashi et al., 2008). For example, mice with knockout of Dbp 
exhibit locomotor hyperactivity after chronic heterogeneous stress (Le-Niculescu et al., 
2008), while Per2 inactivation increases extracellular levels of glutamate and promotes 
alcohol drinking (Spanagel et al., 2005), and Per1 and Per2 inactivation alters sensitivity 
to cocaine (Abarca et al., 2002). These data raise the intriguing possibility that repeated 
restraint might alter the behavioral effects of psychostimulant drugs of abuse and alcohol 
in mice, as has been found with other forms of repeated stress (Boyce-Rustay et al., 
2007). 
 
In summary, the results of the current study provide further evidence of marked 
strain differences in anxiety-like behavior and identify divergent behavioral effects of 
repeated stress between two strains, B6 and D2. These differential effects were specific to 
a measure of anxiety-like behavior and did not generalize to a measure of depression-
related behavior or sensitization of the HPA-axis to stress. Restraint-induced strain 
variation in behavior was associated with marked differences in gene expression in 
corticolimbic brain regions mediating stress-related behaviors.  The hippocampus showed 
that largest number of gene expression differences between B6 and D2 at baseline, while 
the amygdala was the most sensitive region to repeated restraint. We identified a number 
of candidate genes underlying differences in anxiety-like behavior between B6 and D2 
(e.g., Rgs2, Comt, Grin1) and the differential response to repeated restraint between the 
strains (e.g., Grin1, Grik1, Gal). Significant upregulation of circadian clock genes (Per1, 
Per2, Per3, Dbp) were seen in both strains. 
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CHAPTER 5. DISSECTING A QTL HOTSPOT ON MOUSE DISTAL 
CHROMOSOME 1 THAT MODULATES NEUROBEHAVIORAL PHENOTYPES 
AND GENE EXPRESSION
*
 
 
 
5.1 Synopsis 
 
A remarkably diverse set of traits maps to a region on mouse distal chromosome 1 
(Chr 1) that corresponds to human Chr 1q21–q23. This region is highly enriched in 
quantitative trait loci (QTLs) that control neural and behavioral phenotypes, including 
motor behavior, escape latency, emotionality, seizure susceptibility (Szs1), and responses 
to ethanol, caffeine, pentobarbital, and haloperidol. This region also controls the 
expression of a remarkably large number of genes, including genes that are associated 
with some of the classical traits that map to distal Chr 1 (e.g., seizure susceptibility). Here 
we ask whether this QTL-rich region on Chr 1 (Qrr1) consists of a single master locus or 
a mixture of linked, but functionally unrelated QTLs. To answer this question and to 
evaluate candidate genes, we generated and analyzed several gene expression, haplotype, 
and sequence data sets. We exploited six complementary mouse crosses, and combed 
through 18 expression data sets to determine class membership of genes modulated by 
Qrr1. Qrr1 can be broadly divided into a proximal part (Qrr1p) and a distal part (Qrr1d), 
each associated with the expression of distinct subsets of genes. Qrr1d controls RNA 
metabolism and protein synthesis, including the expression of ~20 aminoacyl-tRNA 
synthetases. Qrr1d contains a tRNA cluster, and this is a functionally pertinent candidate 
for the tRNA synthetases. Rgs7 and Fmn2 are other strong candidates in Qrr1d. FMN2 
protein has pronounced expression in neurons, including in the dendrites, and deletion of 
Fmn2 had a strong effect on the expression of a subset of genes modulated by Qrr1d. Our 
analysis revealed a highly complex gene expression regulatory interval in Qrr1, 
composed of multiple loci modulating the expression of functionally cognate sets of 
genes. 
 
 
5.2 Introduction 
 
The distal part of mouse Chr 1 harbors a large number of QTLs that generate 
differences in behavior. Open field activity (DeFries et al., 1978), fear conditioning 
(Caldarone et al., 1997), rearing behavior (Gershenfeld et al., 1997), and several other 
measures of emotionality (Flint et al., 1995) have been repeatedly mapped to distal Chr 1. 
This region is also notable because it appears to influence responses to a wide range of 
drugs including ethanol (Crabbe, 1996), caffeine (Casley et al., 1999), pentobarbital 
(Buck et al., 1999), and haloperidol (Patel et al., 1999). In addition to the behavioral 
traits, a number of metabolic, physiological and immunological phenotypes have been 
mapped to this region (e.g., Beamer et al., 2001; Wang et al., 2004). This QTL rich 
                                                
*
 Adapted with permission. Mozhui K, Ciobanu DC, Schikorski T, Wang X, Lu L, 
Williams RW (2008). Dissection of a QTL hotspot on mouse distal chromosome 1 that 
modulates neurobehavioral phenotypes and gene expression. PLoS Genet 4:e1000260. 
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region on mouse distal Chr 1 exhibits reasonably compelling functional and genetic 
concordance with the orthologous region on human Chr 1q21–q23. Prime examples of 
genes in this region that have been associated with similar traits in mouse and human are 
Rgs2 (anxiety in both species), Apoa2 (atherosclerosis), and Kcnj10 (seizure 
susceptibility) (Ferraro et al., 2004; Wang et al., 2004; Yalcin et al., 2004; Smoller et al., 
2008; Takada et al., 2008). 
 
Studies of gene expression in the central nervous system (CNS) of mice have 
revealed major strain differences in the expression level of numerous genes located on 
distal Chr 1, e.g., Copa, Atp1a2, and Kcnj9 (Sandberg et al., 2000; Hitzemann et al., 
2003; Kerns et al., 2006). These differentially expressed genes are strong candidates for 
the behavioral and neuropharmacological traits that map to this region. We have recently 
shown that sequence variants near each of these candidate genes are often responsible for 
the prominent differences in expression (Hitzemann et al., 2003; Chesler et al., 2005; 
Peirce et al., 2006). In other words, sequence differences near genes such as Kcnj9 cause 
expression to differ, and variation in transcript level maps back to the location of the 
source gene itself. Transcripts of this type are associated with cis-QTLs. 
 
These expression genetic studies have also uncovered another unusual 
characteristic of mouse distal Chr 1. In addition to the extensive cis-effects, a large 
number of transcripts of genes located on other chromosomes map into this same short 
interval on distal Chr 1 (Matthews et al., 2005; Peirce et al., 2006). These types of QTLs 
are often referred to as trans-QTLs. The clustering of trans-QTLs to distal Chr 1 has been 
replicated in multiple crosses and CNS microarray data sets (Peirce et al., 2006). We 
refer to this region of Chr 1, extending from Fcgr3 (172.5 Mb) to Rgs7 (177.5 Mb) as the 
QTL-rich region on Chr 1, or Qrr1. It is possible that these modulatory effects on 
expression are the first steps in a cascade of events that are ultimately responsible for 
many of the prominent differences in behavior and neuropharmacology. For example, 
Qrr1 modulates the expression of several genes that have been implicated in seizure (e.g., 
Scn1b, Pnpo, Cacna1g), and this may be a basis for the strong influence Qrr1 has on 
seizure susceptibility (Ferraro et al., 2004). 
 
In this study, we exploited 18 diverse array data sets derived from different mouse 
crosses to systematically dissect the expression QTLs in Qrr1. The strong trans effects 
are consistently detected in CNS tissues of C57BL/6J (B6) x DBA/2J (D2) and B6 x 
C3H/HeJ (C3H) crosses, but are largely absent in ILS/Ibg (ILS) x ISS/Ibg (ISS) and 
C57BL/6By (B6y) x BALB/cBy (BALB), and in all non-neural tissues we have 
examined. We applied high-resolution mapping and haplotype analysis of Qrr1 using a 
large panel of BXD recombinant inbred (RI) strains that included highly recombinant 
advanced intercross RI lines. Our analyses revealed multiple distinct loci in Qrr1 that 
regulate gene expression specifically in the CNS. The distal part of Qrr1 (Qrr1d) has a 
strong effect on the expression of numerous genes involved in RNA metabolism and 
protein synthesis, including more than half of all aminoacyl-tRNA synthetases. Fmn2 and 
Rgs7, and a cluster of tRNAs are the strongest candidates in Qrr1d. 
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5.3 Materials and Methods 
 
 
5.3.1 Microarray Datasets 
 
The microarray data sets used in this study (Table 5-1) were generated by 
collaborative efforts (Hitzemann et al., 2004; Chesler et al., 2005; Bystrykh et al., 2006; 
Peirce et al., 2006; Yang et al., 2006; Gatti et al., 2007). All data sets can be accessed 
from http://www.genenetwork.org. They provide estimates of global mRNA abundance 
in neural and non-neural tissues in the BXD, LXS, and CXB RI strains, B6D2F2 
intercrosses, and B6C3HF2 intercrosses. Detailed description of each set, tissue 
acquisition, RNA extraction and array hybridization methods, and data processing and 
normalization methods are provided in the “Info” page linked to each data set. In brief, 
the data sets are: 
 
1) BXD CNS transcriptomes: The BXD CNS data sets measure gene expression in 
the forebrain and midbrain (INIA Forebrain), striatum (HBP/Rosen Striatum and 
HQF Striatum), hippocampus (Hippocampus Consortium and UMUTAffy 
Hippocampus), cerebellum (SJUT Cerebellum mRNA), and eye (Hamilton Eye) 
of BXD RI strains. The INIA Brain and HBP/Rosen Striatum data sets have been 
described in Peirce et al. (2006). The Hippocampus Consortium data set measures 
gene expression in the adult hippocampus of 69 BXD RI strains, the parental B6 
and D2 strains, and F1 hybrids. The SJUT Cerebellum data set measures gene 
expression in the adult cerebellum of 45 BXD RI strains, parental strains, and F1 
hybrids. The Eye dataset measures gene expression in the eyes of 64 BXD RI 
strains, parental strains, and F1 hybrids. The HQF BXD Striatum is one of the 
newest data sets and was generated on Illumina Sentrix Mouse–6.1 arrays. It is 
similar to the HBP/Rosen Striatum and measures gene expression in the striatum 
of 54 BXD RI strains, parental strains, and F1 hybrids. 
2) BXD non-neural transcriptomes: The non-neural BXD array sets measure gene 
expression in the liver (UNC Liver) of 40 BXD strains, kidney (Kidney 
Consortium) of 53 BXD strains, and hematopoietic stem cells (GNF 
Hematopoietic Cells) of 30 BXD strains (Bystrykh et al., 2006; Gatti et al., 2007). 
3) LXS hippocampus transcriptome: The LXS Hippocampus data set measures gene 
expression in the adult hippocampus of 75 LXS RI strains and the parental ILS 
and ISS strains. 
4) B6D2F2 CNS transcriptomes: The B6D2F2 data sets measure gene expression in 
the whole brain (OHSU/VA Brain), and striatum (OHSU/VA Striatum) of B6xD2 
F2 intercrosses (Hitzemann et al., 2004; Peirce et al., 2006). The whole brain data 
set comprises of samples from 56 F2 animals, and the striatum data set comprises 
of samples from 58 F2 animals. 
5) B6C3HF2 transcriptomes: These data sets were generated from large numbers of 
B6xC3H F2 intercross progeny and assayed using Agilent arrays (Yang et al., 
2006). These data sets have been described in Yang et al. (2006). 
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Table 5-1 Expression QTLs in Qrr1 in different crosses and tissues 
 
  Dataset   LOD ! 3 
 
Cross 
 
N
A
 
Normali- 
zation 
 
Tissue 
 
Array 
 
T
B
 
 
C
B
 
 
%T
C
 
 
%C
D
 
         
B6D2F2 58 OHSU/VA 
(Sep05) 
PDNN  
Striatum Affymetrix 
M430v2 
197 56 8 5 
B6D2F2 56 OHSU/VA 
(Aug05) 
PDNN  
Whole 
brain 
Affymetrix 
M430 
79 30 1 2 
BXD 45 SJUT 
(Mar05) 
PDNN 
Cerebel- 
lum 
Affymetrix 
M430 
439 44 9 2 
BXD 69 Hippocampus 
Consortium 
(Dec05) 
PDNN  
Hippocam-
pus 
Affymetrix 
M430v2 
345 54 7 1 
BXD 39 INIA 
(Jan06) 
PDNN  
Fore- 
brain 
Affymetrix 
M430 
279 39 5 1 
BXD 64 Hamilton 
Eye 
Institute  
(Sep06) 
RMA  
Eye Affymetrix 
M430v2 
156 43 2 1 
BXD 54 HQF 
(Nov 07) 
RankInv  
Striatum Illumina 
M6.1  
97 31 1 1 
BXD 29 HBP/Rosen 
(Apr05) 
PDNN 
Striatum Affymetrix 
M430v2 
94 25 2 1 
BXD 63 UMUTAffy 
(Mar08) 
RMA 
Hippocam-
pus 
Affymetrix 
Exon 1.0 
ST  
700 302 0.4 1 
BXD 40 UNC 
(Jan06) 
LOWESS  
Liver Agilent 
G4121A 
9 20 0.3 1 
BXD 53 Kidney 
Consortium 
(Aug06) 
PDNN  
Kidney Affymetrix 
M430v2 
8 33 0.2 1 
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Table 5-1 (continued) 
 
  Dataset   LOD ! 3 
 
Cross 
 
N
A
 
Normali- 
zation 
 
Tissue 
 
Array 
 
T
B
 
 
C
B
 
 
%T
C
 
 
%C
D
 
BXD 30 GNF 
(Mar03) 
MAS5  
Hemato- 
poietic 
Cells 
Affymetrix 
U74Av2 
0 6 0 3 
LXS 75 NIAAA 
INIA 
(May07) 
RankInv  
Hippocam-
pus 
Illumina 
M6.1  
10 28 0.4 1 
B6C3F2 238 UCLA 
(2005) 
mlratio 
Brain Agilent 516 51 14 3 
B6C3F2 306 UCLA 
(2005) 
mlratio  
Muscle Agilent 15 33 0.3 2 
B6C3F2 298 UCLA 
(2005) 
mlratio  
Liver Agilent 63 46 0.7 3 
B6C3F2 282 UCLA 
(2005) 
mlratio  
Adipose Agilent 56 34 0.5 3 
CXB 13 Hippocampus 
Consortium 
(Dec05) 
PDNN 
Hippocam-
pus 
Affymetrix 
M430v2 
7 12 0.08 2 
A
Number of RI strains or F2 mice; 
B
Number of trans-QTLs (T) and cis-QTLs (C); 
C
Percent of trans-QTLs in Qrr1 = [(number of trans-QTLs in Qrr1)/(total number of 
trans-QTLs in the whole genome) x 100]; 
D
Percent of cis-QTLs in Qrr1 = [(number of 
cis-QTLs in Qrr1)/(total number of cis-QTLs in the whole genome) x 100]. 
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5.3.2 Mouse Strains and Genotype Data 
 
The conventional BXD RI strains were derived from the B6 and D2 inbred mice 
(Taylor, 1989; Taylor et al., 1999). The newer sets of advanced RI strains were derived 
by inbreeding intercrosses of the RI strains (Peirce et al., 2004). The parental B6 and D2 
strains differ significantly in sequence and have approximately 2 million informative 
SNP. A subset of 14,000 SNPs and microsatellite markers have been used to genotype the 
BXD strains (Williams et al., 2001b; Shifman et al., 2006). We used 3,795 informative 
markers for QTL mapping. Thirty such informative markers are in Qrr1 and we queried 
these markers to identify strains with recombinations in Qrr1; genes with strong cis-
QTLs (Sdhc, Atp1a2, Dfy, and Fmn2) were used as additional markers. Smaller sub-sets 
of markers were used to genotype the two F2 panels (total of 306 markers for the whole 
brain, and 75 markers for the striatum F2 datasets). 
 
The LXS RI strains were derived from the ILS and ISS inbred strains. They have 
been genotyped using 13,377 SNPs, and some microsatellite markers (Williams et al., 
2004). 2,659 informative SNPs and microsatellite markers were used for QTL mapping. 
The CXB panel consists of 13 RI strains derived from C57BL/6By and BALB/cBy 
inbred strains. A total of 1384 informative markers were used for QTL mapping. 
 
The B6 x C3H/HeJ F2 intercrosses have been genotyped using 13,377 SNPs and 
microsatellite markers, and 8,311 informative markers were used for QTL mapping. 
 
 
5.3.3 Animals and Tissue Acquisition 
 
Majority of the BXD and LXS tissues (cerebellum, eye, forebrain, hippocampus, 
kidney, liver, and striatum for the HQF Illumina data set) were dissected at the University 
of Tennessee Health Science Center (UTHSC). Mice were housed at the UTHSC in 
pathogen-free colonies, at an average of three mice per cage. All animal procedures were 
approved by the Animal Care and Use Committee. Mice were killed by cervical 
dislocation, and tissues were rapidly dissected and placed in RNAlater (Ambion, 
http://www.ambion.com) and kept overnight at 4° C, and subsequently stored at –80° C. 
Tissue were then processed at UTHSC or shipped to other locations for processing. 
 
 
5.3.4 RNA Isolation and Sample Preparation 
 
For the tissues that were processed at UTHSC (all BXD and LXS CNS tissues 
except HBP Affymetrix striatum), RNA was isolated using RNA STAT-60 (Tel-Test 
Inc., http://www.tel-test.com) as per manufacturer’s instructions. Samples were then 
purified using standard sodium acetate methods prior to microarray hybridization. The 
eye samples required additional purification steps to remove eye pigment; this was done 
using the RNeasy MinElute Cleanup Kit (Qiagen, http://www.qiagen.com). RNA purity 
and concentration was evaluated with a spectrophotometer using 260/280 nm absorbance  
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ratio, and RNA quality was checked using Agilent Bioanalyzer 2100 prior to 
hybridization. Array hybridizations were then done according to standard protocols. 
 
 
5.3.5 Microarray Probe Set Annotation 
 
We have re-annotated a majority of Affymetrix probe sets to ensure more accurate 
description of probe targets. Each probe set represents a concatenations of eleven 25-mer 
probes, and these have been aligned to the NCBI built 36 version of the mouse genome 
(mm8 in UCSC Genome Browser) by BLAT analysis. We have also re-annotated the 
Illumina probes and incorporated these annotations into GeneNetwork. Each probe in the 
Illumina Mouse–6 and Mouse–6.1 arrays is 50 nucleotides in length, and these have been 
aligned to NCBI built 36. 
 
 
5.3.6 QTL Mapping 
 
We used the strain average expression signal detected by a probe or probe set. 
QTL mapping was done for all transcripts using QTL Reaper (Peirce et al., 2006). QTL 
Reaper performs up to a million permutations of an expression trait to calculate the 
genome-wide empirical p and the LOD score associated with a marker. We selected only 
those transcripts that have highest LOD scores, i.e., genome-wide adjusted best p-values, 
on markers located on Chr 1 from 172 to 178 Mb. This selected transcripts that are 
primarily modulated by Qrr1 but excluded transcripts that have QTLs in Qrr1 but have 
higher LOD scores on markers located on other chromosomal regions. Cis- and trans-
QTLs were distinguished based on criteria described by Peirce et al. (2006). To identify 
trans-QTLs common to multiple data sets, we selected probes/probe sets that target the 
same genes and have peak LOD scores within 10 Mb in the different data sets.  
 
 
5.3.7 Screening Local QTLs 
 
We screened all Affymetrix probe sets with cis-QTLs in Qrr1 for SNPs in target 
sequences. This step was taken to identity false cis-QTLs caused by differences in 
hybridization. As probe design is based on the B6 sequence, such spurious cis-QTLs 
show high expression for the B allele, and low expression for the D allele. Our screening 
identified only two probe sets in which SNPs result in spurious local QTLs—1429382_at 
(Tomm40l) , and 1452308_a_at (Atp1a2). The majority of cis-QTLs in Qrr1 are likely to 
be due to actual differences in mRNA abundance. We did not detect a bias in favor of the 
B allele on cis-regulated expression and the ratio of transcripts with B- and D- positive 
additive effects is close to 1:1. 
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5.3.8 Analysis of Allele Specific Expression Difference 
 
To measure expression difference between the B and D alleles, we exploited 
transcribed SNPs to capture allelic expression difference in F1 hybrids (Cowles et al., 
2006) using a combination of RT-PCR and a single base extension technology 
(SNaPshot, Applied Biosystems, http://www.appliedbiosystems.com). For each transcript 
we analyzed, Primer 3 (Rozen et al., 2000) was used to design a pair of PCR primers that 
target sequences on the same exon and flanking an informative SNP. 
 
We prepared four pools of RNA from the hippocampus, and four pools of 
genomic DNA from the spleen of F1 hybrids (male and female B6xD2 and D2xB6 F1 
hybrids). To avoid contamination by genomic DNA, the four RNA pools were treated 
with Turbo DNase (Ambion, http://www.ambion.com), and then first strand cDNA was 
synthesized (GE Healthcare, http://www.gehealthcare.com). The genomic DNA samples 
were used as controls, and both cDNA and genomic DNA samples were tested 
concurrently using the same assay to compare expression levels of B and D transcripts. 
 
We amplified the cDNA and genomic DNA samples using GoTaq Flexi DNA 
polymerase (Promega Corporation, http://www.promega.com). PCR products were 
purified using ExoSap-IT (USB Corporation, http://www.usbweb.com) followed by 
SNaPshot to extend primer by a single fluorescently labeled ddNTPs. Fluorescently 
labeled products were purified using calf intestinal phosphatase (CIP, New England 
BioLabs, http://www.neb.com) and separated by capillary electrophoresis on ABI3130 
(Applied Biosystems). Quantification was done using GeneMapper v4.0 software 
(Applied Biosystems), and transcript abundance was measured by peak intensities 
associated with each allele. Ratio of B and D allele in both cDNA and gDNA pools was 
computed, and t-test (one tail, unequal variance) was done to validate expression 
difference and polarity of parental alleles. 
 
 
5.3.9 SNP Analysis in Multiple Crosses 
 
GeneNetwork has compiled SNP data from different sources—Celera 
(http://www.celera.com), Perlegen/NIEHS 
(http://mouse.perlegen.com/mouse/download.html), BROAD institute 
(http://www.broad.mit.edu/snp/mouse), Wellcome–CTC (Shifman et al., 2006), dbSNP, 
and Mouse Phenome Database (http://www.jax.org/phenome/SNP). SNP counts were 
done on the GeneNetwork SNP browser. 
 
 
5.3.10 Partial Correlation Analysis 
 
A partial correlation is the correlation between X and Y conditioned on one or 
more control variables. In this study, first order partial correlation was used to detect the 
interaction between trans-regulated transcripts and cis-regulated candidate genes 
conditioned on the genotype (marker rs8242481 at 175.058 Mb). If x, y and z are trans-
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regulated transcripts, cis-regulated transcript, and genotype in the QTL, respectively, then 
the first order partial correlation coefficient is calculated as— 
 
! 
rxy.z =
rxy " rxzryz
1" rxz
2( ) 1" ryz2( )
 
 
where rxy can be either Pearson correlation or Spearman’s rank correlation between x and 
y. We employed the Spearman’s rank correlation because the expression levels of many 
transcripts do not follow a normal distribution. The significance of a partial correlation 
with n data points was assessed with a two-tailed t test— 
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where r is the first order correlation coefficient, and k is the number of variables on 
which we are conditioning. 
 
 
5.3.11 Immunocytochemistry 
 
Cultured hippocampal neurons from male B6 mice, prepared as described in 
Schikorski et al. (2007) and cultured for 23 days, were fixed with 4% paraformaldehyde 
and 0.1% glutaraldehyde in HEPES buffered saline (pH7.2) for 15 min. Cell membranes 
were permeabilized with 0.1% triton X-100 and unspecific binding sites were quenched 
with 10% BSA for 20 min at room temperature (RT). Neurons were incubated with a 
polyclonal anti-FMN2 antibody (Protein Tech Group, http://www.ptglab.com) diluted to 
0.3 &g/ml at RT overnight. An anti-rabbit antibody raised in donkey (1:500, 
http://www.invitrogen.com) conjugated with the fluorescent dye Alexa488 was used for 
the detection of the first antibody. All regions of interest were photographed with 
identical illumination and camera settings to allow for a direct comparison of the staining 
in labeled and control neurons.  
 
 
5.3.12 Microarray Analysis of Fmn2-Knockout Mice 
 
The Fmn2
-/- 
mice were generated using 129/SvEv (now strain 129S6/SvEvTac) 
derived TC-1 embryonic stem cells. Chimeric mice were backcrossed to 129/SvEv 
(Leader et al., 2000). The Fmn2-null and littermate controls are therefore coisogenic. To 
validate the isogenicity of regions surrounding the targeted locus (Gerlai, 1996), we 
genotyped the Fmn2
+/+
,
 
Fmn2
+/-
, and Fmn2
-/- 
mice using ten microsatellite markers 
located on, and flanking Fmn2 (markers distributed from 172 Mb to 182 Mb). These 
markers are D1Mit455, D1Mit113, D1Mit456, D1Mit356, D1Mit206, D1Mit355, 
D1Mit150, D1Mit403, D1Mit315, and D1Mit426. With the exception of a marker at 
Fmn2 (D1Mit150), all alleles in null, heterozygote, and wildtype animals were identical.  
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RNA was isolated from whole brain samples of Fmn2
+/+
 and Fmn2
-/- 
mice, and assayed 
on Illumina Mouse-6 array slides (six samples per slide). We compared five samples 
from Fmn2
-/-
 nulls, and five samples from Fmn2
+/+
 wildtype. Equal numbers of each 
genotypes were placed on each slide to avoid batch confounds. Microarray data were 
processed using both raw and rank invariant protocols provided by Illumina as part of the 
BeadStation software suite (http://www.illumina.com). We subsequently log-transformed 
expression values and stabilized the variance of each array. To identify genes with 
significant expression difference between the Fmn2
-/- 
and Fmn2
+/+
 cases, we carried out 
two-tailed t-tests and applied a Bonferroni correction for multiple testing, and selected 
probes with a minimum adjusted p < 0.05.  
 
 
5.3.13 Bioinformatics Tools 
 
The April 2008 version of Mouse Genome Informatics was used to survey 
classical QTLs in Qrr1 (MGI: http://www.informatics.jax.org) (Eppig et al., 2005). 
Search for tRNAs was done using tRNAscan-SE 1.21 
(http://lowelab.ucsc.edu/tRNAscan-SE/) (Lowe et al., 1997). GO analysis was done using 
the analytical tool DAVID 2007 (http://david.abcc.ncifcrf.gov/) (Dennis et al., 2003). 
Overrepresented GO terms were identified and statistical significance of enrichment was 
calculated using a modified Fisher’s Exact Test or EASE score (Hosack et al., 2003). We 
used the Allen Brain Atlas to analyze expression pattern in the brain of young C57BL/6J 
male mice (http://www.brain-map.org) (Lein et al., 2007; Lau et al., 2008). 
 
 
5.3.14 Control for Non-Syntenic Association and Paralogous Regions 
 
In RI strains, non-syntenic associations can lead to LD between distant loci 
(Petkov et al., 2006; Williams et al., 2001b). In the BXDs, we detected such non-syntenic 
associations between markers in Qrr1 and markers on distal Chr 2 and proximal Chr 15. 
As a result of these associations, some transcripts that have strong cis- or trans-QTLs in 
Qrr1 tend to have weak LOD peaks, usually below the suggestive threshold, on distal Chr 
2 and proximal Ch15. However, there is no bias for genes located in these intervals in LD 
with Qrr1 to have trans-QTLs in Qrr1. 
 
The Qrr1 segment has been reported to have paralogues on mouse Chrs 1 
(proximal region), 2, 3, 6, 7, 9, and 17 (Katsanis et al., 1996; Stanier et al., 1998). We 
examined if the trans-QTLs in Qrr1 are of genes located in these paralogous regions. 
However, genes located in the paralogous regions are not overrepresented among the 
trans-QTL. 
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5.4 Results 
 
 
5.4.1 Enrichment in Expression QTLs in Neural Tissues 
 
In this section, we summarize the number of expression phenotypes that map to 
Qrr1 in different tissues and mouse crosses. The results are based on the analysis of 18 
array data sets that provide estimates of global mRNA abundance in neural and non-
neural tissues from six different crosses. These crosses are—(i) BXD RI and advanced 
intercross RI strains derived from B6 and D2, (ii) CXB RI strains derived from B6y x 
BALB, (iii) LXS RI strains derived from ILS and ISS, (iv) B6xC3H F2 intercrosses, and  
(v & vi) two separate B6xD2 F2 intercrosses. These data sets were generated by 
collaborative efforts over the last few years (Hitzemann et al., 2004; Bystrykh et al., 
2005; Chesler et al., 2005; Peirce et al., 2006; Yang et al., 2006; Gatti et al., 2007) and 
some were generated more recently (e.g., the Illumina data sets for BXD striatum and 
LXS hippocampus, and BXD Hippocampus UMUTAffy Exon Array data set). All data 
sets can be accessed from GeneNetwork (http://www.genenetwork.org). 
 
We mapped loci that modulate transcript levels and selected only those transcripts 
that have peak QTLs in Qrr1 with a minimum LOD score of 3. This corresponds to a 
generally lenient threshold with genome-wide p of 0.1 to 0.05, but corresponds to a 
highly significant pointwise p. Because we are mainly interested in testing a short 
segment on Chr 1, a pointwise (region-wise) threshold is more appropriate to select those 
transcripts that are likely to be modulated by Qrr1. Qrr1 covers approximately 0.2% of 
the genome and extends from Fcgr3 (more precisely, SNP rs8242852 at 172.887364 Mb 
using Mouse Genome Assembly NCBI m36, UCSC Genome Browser mm8) through to 
Rgs7 (SNP rs4136041 at 177.273526 Mb). We defined this region on the basis of the 
large number of transcripts that have maximal LOD scores associated with markers 
between these SNPs. 
 
Hundreds of transcripts map to Qrr1 with LOD scores ! 3 in neural tissue data 
sets of BXD RI strains, B6D2F2 intercrosses, and B6C3HF2 intercrosses (Table 5-1). 
The QTL counts in Qrr1 are far higher than the average of 15 to 35 expression QTLs in a 
typical 6 Mb interval. The fraction of QTLs in Qrr1 is as high as 14% of all trans-QTLs, 
and 5% of all cis-QTLs in the whole genome. The enrichment in trans-QTLs in Qrr1 is 
even more pronounced when the QTL selection stringency is increased to a LOD 
threshold of 4 (genome-wide p of approximately 0.01). For example, 27% of all highly 
significant trans-QTLs in the BXD cerebellum data set are in Qrr1. The BXD 
hippocampus data set that was assayed on the Affymetrix Exon ST array is an 
exception—there are over a million probe sets in this array, and the percent enrichment of 
QTLs in Qrr1 appears to be relatively low. Nevertheless, about 1000 transcripts map to 
Qrr1 in this exon data set. 
 
In contrast to the CNS data sets, relatively few transcripts map to Qrr1 in non-
neural tissues of the BXD strains and B6C3HF2 intercrosses. While the number of cis-
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QTLs is still relatively high (1–3%), Qrr1 has limited or no trans-effect in these data sets 
(Table 5-1). 
 
Qrr1 does not have a strong trans-effect in the LXS and CXB hippocampus data 
sets (Table 5-1). This indicates that the sequence variants underlying the trans-QTLs do 
not segregate to nearly the same extent in the LXS and CXB RI panels as they do in 
B6xD2 and B6xC3H crosses. This contrast among crosses can be exploited to parse Qrr1 
into sub-regions and identify stronger candidate genes. 
 
 
5.4.2 Replication of Trans-QTLs in Multiple Data Sets 
 
The trans-QTLs in Qrr1 are highly replicable. A large fraction of the transcripts, 
in some cases represented by multiple probes or probe sets, map to Qrr1 in multiple CNS 
data sets. For example, there are 747 unique trans-QTLs with LOD scores greater than 4 
(genome-wide p ! 0.01) in the BXD hippocampus data set (assayed on Affymetrix 
M430v2 arrays). Out of these highly significant trans-QTLs, 155 are in Qrr1 and the 
remaining 592 are distributed across the rest of the genome (Figure 5-1). We compared 
the trans-QTLs in the hippocampus data set with a similar collection of trans-QTLs 
(LOD " 4) in the cerebellum data set (assayed on Affymetrix M430 arrays). Only 101 
trans-QTLs in the hippocampus are replicated in the cerebellum (for trans-QTLs that 
were declared as common, the average distance between peak QTL markers in the two 
data sets is 1.6 Mb). But it is remarkable that of the subset of common trans-QTLs, 64 
are in Qrr1 (Figure 5-1). The replication rate of trans-QTLs in Qrr1 is therefore about 6-
fold higher relative to the rest of the genome. When we compared the BXD hippocampus 
data set with the B6C3HF2 brain dataset (assayed on Agilent arrays), we found 54 trans-
QTLs common to both data sets (for the common trans-QTLs, the average distance 
between peak markers in the two data sets is 2.7 Mb). Strikingly, out of the 54 trans-
QTLs common to both crosses, 52 are in Qrr1 (Figure 5-1). 
 
Among the transcripts with the most consistent trans-QTLs are glycyl-tRNA 
synthetase (Gars), cysteinyl-tRNA synthetase (Cars), asparaginyl-tRNA synthetase 
(Nars), isoleucyl tRNA synthetase (Iars), asparagine synthetase (Asns), and activating 
transcription factor 4 (Atf4). These transcripts map to Qrr1 in almost all data sets in 
which the strong trans-effect is detected. Gars, Cars, and Nars are aminoacyl-tRNA 
synthetases (ARS) that charge tRNAs with amino acids during translation. Asns and Atf 4 
are also involved in amino acid metabolism—Asns is required for asparagines synthesis 
and is under the regulation of Atf4, which in turn is sensitive to cellular amino acid levels 
(Sui et al., 2002). Other transcripts that consistently map as trans-QTLs to Qrr1 include 
brain expressed X-linked 2 (Bex2), splicing factor Sfrs3, ribonucleoproteins Snrpc and 
Snrpd1, ring finger protein 6 (Rnf6), and RAS oncogene family member Rab2. 
 
 
 
  83 
 
 
Figure 5-1 Highly replicable trans-QTLs in Qrr1 
The charts illustrate the total number of trans-QTLs (LOD " 4) in Qrr1 (shaded) and in 
other regions of the genome (non-shaded) in three data sets—BXD cerebellum, BXD 
hippocampus, and B6C3H F2 brain. The smaller charts represent the trans-QTLs in BXD 
hippocampus that are also detected in BXD cerebellum, and B6C3HF2 brain data sets. 
Out of the 101 trans-QTLs common to both BXD hippocampus and cerebellum, 64 are in 
Qrr1 and the remaining 37 are located in other regions of the genome. The BXD 
hippocampus and B6C3HF2 brain data sets have 54 common trans-QTLs, and almost all 
(52 out of 54) are in Qrr1. 
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5.4.3 Candidates in Qrr1 
 
Qrr1 contains 164 known genes. The proximal part of Qrr1 is gene-rich and has 
several genes with high expression in the CNS (e.g. Pea15, Kcnj9, Kcnj10, Atp1a2). The 
middle to distal part of Qrr1 is relatively gene sparse and consists mostly of clusters of 
olfactory receptors and members of the interferon activated Ifi200 gene family. Though 
comparatively gene sparse, the middle to distal part of Qrr1 contains a small number of 
genes that have high expression in the CNS—Igsf4b, Dfy, Fmn2, and Rgs7. 
 
A subset of 35 genes were initially selected as high priority candidates based on 
the number of known and inferred sequence differences between the B6 allele (B) and D2 
allele (D) and based on expression levels in multiple CNS data sets (Table 5-2). Eleven 
of these candidates contain missense SNPs segregating in B6xD2 crosses. We also 
scanned Qrr1 for variation in copy number (Li et al., 2004; Graubert et al., 2007). 
Graubert et al. (2007) reported segmental duplication in Qrr1 with a copy number gain in 
D2 compared to B6 near the intelectin 1 (Itlna) gene at 173.352 Mb. We failed to detect 
any expression signatures of a copy number variation around Itlna in any of the 
GeneNetwork data sets. However, we did identify an apparent 150 kb deletion across the 
Ifi200 gene cluster (175.584–175.733 Mb). Affymetrix probe sets 1426906_at, 
1452231_x_at, and 1452349_x_at detect Ifi204 and Mnda transcripts in B6 but not in D2. 
The expression difference is robust enough to generate cis-QTLs with very high LOD 
scores (> 40). This gene cluster has low expression in the CNS (Affymetrix declares this 
probe sets to be “not present”), but high expression in tissues such as hematopoietic stem 
cells and kidney, in which the trans-effect of Qrr1 is not detected. The Ifi200 gene cluster 
was therefore excluded as a high priority candidate. 
 
 
5.4.4 Cis-QTLs in Qrr1 
 
Transcripts of 26 of the 35 selected candidate genes map as cis-QTLs (LOD " 3) 
in the BXD CNS data sets (Table 5-2). These putatively cis-regulated genes are among 
the strongest candidates in the QTL interval. The D allele in Qrr1 has the positive effect 
on the expression of Sdhc, Ndufs2, Adamts4, Dedd, Pfdn2, Ltap, Pea15, Atp1a2, Kcnj9, 
Kcnj10, Igsf4b, and Grem2. Increase in expression caused by the D allele ranges from 
about 10% for Adamts4 to over 2-fold for Atp1a2. In contrast, the B allele has the positive 
effect on the expression of Pcp4l1, Fcer1g, B4galt3, Ppox, Ufc1, Nit1, Usf1, Copa, 
Pex19, Wdr42a, Igsf8, Dfy, Fmn2, and Rgs7. Increase in expression caused by the B 
allele ranges from about 7% for Usf1 to 40% for Pex19. 
 
Individual probes were screened to assess if the strong cis-effects are due to 
hybridization artifacts caused by SNPs in probe targets. Thirteen candidate genes with 
cis-QTLs were then selected for further analysis and validation of cis-regulation by 
measuring allele specific expression (ASE) difference (Cowles et al., 2002). This method 
exploits transcribed SNPs, and uses single base extension to assess expression difference 
in F1 hybrids. By means of ASE, we validated the cis-regulation of 10 candidate genes—
Ndufs2, Nit1, Pfdn2, Usf1, Copa, Atp1a2, Kcnj9, Kcnj10, Dfy, and Fmn2 (Table 5-3).  
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Table 5-2 Candidate genes in Qrr1 
 
Gene SNP
A
 Exp
B
 BXD
C
 B6C3H 
F2
C
 
CXB
C
 LXS
C
 
       
Fcgr3 2 8.2    cis 
Sdhc 2 12.3 cis   cis 
Pcp4l1  8.7 cis cis   
Tomm40l  9.67 cis  cis  
Apoa2  7.2  cis cis cis 
Fcer1g   8.5 cis   cis 
Ndufs2 2 13.6 cis    
Adamts4 1 8.1 cis cis cis cis 
B4galt3  9.5 cis    
Ppox  7.8 cis cis  cis 
Usp21  9.0    cis 
Ufc1  10.8 cis cis cis cis 
Dedd   9.7 cis    
Nit1  1 9.8 cis cis cis cis 
Pfdn2  12.8 cis cis cis  
Arhgap30 4 7.6     
Usf1  7.5 cis cis  cis 
Refbp2 2 9.7  cis  cis 
Vangl2  7.6 cis cis cis cis 
Ncstn  8.5  cis  cis 
Copa 1 12.7 cis cis  cis 
Pex19 1 9.9 cis  cis cis 
Wdr42a  10.3 cis cis   
Pea15  14.1  cis   
Atp1a2  15.4 cis cis cis cis 
Igsf8   12.1 cis    
Kcnj9  9.1 cis cis cis cis 
Kcnj10 1 11.2 cis cis cis  
Tagln2   8.8     
Dusp23  7.4  cis   
Dfy  10.3 cis  cis cis 
Igsf4b  10.6 cis    
Fmn2 3 10.4 cis cis cis  
Grem2  8.2 cis    
Rgs7   11.5 cis cis   
A
Number of missense SNPs between B and D, 
B
Mean expression signal of probe sets in 
BXD Hippocampus PDNN dataset; below 7 is considered below background; 
C
Cis-QTLs 
in BXD, B6C3HF2, CXB, and LXS crosses. 
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Table 5-3 Validation of cis-QTLs 
 
 
 
Gene 
 
 
ProbeSet ID 
 
 
SNP ID 
 
Cis- 
LOD 
Add. 
Effect 
(QTL)
A
 
High 
Allele 
(ASE) 
 
 
P 
       
Ndufs2 1451096_at rs8245216 12 0.172 D 2.4x10
-5
 
Adamts4 1455965_at rs31537832 25 -0.376  0.2 
Ufc1 1416327_at rs13470410 21 -0.262 D 0.02 
Nit1 1417468_at rs31552469 15 -0.154 B 0.01 
Pfdn2 1421950_at rs31549998 5 0.174 D 4.1x10
-7
 
Usf1 1426164_a_at rs31542370 5 -0.166 B 0.004 
Copa 1415706_at rs13461812 9 -0.148 B 3.9x10
-5
 
Atp1a2 1455136_at rs31570902 49 1.186 D 0.02 
Kcnj9 1450712_at rs31569118 19 0.511 D 0.01 
Kcnj10 1419601_at rs30789204 28 0.349 D 0.003 
Dfy 1432273_a_at rs31616337 24 -0.337 B 0.006 
Igsf4b 1418921_at rs31613626 7 0.171  0.3 
Fmn2 1450063_at rs33800912 17 -0.286 B 5.5x10
-6
 
A
Additive effect is computed as [(mean expression in DD homozygote) – (mean 
expression in BB homozygote)]/2 on a log2 scale. Positive value means D high 
expression, and negative value means B high expression. 
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Adamts4 and Igsf4b failed to show significant allelic expression difference. In the case of 
Ufc1, the polarity of the allele effect failed to agree with the ASE result (D positive at p = 
0.02). 
 
 
5.4.5 High-Resolution Cis-QTL Mapping 
 
The BXD CNS data sets were generated from a combined panel of conventional 
RI strains and advanced RI strains that were derived by inbreeding advanced intercross 
progeny. The advanced RIs have approximately twice as many recombinations compared 
to standard RIs and the merged panel offers over a 3-fold increase in mapping resolution 
(Peirce et al., 2004). This expanded RI set combined with the relatively high intrinsic 
recombination rate within Qrr1 (Paigen et al., 2008) provides comparatively high  
mapping resolution. Mapping precision can be empirically determined by analyzing cis-
QTLs in multiple large data sets, particularly the BXD Hippocampus Consortium, 
UMUTAffy Hippocampus, and Hamilton Eye data sets. These three data sets were 
selected because they have expression measurements from six BXD strains with 
recombinations in Qrr1. These strains—BXD8, BXD29, BXD62, BXD64, BXD68, and 
BXD84—collectively provide six sets of informative markers and divide Qrr1 into six 
non-recombinant segments, labeled as segments 1–6 (haplotype structures shown in 
Figure 5-2). 
 
As cis-acting regulatory elements are usually located within a few kilobases of a 
gene’s coding sequence (Cowles et al., 2002), we used the cis-QTLs as an internal metric 
of mapping precision by measuring the offset distance between a cis-QTL (position of 
peak QTL marker) and the parent gene (Figure 5-3). For cis-QTLs with LOD scores 
between 3–4 (genome-wide p of 0.1–0.01) the mean gene-to-QTL peak distance is 900 
kb. The offset decreases to a mean of 640 kb for cis-QTLs with LOD scores greater than 
4 (p < 0.001). Very strong cis-QTLs with LOD scores greater than 11 (p < 10
-6
) have a 
mean gene-to-QTL peak distance of only 450 kb. In all, 60% of cis-QTLs we examined 
have peak linkage on markers located precisely in the same non-recombinant segment as 
the parent gene, and 30% have peak linkage on markers in a segment adjacent to the 
parent gene (dataset S1). These cis-QTLs provide an empirical metric of mapping 
precision within Qrr1. 
 
Parsing trans-QTLs by high-resolution mapping and gene functions  
Mapping precision of cis-QTLs is comparatively higher in the BXD hippocampus data 
set (average offset of only 410 kb), and we used this set to examine the trans-QTLs  
(LOD " 3) at higher resolution. The trans-QTLs in Qrr1 were parsed into subgroups 
based on the location of peak LOD score markers. This method of resolving trans-QTLs 
effectively grouped subsets of transcripts into functionally related cohorts. For instance, 
all the QTLs for the aminoacyl-tRNA synthetases (ARS) have peak LOD scores only 
within the distal three segments of Qrr1 (Figure 5-4). This consistency in QTL peaks for 
transcripts of the same gene family is itself a good indicator of mapping precision. In 
addition to the ARS, numerous other genes involved in amino acid metabolism and 
translation map to the distal part of Qrr1 (e.g., Atf4, Asns, Eif4g2, and Pum2). 
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Figure 5-2 Haplotype maps of Qrr1 recombinant BXD strains 
BXD8, BXD29, BXD62, BXD64, BXD68, and BXD84 have recombinations in Qrr1. B 
haplotype is assigned blue (–), D haplotype is assigned pink (+), and recombination 
regions are shown in grey. The Qrr1 interval (in Mb scale) is shown above and 
approximate positions of recombination are highlighted (red). The recombinant strains 
collectively divide Qrr1 into six segments (labeled 1–6), and provide six sets of 
informative markers. Markers are shown below and approximate positions of candidate 
genes (yellow bars) and tRNA clusters (orange triangles) are indicated. 
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Figure 5-3 QTL mapping precision in Qrr1 
Mapping precision was empirically determined by measuring the distance between a cis-
QTL peak and location of parent gene. Cis-QTLs in BXD Hippocampus Consortium, 
UMUTAffy Hippocampus, and Hamilton Eye data sets were used for this purpose. Mean 
gene-to-QTL peak distance (y-axis) was plotted as a function of LOD score (LOD score 
range on x-axis). Number of probe sets in each LOD range is shown. Mapping precision 
increases with increase in LOD score. The mean offset for cis-QTLs with LOD scores 3–
4 (genome-wide adjusted p-value of 0.1–0.01) is 900 kb, and the offset decreases to 650 
kb at 4–5 LOD scores (p-value of 0.01–0.001). Cis-QTLs with LOD scores greater than 
11 (p-value < 10
-6
) have mean offset of only 450 kb. 
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Figure 5-4 QTL for aminoacyl-tRNA synthetase in distal Qrr1 
Transcripts of Gars, Cars, Nars, Mars, and Yars map as trans-QTLs to Qrr1 at LOD > 4 
(genome-wide p < 0.01) in the BXD hippocampus data set. The trans-QTLs have peak 
LOD precisely on markers in distal part of Qrr1, ~175–177.5 Mb (shaded regions). 
Yellow seismograph on Chr 1 (x-axis) tracks SNP density between B and D alleles. 
Affymetrix probe set ID for each transcript is shown. 
 
 
We divided the trans-QTLs into two broad subgroups—those with peak QTLs on 
markers in the proximal part of Qrr1 (Qrr1p; 172-174.5 Mb or segments 1, 2, 3 in Figure 
5-2), and those with peak QTLs on markers in the distal part of Qrr1 (Qrr1d; 174.5-177.5 
Mb or segments 4, 5, and 6 in Figure 5-2). While Qrr1p is relatively gene-rich, only 35% 
of the trans-QTLs (129 out of 365 probe sets) have peak LOD scores in this region. The 
majority of trans-QTLs—about 65% (236 out of 365 probe sets)—have peak QTLs in the 
relatively gene-sparse Qrr1d. 
 
The two subsets of transcripts—those with trans-QTLs in Qrr1p and those with 
trans-QTLs in Qrr1d—were analyzed for overrepresented gene functions using the 
DAVID functional annotation tool (http://david.abcc.ncifcrf.gov/). This revealed distinct 
gene ontology (GO) categories enriched in the two subsets. Enriched GOs among the 
transcripts modulated by Qrr1p include GTPase-mediate signal transduction (modified 
Fisher’s exact test p = 0.001), and structural constituents of ribosomes (p = 0.003). 
Transcripts modulated by Qrr1d are highly enriched in genes involved in RNA  
metabolism (p = 4 x 10
-7
), tRNA aminoacylation (p = 1 x 10
-5
) and translation (p = 2 x 
10
-5
), RNA transport (p = 0.003), cell cycle (p = 0.004), and ubiquitin mediated protein 
catabolism (p = 0.006). Other GO categories show enrichment in both Qrr1p and Qrr1d. 
For example, genes involved in RNA metabolism and ubiquitin-mediated protein 
catabolism are also overrepresented among the transcripts modulated by Qrr1p (p = 
0.002 for RNA metabolism and p = 0.005 for ubiquitin-protein ligases). This may either 
be due to limitations in QTL resolution, or due to multiple loci in Qrr1p and Qrr1d 
controlling these subsets of transcripts. 
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5.4.6 An Aminoacyl-tRNA Synthetase Trans-QTL in Distal Qrr1 
 
A remarkable number of transcripts of the ARS gene family map to Qrr1. A total 
of 16 ARS transcripts have trans-QTLs at a minimum LOD score of 3 in one or multiple 
BXD, B6D2F2, and B6C3H CNS data sets (Table 5-4). In almost all cases, QTLs peak 
on markers on the distal part of Qrr1. Except for Hars, the B allele in Qrr1 consistently 
increases expression by 10% to 30%. In the case of Hars, the D allele has the positive 
additive effect and increases expression by about 10%. 
 
We examined all probes or probe sets that target ARS and ARS-like genes in the 
B6xD2 CNS data sets. The Affymetrix platform measures the expression of 34 ARS and 
ARS-like genes; 24 of these map to Qrr1 at LOD scores ranging from a low of 2 to a 
high of 12. Even in the case of the suggestive trans-QTLs (i.e., LOD values between 2 
and 3), the B allele in Qrr1 has the positive effect on expression. The ARS family is also 
highly represented among trans-QTLs in the B6C3HF2 brain data set. Thirty-seven 
probes in this data set target the tRNA synthetases, eleven of these have trans-QTLs in 
Qrr1d (LOD scores ranging from 2 to 20), and almost all have a B positive additive effect 
(exceptions are Hars and Qars). The co-localization of trans-QTLs to Qrr1d, the general 
consensus in parental allele effect, and their common biological function indicate that 
there is a single QTL in the distal part of Qrr1 modulating the expression of the ARS. It 
is crucial to note that this genetic modulation is only detected in CNS tissues. 
 
In the LXS hippocampus data set, Qrr1 has only a limited trans-effect on gene 
expression. Despite the weak effect, expression of Dars2 (probe ID ILM580427) maps to 
the distal part of Qrr1 at a LOD of 3. Although this is only a weak detection of the ARS 
QTL in the LXS data set, it nonetheless demonstrates the strong regulatory effect of Qrr1 
on the expression of this gene family. In the case of the CXB hippocampus data set, not a 
single trans-QTL for the ARS is detected in Qrr1. 
 
 
5.4.7 Trans-QTLs for Transcripts Localized in Neuronal Processes 
 
In addition to the high overrepresentation of transcripts involved in translation 
and RNA metabolism, several transcripts known to be transported to neuronal processes 
or involved in RNA transport also map to Qrr1d, including Camk2a, Bdnf, Cdc42, Eif4e, 
Eif4g2, Hnrpab, Ppp1cc, Pabpc1, Eif5, Kpnb1, Rhoip3, Stau2, and Pum2 (Duchaîne et 
al., 2002; Eberwine et al., 2002; Poon et al., 2006; Vessey et al., 2006). An interesting 
example is provided by the brain derived neurotrophic factor (Bdnf). Two alternative 
forms of Bdnf mRNA are known—one isoform has a long 3’ UTR and is specifically 
transported into the dendrites; the other isoform has a short 3’ UTR and remains 
primarily in the somatic cytosol (An et al., 2008) The Affymetrix M430 arrays contain 
two different probe sets that target these Bdnf isoforms. Probe set 1422169_a_at targets 
the distal 3’ UTR and is essentially specific for the dendritic isoform, and probe set 
1422168_a_at targets a coding sequence common to both isoforms. Although both probe 
sets detect high expression signal in the hippocampus, only the dendritic isoform maps as 
a trans-QTL to Qrr1d. This enrichment in transcripts that are transported to neuronal  
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Table 5-4 Aminoacyl-tRNA synthetases that have trans-QTLs in Qrr1 
 
Gene Name ProbeID
A
 Chr
B
 Data set
C
 LOD
D
 B/D
C
 
       
Nars asparaginyl-
tRS 
1452866_at
_A 
Chr 18 BXD 
cerebellum 
12.0 B 
Gars glycyl-tRS 1423784_at Chr 6 BXD 
hippocampus 
10.6 B 
Rars arginyl-tRS 1416312_at
_A 
Chr 11 BXD 
forebrain 
8.9 B 
Cars cysteinyl-tRS 100244060
01 
Chr 7 B6C3HF2 
brain 
8.9 B 
Yars tyrosyl-tRS 100243998
42 
Chr 4 B6C3HF2 
brain 
8.0 B 
Iars isoleucine-tRS 1426705_s
_at 
Chr 13 BXD 
cerebellum 
7.8 B 
Sars seryl-tRS 1426257_a
_at 
Chr 3 BXD 
cerebellum 
6.9 B 
Mars methionine-
tRS 
1455951_at Chr 10 BXD 
hippocampus 
6.5 B 
Hars histidyl-tRS 1438510_a
_at 
Chr 18 BXD 
hippocampus 
5.2 D 
Iars2 isoleucine-tRS 1426735_at Chr 1 BXD 
hippocampus 
4.3 B 
Tars threonyl-tRS 100243956
55 
Chr 15 B6C3HF2 
brain 
4.0 B 
Aars alanyl-tRS 1451083_s
_at 
Chr 8 BXD 
eye 
3.9 B 
Lars leucyl-tRS 1448403_at
_A 
Chr 18 BXD 
cerebellum 
3.7 B 
Ears2 glutmyl-tRS  ILM52904
46 
Chr 7 BXD ILM 
striatum 
3.7 B 
Aarsd
1 
alanyl-tRS 
domain 1 
1424006_at Chr 11 B6D2F2 
brain 
3.5 B 
Dars aspartyl-tRS 1423800_at
_A 
Chr 1 BXD 
cerebellum 
3.2 B 
A
Probe/Probe set ID; 
B
Physical location of gene; Iars2 is located on Chr 1 at 186.9 Mb, 
and Dars on Chr 1 at 130 Mb; 
C
Data set in which transcript has highest trans-QTL in 
Qrr1; 
D
Highest LOD score in Qrr1; 
E
Allele that increases expression. 
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processes raises the possibility that this CNS specific trans-effect may be related to local 
protein synthesis. 
 
 
5.4.8 tRNAs in Qrr1 
 
Prompted by the many ARS transcripts that consistently map to Qrr1d, we 
searched the genomic tRNA database (Lowe et al., 1997) for tRNAs in this region. 
Interestingly, distal Chr 1 is one of many tRNA hotspots in the mouse genome and 
several predicted tRNAs are clustered in the non-coding regions of Qrr1 (Figure 5-2). 
The majority of these tRNA sequences are in the proximal end of Qrr1, over 2 Mb away 
from Qrr1d. We scanned the intergenic non-coding regions in Qrr1d for tRNAs using the 
tRNAscan-SE software (Lowe et al., 1997) and uncovered tRNAs for arginine and serine, 
and three pseudo-tRNA sequences between genes Igsf4b and Aim2 (175.204–175.257 
Mb) in Qrr1d (dataset S3). Transfer RNAs are involved in regulating transcription of the 
ARS in response to cellular amino acid levels (Rychelynck et al., 2005) and are  
functionally highly relevant candidates in Qrr1d.  Polymorphism in the tRNA clusters 
(e.g., possible copy number variants, differences in tRNA species) may have significant 
impact on the expression of the ARS. 
 
 
5.4.9 Sequence Analysis of Multiple Crosses 
 
Trans-regulation of large number of transcripts by Qrr1 is a strong feature of 
crosses between B6 and D2 —both the BXD RI set and B6D2F2 intercrosses—and in the 
B6 and C3H intercrosses. The feature is much weaker in the large LXS RI set and in the 
small CXB panel. The effect specificity demonstrates that a major source of the Qrr1 
signal is generated by variations between B and D, and B and C3H alleles (H) but not by 
variations between the ILS and ISS alleles (L and S, respectively), and B and BALB 
alleles (C). This contrast can be exploited to identify sub-regions that underlie the trans-
QTLs (Hitzemann et al., 2002). 
 
SNPs were counted for all four pairs of parental haplotypes—B vs D, B vs H, B vs 
C, and L vs S—and SNP profiles for the four crosses were compared (Figure 5-5). Qrr1 
is a highly polymorphic interval in the B6xD2 crosses. The flanking regions, however, 
have few SNPs (170–172.25 Mb proximally, and 177.5–179.5 Mb distally) and are 
almost identical-by-descent between B6 and D2. The B6xBALB crosses, despite being 
negative for the trans-effect, have moderate to high SNP counts in Qrr1 and share a SNP 
profile somewhat similar to B6xD2 crosses. The B6xC3H crosses also have moderate to 
high SNP counts in Qrr1, with a relatively higher SNP count in Qrr1d compared to 
Qrr1p. In contrast, in the LXS, Qrr1p is more SNP-rich than Qrr1d. Most notably, the 
segments that harbor the tRNAs and candidates Fmn2, Grem2, and Rgs7 are almost 
identical by descent between ILS and ISS. This SNP comparison indicates that the 
strongest trans-effect is from Qrr1d. A possible reason why the trans-effect is not 
detected in the CXB RI strains, despite being SNP rich in Qrr1, is that the crucial SNPs 
underlying the trans-QTLs may not be segregating in this cross or that undetected copy  
  94 
 
 
Figure 5-5 SNP comparison of multiple crosses 
SNPs in Qrr1 were counted for (A) C57BL/6J (B6) x DBA/2J (D2), (B) B6 x BALB/cBy 
(BALB), (C) B6 x C3H/HeJ (C3H), and (D) ILS x ISS. Vertical red lines mark the 
approximate positions of recombination. Region covered by Qrr1p (horizontal line), 
candidate genes in Qrr1d (yellow bars), and position of tRNA clusters (triangles) are 
shown above the graphs. The B6xD2, B6xBALB, and B6xC3H crosses have moderate to 
high SNP counts throughout Qrr1. In the ILSxISS cross, Qrr1p is relatively SNP-rich but 
Qrr1d is SNP-sparse.
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number variants make important contributions to the Qrr1 effects. A final explanation 
may be that the small CXB data set (13 strains) is simply underpowered. 
 
 
5.4.10 High-Ranking Candidates Based on Cross-Specificity of Cis-QTLs 
 
We used the specificity of cis-QTLs in the multiple crosses to identify higher 
priority candidates in Qrr1. The assumption is that candidate genes whose transcripts 
have cis-QTLs (LOD score above 3) in the B6xD2 and B6xC3H crosses but not in the 
LXS and CXB RI strains are stronger candidates for trans-QTLs that are detected in the 
former two crosses but not in the latter two crosses. In contrast, cis-QTLs with the 
inverse cross specificity are less likely to underlie these trans-QTLs. Based on this 
criterion, there are four high-ranking candidates in Qrr1p—Purkinje cell protein 4-like 1 
(Pcp4l1), prefoldin (Pfdn2), WD repeat domain 42 a (Wdr42a), and Kcnj10 (Table 5-2).  
There are only two high-ranking candidates in Qrr1d—formin 2 (Fmn2), an actin binding 
protein involved in cytoskeletal organization, and regulator of G-protein signaling 7 
(Rgs7) (Table 5-2). 
 
Both Fmn2 and Rgs7 are almost exclusively expressed in the CNS and are high 
priority candidates for the CNS specific trans-QTLs. A point of distinction between the 
two candidates is that while expression of Rgs7 maps as a cis-QTL only in the B6xD2 
and B6xC3H crosses, expression of Fmn2 maps as a cis-QTL in B6xD2 and B6xC3H 
crosses, and in the CXB RI strains in which the trans-effect is not detected (Table 5-2). 
Based on the pattern of specificity of cis-QTLs in multiple crosses, Rgs7 is a more 
appealing candidate. However, Fmn2 has known missense SNPs that segregate in the 
B6xD2 (Glu610Asp, Pro1077Leu, Asp1431Glu) and B6xC3H crosses (Val372Ala). 
There are no known missense mutations in Fmn2 in the CXB and LXS RI strains, and no 
known missense mutation in Rgs7 in any of the four crosses. 
 
 
5.4.11 Partial Correlation Analysis 
 
Linkage disequilibrium (LD) is a major confounding factor that limits fine-scale 
discrimination among physically linked candidates in a QTL. To further evaluate the two 
high-priority candidates in Qrr1d—Fmn2 and Rgs7—we implemented a partial 
correlation analysis (de La Fuente et al., 2004) in which the effect of genotype at Qrr1d 
was controlled.  For this analysis, we computed the partial correlation coefficient between 
cis-regulated transcripts and each trans-regulated transcript after regression against the 
Qrr1d genotype. This partial correlation reveals residual variance that links cis candidates 
with trans targets, independent of genetic variance at Qrr1d. We computed the partial 
correlation between Rgs7 and Fmn2, and 14 transcripts representative of the different 
GOs that map to Qrr1d. The highest partial correlations are between Fmn2 and Rnf6 (r = 
0.68, p < 10
-13
), Atf4 (r = 0.6, p < 10
-9
), Asns (r = 0.55, p < 10
-7
), Ube2d3 (r = 0.5, p <  
10
-6
), Hnrpk (r = 0.5, p = 10
-5
), Rab2 (r = –0.5, p = 10
-5
), and Gars (r = 0.5, p = 10
-5
). 
The strongest correlate of Fmn2 is Rnf6, a gene involved in regulating actin dynamics in 
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axonal growth cones (Tursun et al., 2005) Although not unequivocal, this analysis 
provides stronger support for Fmn2 than for Rgs7. 
 
 
5.4.12 Effect of Fmn2-Deletion on Gene Expression 
 
Fmn2 is almost exclusively expressed in the nervous system (Leader et al., 2000) 
and is a strong candidate for a trans-effect specific to neural tissues. However, its precise 
function in the brain has not been established. Fmn2-null mice do not have notable CNS 
abnormalities (Leader et al., 2002), but to evaluate a possible role of Fmn2 on expression 
of genes that map to Qrr1d, we generated array data from brains of Fmn2-null (Fmn2
-/-
) 
and coisogenic (Fmn2
+/+
) 129/SvEv controls. At a stringent statistical threshold 
(Bonferroni corrected p < 0.05), only eight genes have significant expression differences 
between Fmn2
-/-
 and Fmn2
+/+
 genotypes (Table 5-5). Five out of the eight genes, 
including Pou6f1, Usp53, and Slc11a, have trans-QTLs in Qrr1d. Deletion of Fmn2 had 
the most drastic effect on the expression of the transcription factor gene Pou6f1, a gene 
implicated in CNS development and regulation of brain-specific gene expression (Cui et 
al., 1998; Drews et al., 2007). Expression of Pou6f1 maps as a trans-QTL (at LOD score 
of 3) to Qrr1d in the hippocampus data set, and its expression was down-regulated more 
than 44-fold in the Fmn2
-/-
 line. While the expression analysis of Fmn2-null mice does 
not definitively link all the trans-QTLs to Fmn2, variation in this gene is likely to 
underlie some of the trans-QTLs in Qrr1d. The possible compensatory mechanism in the 
Fmn2-null CNS, and the different genetic background of the mice (129/SvEv) are factors 
that may have contributed to the weak detection of trans-effects in the knockout line. 
 
 
5.4.13 Sub-Cellular Localization of FMN2 in Hippocampal Neurons 
 
We examined the intracellular distribution of FMN2 protein in neurons using 
immunocytochemical techniques. All hippocampal pyramidal neurons on a culture dish 
exhibited distinct and fine granular immunoreactivity for FMN2.  The cell body itself had 
the strongest signal (Figure 5-6). This fine punctate labeling extended into proximal 
dendrites and could be followed into distal dendrites. In some instances very thin 
processes, possibly the axons, were also labeled. 
 
 
5.4.14 Linking Expression and Classical QTLs: Szs1 
 
The strong trans-effect that Qrr1 has on gene expression is a likely basis for the 
classical QTLs that map to this region. For example, the major seizure susceptibility QTL 
(Szs1) has been precisely narrowed to Qrr1p (Ferraro et al., 2007). We found that 10 
genes already known to be associated with seizure or epilepsy have trans-QTLs with 
peak LOD scores near Szs1and in Qrr1p. These include Scn1b, Cacna1g, Pnpo, and 
Dapk1 (Table 5-6). In every case, the D allele has the positive additive effect on the 
expression of these seizure related transcripts, increasing expression 5% to 20%. The two 
potassium channel genes, Kcnj9 and Kcnj10, are the primary candidates (Ferraro et al., 
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Table 5-5 Genes differentially expressed between Fmn2
+/+
 and Fmn2
-/- 
 
 
Gene 
 
Chr
A
 
Fmn
2
+/+B
 
Fmn
2
-/-B
 
 
Fold
C
 
 
P
D
 
 
LOD
E
 
 
Dataset
E
 
        
Pou6f1 15 11.96 6.48 45 3X10
-6
 
3.0 BXD 
Hippocampus 
Zfp420 7 10.12 7.70 5 0.002   
 
Txnl1 18 10.72 6.70 16 0.002 3.0 B6D2F2 
striatum 
Usp53 3 7.17 9.32 4 0.009 3.3 BXD 
Hippocampus 
LOC33113
9 
4 14.45 10.59 15 0.01   
 
Slc11a2 15 9.92 9.17 2 0.02 3.9 BXD 
Hippocampus 
Pgbd5 8 13.40 12.12 2 0.02 3.3 BXD HBP 
Striatum 
6330569M2
2Rik 
3 6.42 10.63 18 0.03   
A
Physical location of gene; 
B
Average expression signal in Fmn2-null and wild-type lines; 
C
Fold difference in expression between Fmn2-null and wild-type lines; 
D
Bonferroni 
adjusted p-values; corrected for 46,620 tests; 
E
Highest LOD in Qrr1 and data set in 
which transcript has highest LOD in Qrr1. 
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Figure 5-6 Expression of FMN2 protein in hippocampal neurons 
(A) Neurons exhibited pronounced fine granular immunoreactivity for FMN2. The cell 
body had the strongest signal. The fine granular staining extended into apical and distal 
dendrites (arrows). Thin axon-like processes were also labeled (arrow head). (B) The fine 
granular staining is not detected in controls of sister cultures processed in parallel without 
the first antibody. 
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Table 5-6 Seizure associated genes with trans-QTLs in Qrr1p 
 
Gene Chr
A
 Data set
B
 LOD
C
 B/D
D
 Reference 
      
Scn1b Chr 7 Forebrain 3.5 D Wallace et al., 1998 
Akt1 Chr 12 Forebrain 3.0 D Henshall et al., 2002 
Cacna1g Chr 11 Forebrain 2.8 D Song et al., 2004 
Pnpo Chr 11 Cerebellum 29 D Mills et al., 2005 
Dapk1 Chr 13 Cerebellum 6.3 D Henshall et al., 2004 
Kcnma1 Chr 14 Cerebellum 3.7 D Du et al., 2005 
Socs2 Chr 10 Cerebellum 3.7 D Rosell et al., 2003 
Nsf Chr 11 Cerebellum 3.3 D Yin et al., 2005 
Grm2 Chr 9 Cerebellum 3.3 D Thomsen et al., 1994 
Adora1 Chr 1  Hippocampus 3.0 D Fedele et al., 2006 
A
Physical location of gene; Adora1 is located on Chr 1 at 136 Mb; 
B
Dataset in which 
transcript has highest trans-QTL in Qrr1p; 
C
Highest  LOD scores in Qrr1p; 
D
Allele that 
increases expression. 
 
 
2007). Both are strongly cis-regulated. The tight linkage between these genes (within 100 
kb) limits further genetic dissection, but in situ expression data from the Allen Brain 
Atlas (ABA, http://www.brain-map.org) provides us with a powerful complementary 
approach to evaluate these candidates (Lau et al., 2008). Kcnj9 (Figure 5-7A) is 
expressed most heavily in neurons within the dentate gyrus, whereas Kcnj10 (Figure     
5-7B) is expressed diffusely in glial cells in all parts of the CNS. The seizure-related 
transcripts with trans-QTLs near Szs1 are most highly expressed in neurons, and all have 
comparatively high expression in the hippocampus. Furthermore, expression patterns of 
six of the seizure transcripts that map to Qrr1p show spatial correlations with Kcnj9. 
Dapk1 and Cacna1g (Figure 5-7C) have expression pattern that match Kcnj9 with strong 
labeling in the dentate gyrus and CA1, and weaker labeling in CA2 and CA3. In contrast, 
Socs2 (Figure 5-7D), Adora1, Pnpo, and Kcnma1 complement the expression of Kcnj9 
with comparatively strong expression in CA2 and CA3, and weak expression in CA1 and 
dentate gyrus. 
 
 
5.5 Discussion 
 
Qrr1 is a complex regulatory region that modulates expression of many genes and 
classical phenotypes. By exploiting a variety of microarray data sets and by applying a 
combination of high-resolution mapping, sequence analysis, and multiple cross analysis, 
we have dissected Qrr1 into segments that are primarily responsible for variation in the 
expression of functionally coherent sets of transcripts. The distal portion of Qrr1 (Qrr1d) 
has a strong trans-effect on RNA metabolism, translation, tRNA aminoacylation, and 
transcripts that are transported into neuronal dendrites. Fmn2, Rgs7, and a cluster of 
tRNAs are strong candidates in Qrr1d. We analyzed gene expression changes in the CNS 
of Fmn2-null mice and detected a profound effect on the expression of a small number of 
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Figure 5-7 Expression pattern of seizure-related genes with QTLs in Qrr1 
Candidate gene Kcnj9 (A) has heavy expression in neurons. Kcnj9 shows a regionally 
restricted expression in the hippocampus with intense labeling in dentate gyrus, strong 
labeling in CA1, and relatively weak labeling in CA2 and CA3. Candidate gene Kcnj10 
(B) has a more diffused pattern and expressed primarily in glial cells. There is almost no 
labeling for Kcnj10 in the hippocampus. Transcripts of seizure-related genes, Cacna1g 
(C) and Socs2 (D), have trans-QTLs in Qrr1p. Both genes show high expression in 
neurons. Cacna1g matches the expression of Kcnj9 with strong labeling in dentate gyrus 
and CA1, and weak labeling in CA2 and CA3. Socs2 complements the expression of 
Kcnj9 and Cacna1g with intense labeling in CA2 and CA3. In situ expression data are 
from the Allen Brain Atlas. 
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transcripts that map to Qrr1d, particularly on the expression of the transcription factor 
Pou6f1. We have shown that the FMN2 protein is highly expressed in the cell body and 
processes of neurons, and is a high priority candidate in Qrr1d. 
 
 
5.5.1 Kcnj9 vs. Kncj10 and Seizure Susceptibility 
 
The two inwardly rectifying potassium channel genes—Kcnj9 and Kcnj10—are 
strong candidates for the seizure susceptibility QTL in Qrr1p that has been 
unambiguously narrowed to the short interval from Atp1a2 to Kcnj10 (Ferraro et al., 
2004). In BXD CNS data sets, Qrr1 also modulates the expression of a set of genes 
implicated in the etiology of seizure and epilepsy, including Pnpo, Scn1b, Kcnma1, 
Socs2, and Cacna1g. Polymorphisms in the Kcnj9/Kcnj10 interval that influence 
expression of these genes are excellent candidates for the Szs1 locus. 
 
The in situ expression data in the ABA shows a striking spatial correlation 
between expression of Kcnj9 and other seizure-related transcripts that have trans-QTLs 
in Qrr1p. The complementary expression of Kcnj9 and the seizure-related transcripts 
make Kcnj9 a stronger candidate than Kcnj10. Kcnj9 has over a 2-fold higher expression 
in D2 (Hitzemann et al., 2003), a seizure prone strain, compared to B6, a relatively 
seizure resistant strain, suggesting that the proximal cause of Szs1 may be high 
expression of this gene, perhaps due to the promoter polymorphism discovered by 
Hitzemann and colleagues (2003). 
 
 
5.5.2 Multiple Loci in a Major QTL Interval 
 
Fine mapping of complex traits have often yielded multiple constituent loci within 
a QTL interval (Legare et al., 2000; Demarest et al., 2001). Our mapping analyses of 
expression traits also show that multiple gene variants, rather than one master regulatory 
gene, cause the aggregation of expression QTLs in Qrr1. Subgroups of genes with tight 
coexpression can be dissected from the dense cluster of QTLs. Most notable is the strong 
trans-regulatory effect of Qrr1d on genes involved in amino acid metabolism and 
translation, including a host of ARS transcripts. However, there are limits to our ability to 
dissect Qrr1, and genes associated with protein degradation and RNA metabolism map 
throughout the region. In part this may be due to inadequate mapping resolution, but it 
may also reflect clusters of functionally related loci and genes (Petkov et al., 2006). At 
this stage we are also unable to discern whether there is a single or multiple QTLs within 
Qrr1d. While it is likely that a single QTL modulates the expression of the ARS, there 
may be additional gene variants in Qrr1d that modulate other transcripts involved in 
translation and RNA metabolism. With increased resolving power it may be possible to 
further subdivide transcripts that map to Qrr1p and Qrr1d into smaller functional 
modules. 
 
There may be multiple loci in Qrr1 that modulate different stages of protein 
metabolism in the CNS. Maintenance of cellular protein homeostasis requires finely 
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tuned cross talk between transcription and RNA processing, the translation machinery, 
and protein degradation (Ding et al., 2007), gene functions highly overrepresented among 
the transcripts that map to Qrr1. While these are generic cellular processes, there are 
unique demands on protein metabolism in the nervous system. Neurons are highly 
polarized cells and specialized mechanisms are in place to manage local protein synthesis 
and degradation in dendrites and axons (Steward et al., 2003). The nervous system is also 
particularly sensitive to imbalances in protein homeostasis (Malgaroli et al., 2006), a 
possible reason why the trans-effects of Qrr1 are detected only in neural tissues. 
 
 
5.5.3 Candidates in Qrr1d and Possible Link with Local Protein Synthesis 
 
Transfer RNAs are direct biological partners of the ARS, and the cluster of 
tRNAs in the highly polymorphic intergenic region of Qrr1d is an enticing candidate. In 
addition to their role in shuttling amino acids, tRNAs also act as sensors of cellular amino 
acid levels and regulate transcription of genes involved in amino acid metabolism and the 
ARS (Ryckelynck et al., 2005). There is tissue specificity in the expression of different 
tRNA isoforms (Dittmar et al., 2006) and we speculate that the tRNA cluster in Qrr1d is 
specifically functional in neural tissues. 
 
Rgs7, a member of the RGS (regulator of G-protein signaling) family, is another 
high-ranking candidate in Qrr1d. RGS proteins are important regulators of G-protein 
mediated signal transduction. Rgs7 is predominantly expressed in the brain and has been 
implicated in regulation of neuronal excitability and synaptic transmission (Saitoh et al., 
1999; Hunt et al., 2003). Although RGS proteins are usually localized in the plasma 
membrane, RGS7 has been found to shuttle between the membrane and the nucleus 
(Drenan et al., 2005). This implies a role for RGS7 in gene expression regulation in 
response to external stimuli. 
 
Our final high-ranking candidate in Qrr1d is Fmn2. It codes for an actin binding 
protein exclusively expressed in the CNS and oocytes, and is involved in the 
establishment of cell polarity (Leader et al., 2000; Leader et al., 2002). In Drosophila, the 
formin homolog, cappuccino, has a role in RNA transport and in localizing the staufen 
protein to oocyte poles (Emmons et al., 1995; Johnstone et al., 2001). It is possible that 
FMN2 has parallel functions in mammalian neurons. Interestingly, Staufen 2 (Stau2), a 
gene involved in RNA transport to dendrites (Duchaîne et al., 2002), maps to Qrr1d in 
BXD CNS data sets. Furthermore, deletion of formin homologs in yeast results in 
inhibition of protein translation (Gross & Kinzy, 2007), compelling evidence for an 
interaction between the protein translation system and formins. Evidence for a role for 
Fmn2 in dendrites also comes from our immunocytochemical analysis that clearly 
demonstrates the expression of FMN2 protein in dendrites. Taken together, Fmn2 is a 
functionally relevant candidate gene in Qrr1d and may be related to RNA transport and 
protein synthesis in the CNS.
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CHAPTER 6. SUMMARY AND CONCLUDING REMARKS 
 
 
The work presented in this dissertation is an integrative, systems genetics 
approach to explore the molecular factors and brain structures that underlie emotional 
processing and behavior. The overarching question that was pursued in this study was—
how does information in the DNA sequence give rise to the rich variants of neural and 
behavioral traits? A combination of analytical methods, including morphometric analysis, 
classic QTL mapping, behavioral assays, gene expression analysis, and expression QTL 
mapping was used to identify the genetic modulators of the corticolimbic brain structures, 
particularly the basolateral amygdala (BLA), and associated emotion-related behavior. 
 
The molecular origins of psychological conditions such as stress, anxiety and fear, 
and the resultant behavioral traits are extraordinarily complex and arise from the 
interaction of a host of genetic, epigenetic, and environmental factors. The integrative 
approach taken by system genetics is to consider each phenotype within the context of a 
vast network of causal factors and interrelated phenotypes. For example, multiple gene 
variants and molecular traits define the cellular and physiological traits that make up 
neural structures such as the BLA, which in turn give rise to higher-order cognitive and 
behavioral traits. In this light, genetic variations can be viewed as perturbations that 
resonate across multiple phenotypic levels. 
 
Within the framework of systems genetics, each phenotype that was examined in 
this study was considered in relation to other phenotypes. The analytical strategy can be 
broken down into four basic steps: (1) exploit natural variations in neuroanatomy to 
uncover genes that may have pleiotropic influence on brain structure and behavior, (2) 
examine the association between variations in neuroanatomy and behavior, (3) examine 
gene expression (both baseline and in response to stressful experience) in the 
neuroanatomic substrates of behavior, and (4) examine genetic regulators of expression 
traits to identify genes and gene-networks that underlie higher-order structural and 
behavioral traits. 
 
In the first step, variation in the size and cytoarchitecture of the BLA was 
analyzed to identify the underlying DNA sequence variants. As a central modulator of 
emotional processes, we reasoned that such variations associated with the BLA might be 
coupled to variations in fear, anxiety and stress responses. This analysis was done in a 
genetically segregating population of BXD RI mouse strains and harvests the power of 
natural variations to uncover multiple genes and gene-networks. This stands in contrast to 
the very reductive approach of examining a single or few genes at a time, as is the case 
with most gene knockout and transgenic studies. Genetic mapping of the BLA traits 
uncovered multiple QTLs linked to the BLA neuroanatomy (Vol8a in Chr 8, and loci on 
Chrs 11 and 13). This study implicated genes with no prior known association with the 
BLA (e.g., Large, Neurocan), and also genes already known to be involved in the 
development of the BLA, e.g., NeuroD2 (Lin et al., 2005). 
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Following the morphometric and QTL analyses, the second step was to examine 
whether the variation in BLA neuroanatomy could indeed predict behavioral outcome. A 
correlative analysis with a variety of behavioral traits collected from the BXD strains 
showed significant correlations between the BLA and emotion- and addiction-related 
behavior. A systematic analysis was also done to compare the behaviors of BXD strains 
with small, medium, and large BLAs. The three groups of BXD strains showed 
significant differences in fear learning and stress reactivity. Mice with smaller BLA 
volumes showed significantly higher fear responses to conditioned auditory stimuli and 
contextual stimuli. The smaller BLA group also showed a more pronounced 
glucocorticoid response to stress. Given that the neuroanatomical data and behavioral 
data were collected from two different sites (UTHSC and NIH, respectively), this 
association between the traits demonstrates the robustness of the effect of BLA size on 
emotion-related processes. 
 
To introduce more genetic diversity, we then went on to survey a panel of seven 
inbred strains (129/SvImJ, A/J, BALB/cJ, BALB/cByJ, FVBN/J, and B6 and D2) for 
emotion-related behavior. We also asked how these strains differed in their relative 
vulnerability to stressful experience by examining their behavior prior to, and following 
stress. We found that B6 and D2 showed the most interesting divergence in behavior. 
Consistent with previous studies, D2 showed a higher anxiety-like trait compared to B6. 
In addition, while B6 remained relatively resilient to restraint-stress (i.e., this strain 
showed no difference in anxiety-like behavior before and after restraint), D2 mice 
showed heightened anxiety-like behavior after restraint-stress. 
 
In the third step, to elucidate the molecular correlates of such behavioral contrasts, 
we examined gene expression in the amygdala (primarily the BLA) of B6 and D2 mice. 
The prefrontal cortex and hippocampus were also included in the expression analysis as 
these two regions have also been implicated in stress-responsiveness and anxiety-related 
behavior. By comparing both baseline expression between B6 and D2, and expression 
changes following restraint-stress, we hoped to identify genes that contribute to the 
striking trait divergence that characterizes these two strains. This study revealed 
substantial quantitative differences in expression between B6 and D2. There was also 
marked strain difference in the set of genes that showed stress-induced changes in 
expression. Interestingly, several of the genes that were identified by this study have been 
implicated in human neuropsychiatric disorders (e.g. Rgs2, Nr4a2, Comt, and clock genes 
such as Dbp, Per1, Per2, and Per3). 
 
In the fourth step, we sought to identify DNA sequence variants that influence 
both molecular phenotypes as well as phenotypes at the structural and behavioral level. A 
remarkable region located on the distal end of mouse Chr 1 (172–178 Mb) was the ideal 
subject for such an integrative study. This region, which we have named as Qrr1 (QTL 
rich region on distal Chr 1), is known for its unusually high density of QTLs for neural 
and behavioral traits, e.g., traits like anxiety-related behavior, seizure, hippocampal 
volume, and alcohol preference consistently map to this region. Additionally, Qrr1 is also 
an expression QTL hotspot and controls the expression of hundreds of mRNA transcripts 
in neural tissues. Our analysis of Qrr1 uncovered much complexity in this QTL region. 
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Rather than one “master-regulator” gene controlling multiple phenotypes, Qrr1 appears 
to be a complicated cluster of QTLs controlling modules of gene-networks. At the current 
level of resolution, we were able to delineate a proximal region (Qrr1p) in which Kcnj9 is 
a strong candidate, and a distal region (Qrr1d) in which Fmn2 is the strongest candidate. 
Increasing the mapping resolution may be able to further subdivide the proximal and 
distal regions into even finer regulatory loci. This influence on gene expression may be 
the reason why so many classical QTLs have been mapped to Qrr1. 
 
The complexity highlighted by Qrr1 may very well be the rule rather than the 
exception for loci that modulate complex traits. Efforts to fine-map a single QTL have 
often been confronted by clusters of multiple small effect QTLs within the original 
interval (Legare et al., 2000; Demarest et al., 2001). This poses a serious challenge, and 
to date, only a small handful of genes have been definitively identified for complex traits. 
Our own efforts to identify a causal gene were stymied by the compound nature of QTLs 
and the high gene density in Qrr1, and in Vol8a. Furthermore, it is now becoming clear 
that in addition to the canonical candidate genes, there are multiple spliced variants, 
microRNAs, and epigenetic factors to be considered. 
 
With what appears to be an increasingly complex genomic landscape, it is now all 
the more necessary to apply the multipronged approach taken by systems genetics. The 
work expounded in this dissertation is an example of such an integrative approach and 
could be considered as the groundwork for even deeper analyses of the information coded 
in the DNA. Further advancement in genomic technology, higher resolution sequencing 
of the DNA, and more sophisticated statistical and analytical techniques will ultimately 
yield answers that, up to this point, may seem elusive.
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